BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A, Fearnside J, Tatoud R, Blanc V, Lindon JC, Mitchell SC, Holmes E, McCarthy MI, Scott J, Gauguier D, Nicholson JK. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA. 2006;103:12511-12516. [PMID: 16895997 DOI: 10.1073/pnas.0601056103] [Cited by in Crossref: 760] [Cited by in F6Publishing: 694] [Article Influence: 47.5] [Reference Citation Analysis]
Number Citing Articles
1 Davidovic L, Navratil V, Bonaccorso CM, Catania MV, Bardoni B, Dumas ME. A metabolomic and systems biology perspective on the brain of the fragile X syndrome mouse model. Genome Res 2011;21:2190-202. [PMID: 21900387 DOI: 10.1101/gr.116764.110] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 6.6] [Reference Citation Analysis]
2 Huang H, Krishnan HB, Pham Q, Yu LL, Wang TT. Soy and Gut Microbiota: Interaction and Implication for Human Health. J Agric Food Chem 2016;64:8695-709. [PMID: 27798832 DOI: 10.1021/acs.jafc.6b03725] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 9.2] [Reference Citation Analysis]
3 Lau E, Carvalho D, Freitas P. Gut Microbiota: Association with NAFLD and Metabolic Disturbances. Biomed Res Int. 2015;2015:979515. [PMID: 26090468 DOI: 10.1155/2015/979515] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
4 Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, Gu X, Huang Y, Zamanian-Daryoush M, Culley MK, DiDonato AJ, Fu X, Hazen JE, Krajcik D, DiDonato JA, Lusis AJ, Hazen SL. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis. Cell. 2015;163:1585-1595. [PMID: 26687352 DOI: 10.1016/j.cell.2015.11.055] [Cited by in Crossref: 575] [Cited by in F6Publishing: 536] [Article Influence: 95.8] [Reference Citation Analysis]
5 Ohtani N. Microbiome and cancer. Semin Immunopathol. 2015;37:65-72. [PMID: 25404117 DOI: 10.1007/s00281-014-0457-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
6 Zhang Q, Tian F, Zhao J, Zhang H, Zhai Q, Chen W. The influence of dietary patterns on gut microbiome and its consequences for nonalcoholic fatty liver disease. Trends in Food Science & Technology 2020;96:135-44. [DOI: 10.1016/j.tifs.2019.12.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
7 Tripolt NJ, Leber B, Triebl A, Köfeler H, Stadlbauer V, Sourij H. Effect of Lactobacillus casei Shirota supplementation on trimethylamine-N-oxide levels in patients with metabolic syndrome: An open-label, randomized study. Atherosclerosis 2015;242:141-4. [PMID: 26188537 DOI: 10.1016/j.atherosclerosis.2015.05.005] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
8 Maher AD, Crockford D, Toft H, Malmodin D, Faber JH, Mccarthy MI, Barrett A, Allen M, Walker M, Holmes E, Lindon JC, Nicholson JK. Optimization of Human Plasma 1 H NMR Spectroscopic Data Processing for High-Throughput Metabolic Phenotyping Studies and Detection of Insulin Resistance Related to Type 2 Diabetes. Anal Chem 2008;80:7354-62. [DOI: 10.1021/ac801053g] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
9 Rezzi S, Martin FP, Kochhar S. Defining personal nutrition and metabolic health through metabonomics. Ernst Schering Found Symp Proc 2007;:251-64. [PMID: 18811061 DOI: 10.1007/2789_2008_097] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
10 Musso G, Gambino R, Cassader M. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care. 2010;33:2277-2284. [PMID: 20876708 DOI: 10.2337/dc10-0556] [Cited by in Crossref: 360] [Cited by in F6Publishing: 326] [Article Influence: 32.7] [Reference Citation Analysis]
11 Kigerl KA, Hall JC, Wang L, Mo X, Yu Z, Popovich PG. Gut dysbiosis impairs recovery after spinal cord injury. J Exp Med. 2016;213:2603-2620. [PMID: 27810921 DOI: 10.1084/jem.20151345] [Cited by in Crossref: 127] [Cited by in F6Publishing: 123] [Article Influence: 21.2] [Reference Citation Analysis]
12 Conterno L, Fava F, Viola R, Tuohy KM. Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? Genes Nutr. 2011;6:241-260. [PMID: 21559992 DOI: 10.1007/s12263-011-0230-1] [Cited by in Crossref: 138] [Cited by in F6Publishing: 122] [Article Influence: 12.5] [Reference Citation Analysis]
13 Lee CJ, Sears CL, Maruthur N. Gut microbiome and its role in obesity and insulin resistance.Ann N Y Acad Sci. 2020;1461:37-52. [PMID: 31087391 DOI: 10.1111/nyas.14107] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 17.3] [Reference Citation Analysis]
14 Singer BH, Utzinger J, Ryff CD, Wang Y, Holmes E. Exploiting the Potential of Metabonomics in Large Population Studies: Three Venues. The Handbook of Metabonomics and Metabolomics. Elsevier; 2007. pp. 289-325. [DOI: 10.1016/b978-044452841-4/50012-6] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
15 Zhou SS, Xu J, Zhu H, Wu J, Xu JD, Yan R, Li XY, Liu HH, Duan SM, Wang Z, Chen HB, Shen H, Li SL. Gut microbiota-involved mechanisms in enhancing systemic exposure of ginsenosides by coexisting polysaccharides in ginseng decoction. Sci Rep 2016;6:22474. [PMID: 26932472 DOI: 10.1038/srep22474] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 12.7] [Reference Citation Analysis]
16 Bae S, Ulrich CM, Neuhouser ML, Malysheva O, Bailey LB, Xiao L, Brown EC, Cushing-Haugen KL, Zheng Y, Cheng TY, Miller JW, Green R, Lane DS, Beresford SA, Caudill MA. Plasma choline metabolites and colorectal cancer risk in the Women's Health Initiative Observational Study. Cancer Res 2014;74:7442-52. [PMID: 25336191 DOI: 10.1158/0008-5472.CAN-14-1835] [Cited by in Crossref: 118] [Cited by in F6Publishing: 63] [Article Influence: 14.8] [Reference Citation Analysis]
17 Wall R, Ross RP, Shanahan F, O’mahony L, O’mahony C, Coakley M, Hart O, Lawlor P, Quigley EM, Kiely B, Fitzgerald GF, Stanton C. Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues. The American Journal of Clinical Nutrition 2009;89:1393-401. [DOI: 10.3945/ajcn.2008.27023] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 9.3] [Reference Citation Analysis]
18 Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol 2014; 20(43): 16079-16094 [PMID: 25473159 DOI: 10.3748/wjg.v20.i43.16079] [Cited by in CrossRef: 236] [Cited by in F6Publishing: 193] [Article Influence: 29.5] [Reference Citation Analysis]
19 Nishitsuji K, Watanabe S, Xiao J, Nagatomo R, Ogawa H, Tsunematsu T, Umemoto H, Morimoto Y, Akatsu H, Inoue K, Tsuneyama K. Effect of coffee or coffee components on gut microbiome and short-chain fatty acids in a mouse model of metabolic syndrome. Sci Rep. 2018;8:16173. [PMID: 30385796 DOI: 10.1038/s41598-018-34571-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
20 Koopman N, Molinaro A, Nieuwdorp M, Holleboom AG. Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2019;50:628-639. [PMID: 31373710 DOI: 10.1111/apt.15416] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
21 Li JV, Swann J, Marchesi JR. Biology of the Microbiome 2. Gastroenterology Clinics of North America 2017;46:37-47. [DOI: 10.1016/j.gtc.2016.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
22 Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis. Hepatology 2010;52:1836-46. [DOI: 10.1002/hep.24001] [Cited by in Crossref: 1281] [Cited by in F6Publishing: 1207] [Article Influence: 106.8] [Reference Citation Analysis]
23 Ma L, Li H, Hu J, Zheng J, Zhou J, Botchlett R, Matthews D, Zeng T, Chen L, Xiao X, Athrey G, Threadgill DW, Li Q, Glaser S, Francis H, Meng F, Li Q, Alpini G, Wu C. Indole Alleviates Diet-Induced Hepatic Steatosis and Inflammation in a Manner Involving Myeloid Cell 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3. Hepatology 2020;72:1191-203. [PMID: 31953865 DOI: 10.1002/hep.31115] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
24 Zhang X, Wu Q, Zhao Y, Aimy A, Yang X. Consumption of post-fermented Jing-Wei Fuzhuan brick tea alleviates liver dysfunction and intestinal microbiota dysbiosis in high fructose diet-fed mice. RSC Adv 2019;9:17501-13. [DOI: 10.1039/c9ra02473e] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
25 Bao Q, Yu L, Chen D, Li L. Variation in the gut microbial community is associated with the progression of liver regeneration. Hepatol Res 2020;50:121-36. [PMID: 31465626 DOI: 10.1111/hepr.13424] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
26 Chikayama E, Suto M, Nishihara T, Shinozaki K, Kikuchi J. Systematic NMR analysis of stable isotope labeled metabolite mixtures in plant and animal systems: coarse grained views of metabolic pathways. PLoS One 2008;3:e3805. [PMID: 19030231 DOI: 10.1371/journal.pone.0003805] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 5.0] [Reference Citation Analysis]
27 Chen YM, Liu Y, Zhou RF, Chen XL, Wang C, Tan XY, Wang LJ, Zheng RD, Zhang HW, Ling WH, Zhu HL. Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults. Sci Rep. 2016;6:19076. [PMID: 26743949 DOI: 10.1038/srep19076] [Cited by in Crossref: 122] [Cited by in F6Publishing: 124] [Article Influence: 20.3] [Reference Citation Analysis]
28 Al Akeel R. Role of epigenetic reprogramming of host genes in bacterial pathogenesis. Saudi J Biol Sci 2013;20:305-9. [PMID: 24235865 DOI: 10.1016/j.sjbs.2013.05.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
29 Arslan N. Obesity, fatty liver disease and intestinal microbiota. World J Gastroenterol 2014; 20(44): 16452-16463 [PMID: 25469013 DOI: 10.3748/wjg.v20.i44.16452] [Cited by in CrossRef: 92] [Cited by in F6Publishing: 79] [Article Influence: 11.5] [Reference Citation Analysis]
30 Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, Mascianà R, Forgione A, Gabrieli ML, Perotti G, Vecchio FM, Rapaccini G, Gasbarrini G, Day CP, Grieco A. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 2009;49:1877-87. [DOI: 10.1002/hep.22848] [Cited by in Crossref: 785] [Cited by in F6Publishing: 768] [Article Influence: 60.4] [Reference Citation Analysis]
31 Shanahan F, Kiely B. The gut microbiota and disease – an inner repository for drug discovery. Drug Discovery Today: Therapeutic Strategies 2007;4:195-200. [DOI: 10.1016/j.ddstr.2008.02.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
32 Wang X, Zhao T, Qiu Y, Su M, Jiang T, Zhou M, Zhao A, Jia W. Metabonomics Approach to Understanding Acute and Chronic Stress in Rat Models. J Proteome Res 2009;8:2511-8. [DOI: 10.1021/pr801086k] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
33 Kessoku T, Kobayashi T, Tanaka K, Yamamoto A, Takahashi K, Iwaki M, Ozaki A, Kasai Y, Nogami A, Honda Y, Ogawa Y, Kato S, Imajo K, Higurashi T, Hosono K, Yoneda M, Usuda H, Wada K, Saito S, Nakajima A. The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target. Int J Mol Sci 2021;22:8161. [PMID: 34360923 DOI: 10.3390/ijms22158161] [Reference Citation Analysis]
34 Zhang X, Yap Y, Wei D, Chen G, Chen F. Novel omics technologies in nutrition research. Biotechnology Advances 2008;26:169-76. [DOI: 10.1016/j.biotechadv.2007.11.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
35 Waldram A, Holmes E, Wang Y, Rantalainen M, Wilson ID, Tuohy KM, McCartney AL, Gibson GR, Nicholson JK. Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. J Proteome Res. 2009;8:2361-2375. [PMID: 19275195 DOI: 10.1021/pr8009885] [Cited by in Crossref: 175] [Cited by in F6Publishing: 156] [Article Influence: 13.5] [Reference Citation Analysis]
36 Gerges SH, Wahdan SA, Elsherbiny DA, El-Demerdash E. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Life Sci 2021;271:119220. [PMID: 33592199 DOI: 10.1016/j.lfs.2021.119220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
37 Rezzonico E, Mestdagh R, Delley M, Combremont S, Dumas ME, Holmes E, Nicholson J, Bibiloni R. Bacterial adaptation to the gut environment favors successful colonization: microbial and metabonomic characterization of a simplified microbiota mouse model. Gut Microbes 2011;2:307-18. [PMID: 22157236 DOI: 10.4161/gmic.18754] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
38 Dessein R, Rosenstiel P, Chamaillard M. Debugging the intestinal microbiota in IBD. Gastroenterol Clin Biol 2009;33 Suppl 3:S131-6. [PMID: 20117336 DOI: 10.1016/S0399-8320(09)73148-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
39 Han H, Jiang Y, Wang M, Melaku M, Liu L, Zhao Y, Everaert N, Yi B, Zhang H. Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut-liver axis. Crit Rev Food Sci Nutr 2021;:1-18. [PMID: 34404276 DOI: 10.1080/10408398.2021.1966738] [Reference Citation Analysis]
40 Schnackenberg LK. Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st century. Expert Rev Mol Diagn 2007;7:247-59. [PMID: 17489732 DOI: 10.1586/14737159.7.3.247] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
41 Moran-Ramos S, López-Contreras BE, Canizales-Quinteros S. Gut Microbiota in Obesity and Metabolic Abnormalities: A Matter of Composition or Functionality? Arch Med Res 2017;48:735-53. [PMID: 29292011 DOI: 10.1016/j.arcmed.2017.11.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
42 Abdollahi-Roodsaz S, Abramson SB, Scher JU. The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions. Nat Rev Rheumatol. 2016;12:446-455. [PMID: 27256713 DOI: 10.1038/nrrheum.2016.68] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 11.2] [Reference Citation Analysis]
43 Hasanpour M, Iranshahy M, Iranshahi M. The application of metabolomics in investigating anti-diabetic activity of medicinal plants. Biomedicine & Pharmacotherapy 2020;128:110263. [DOI: 10.1016/j.biopha.2020.110263] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
44 Duarte SMB, Stefano JT, Oliveira CP. Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH). Ann Hepatol 2019;18:416-21. [PMID: 31036494 DOI: 10.1016/j.aohep.2019.04.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
45 Anstee QM, Concas D, Kudo H, Levene A, Pollard J, Charlton P, Thomas HC, Thursz MR, Goldin RD. Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis. J Hepatol. 2010;53:542-550. [PMID: 20557969 DOI: 10.1016/j.jhep.2010.03.016] [Cited by in Crossref: 108] [Cited by in F6Publishing: 104] [Article Influence: 9.0] [Reference Citation Analysis]
46 Martinez KB, Leone V, Chang EB. Microbial metabolites in health and disease: Navigating the unknown in search of function. J Biol Chem. 2017;292:8553-8559. [PMID: 28389566 DOI: 10.1074/jbc.r116.752899] [Cited by in Crossref: 59] [Cited by in F6Publishing: 35] [Article Influence: 11.8] [Reference Citation Analysis]
47 Cho MS, Kim SY, Suk KT, Kim BY. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics. J Microbiol. 2018;56:855-867. [PMID: 30377993 DOI: 10.1007/s12275-018-8346-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
48 Martin FP, Wang Y, Sprenger N, Yap IK, Lundstedt T, Lek P, Rezzi S, Ramadan Z, van Bladeren P, Fay LB. Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol Syst Biol. 2008;4:157. [PMID: 18197175 DOI: 10.1038/msb4100190] [Cited by in Crossref: 274] [Cited by in F6Publishing: 257] [Article Influence: 19.6] [Reference Citation Analysis]
49 Chao J, Cheng HY, Chang ML, Huang SS, Liao JW, Cheng YC, Peng WH, Pao LH. Gallic Acid Ameliorated Impaired Lipid Homeostasis in a Mouse Model of High-Fat Diet-and Streptozotocin-Induced NAFLD and Diabetes through Improvement of β-oxidation and Ketogenesis. Front Pharmacol 2020;11:606759. [PMID: 33643038 DOI: 10.3389/fphar.2020.606759] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
50 Wang D, Wang X, Zhang P, Wang Y, Zhang R, Yan J, Zhou Z, Zhu W. The fate of technical-grade chlordane in mice fed a high-fat diet and its roles as a candidate obesogen. Environ Pollut 2017;222:532-42. [PMID: 28041837 DOI: 10.1016/j.envpol.2016.11.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
51 Burgio E, Lopomo A, Migliore L. Obesity and diabetes: from genetics to epigenetics. Mol Biol Rep 2015;42:799-818. [DOI: 10.1007/s11033-014-3751-z] [Cited by in Crossref: 60] [Cited by in F6Publishing: 42] [Article Influence: 7.5] [Reference Citation Analysis]
52 Xue BC, Zhang JX, Wang ZS, Wang LZ, Peng QH, Da LC, Bao SK, Kong XY, Xue B. Metabolism response of grazing yak to dietary concentrate supplementation in warm season. Animal 2021;15:100175. [PMID: 33610519 DOI: 10.1016/j.animal.2021.100175] [Reference Citation Analysis]
53 Yan S, Shi R, Li L, Ma S, Zhang H, Ye J, Wang J, Pan J, Wang Q, Jin X, Liu X, Liu Z. Mannan Oligosaccharide Suppresses Lipid Accumulation and Appetite in Western-Diet-Induced Obese Mice Via Reshaping Gut Microbiome and Enhancing Short-Chain Fatty Acids Production. Mol Nutr Food Res 2019;63:e1900521. [PMID: 31487425 DOI: 10.1002/mnfr.201900521] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
54 Donohoe DR, Bultman SJ. Metaboloepigenetics: interrelationships between energy metabolism and epigenetic control of gene expression. J Cell Physiol 2012;227:3169-77. [PMID: 22261928 DOI: 10.1002/jcp.24054] [Cited by in Crossref: 143] [Cited by in F6Publishing: 125] [Article Influence: 14.3] [Reference Citation Analysis]
55 Wu Q, Wu S, Cheng Y, Zhang Z, Mao G, Li S, Yang Y, Zhang X, Wu M, Tong H. Sargassum fusiforme fucoidan modifies gut microbiota and intestinal metabolites during alleviation of hyperglycemia in type 2 diabetic mice. Food Funct 2021;12:3572-85. [PMID: 33900346 DOI: 10.1039/d0fo03329d] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
56 Ye J, Haskey N, Dadlani H, Zubaidi H, Barnett JA, Ghosh S, Gibson DL. Deletion of mucin 2 induces colitis with concomitant metabolic abnormalities in mice. Am J Physiol Gastrointest Liver Physiol 2021;320:G791-803. [PMID: 33728986 DOI: 10.1152/ajpgi.00277.2020] [Reference Citation Analysis]
57 Li A, Liu B, Li F, He Y, Wang L, Fakhar-E-Alam Kulyar M, Li H, Fu Y, Zhu H, Wang Y, Jiang X. Integrated Bacterial and Fungal Diversity Analysis Reveals the Gut Microbial Alterations in Diarrheic Giraffes. Front Microbiol 2021;12:712092. [PMID: 34475863 DOI: 10.3389/fmicb.2021.712092] [Reference Citation Analysis]
58 Tranchida F, Rakotoniaina Z, Shintu L, Tchiakpe L, Deyris V, Yemloul M, Stocker P, Vidal N, Rimet O, Hiol A, Caldarelli S. Hepatic metabolic effects of Curcuma longa extract supplement in high-fructose and saturated fat fed rats. Sci Rep 2017;7:5880. [PMID: 28724959 DOI: 10.1038/s41598-017-06220-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
59 Hoyles L, Fernández-Real JM, Federici M, Serino M, Abbott J, Charpentier J, Heymes C, Luque JL, Anthony E, Barton RH, Chilloux J, Myridakis A, Martinez-Gili L, Moreno-Navarrete JM, Benhamed F, Azalbert V, Blasco-Baque V, Puig J, Xifra G, Ricart W, Tomlinson C, Woodbridge M, Cardellini M, Davato F, Cardolini I, Porzio O, Gentileschi P, Lopez F, Foufelle F, Butcher SA, Holmes E, Nicholson JK, Postic C, Burcelin R, Dumas ME. Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. Nat Med 2018;24:1070-80. [PMID: 29942096 DOI: 10.1038/s41591-018-0061-3] [Cited by in Crossref: 214] [Cited by in F6Publishing: 197] [Article Influence: 53.5] [Reference Citation Analysis]
60 Murphy EF, Clarke SF, Marques TM, Hill C, Stanton C, Ross RP, O'Doherty RM, Shanahan F, Cotter PD. Antimicrobials: Strategies for targeting obesity and metabolic health? Gut Microbes 2013;4:48-53. [PMID: 23018760 DOI: 10.4161/gmic.22328] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
61 Dewulf EM, Cani PD, Claus SP, Fuentes S, Puylaert PG, Neyrinck AM, Bindels LB, de Vos WM, Gibson GR, Thissen JP. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut. 2013;62:1112-1121. [PMID: 23135760 DOI: 10.1136/gutjnl-2012-303304] [Cited by in Crossref: 426] [Cited by in F6Publishing: 386] [Article Influence: 42.6] [Reference Citation Analysis]
62 Greiner T, Bäckhed F. Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol Metab. 2011;22:117-123. [PMID: 21353592 DOI: 10.1016/j.tem.2011.01.002] [Cited by in Crossref: 188] [Cited by in F6Publishing: 171] [Article Influence: 17.1] [Reference Citation Analysis]
63 Shanahan F. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: host-microbe interactions in the gut: target for drug therapy, opportunity for drug discovery. Clin Exp Immunol 2010;160:92-7. [PMID: 20415857 DOI: 10.1111/j.1365-2249.2010.04135.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
64 Maher AD, Lindon JC, Nicholson JK. 1 H NMR-based metabonomics for investigating diabetes. Future Medicinal Chemistry 2009;1:737-47. [DOI: 10.4155/fmc.09.54] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
65 Wilson ID. Drugs, bugs, and personalized medicine: pharmacometabonomics enters the ring. Proc Natl Acad Sci U S A 2009;106:14187-8. [PMID: 19706501 DOI: 10.1073/pnas.0907721106] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 5.0] [Reference Citation Analysis]
66 Yan SK, Wei BJ, Lin ZY, Yang Y, Zhou ZT, Zhang WD. A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia. Oral Oncol. 2008;44:477-483. [PMID: 17936673 DOI: 10.1016/j.oraloncology.2007.06.007] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 4.1] [Reference Citation Analysis]
67 Li DY, Yang M, Edwards S, Ye SQ. Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota? JPEN J Parenter Enteral Nutr. 2013;37:787-793. [PMID: 23538296 DOI: 10.1177/0148607113481623] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
68 Sanmiguel C, Gupta A, Mayer EA. Gut Microbiome and Obesity: A Plausible Explanation for Obesity. Curr Obes Rep. 2015;4:250-261. [PMID: 26029487 DOI: 10.1007/s13679-015-0152-0] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 13.2] [Reference Citation Analysis]
69 Marrero I, Maricic I, Feldstein AE, Loomba R, Schnabl B, Rivera-Nieves J, Eckmann L, Kumar V. Complex Network of NKT Cell Subsets Controls Immune Homeostasis in Liver and Gut. Front Immunol 2018;9:2082. [PMID: 30254647 DOI: 10.3389/fimmu.2018.02082] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
70 Betrapally NS, Gillevet PM, Bajaj JS. Gut microbiome and liver disease. Transl Res. 2017;179:49-59. [PMID: 27477080 DOI: 10.1016/j.trsl.2016.07.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 7.2] [Reference Citation Analysis]
71 Zhou JW, Muhammad J, Sun B, Yang R, Wadood A, Wang JS, Jia AQ. Metabolomic analysis of quorum sensing inhibitor hordenine on Pseudomonas aeruginosa. Appl Microbiol Biotechnol 2019;103:6271-85. [PMID: 31161392 DOI: 10.1007/s00253-019-09878-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
72 Goldsmith JR, Sartor RB. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol. 2014;49:785-798. [PMID: 24652102 DOI: 10.1007/s00535-014-0953-z] [Cited by in Crossref: 115] [Cited by in F6Publishing: 109] [Article Influence: 14.4] [Reference Citation Analysis]
73 Patterson E, Cryan JF, Fitzgerald GF, Ross RP, Dinan TG, Stanton C. Gut microbiota, the pharmabiotics they produce and host health. Proc Nutr Soc 2014;73:477-89. [PMID: 25196939 DOI: 10.1017/S0029665114001426] [Cited by in Crossref: 79] [Cited by in F6Publishing: 33] [Article Influence: 9.9] [Reference Citation Analysis]
74 Pietzner M, Budde K, Homuth G, Kastenmüller G, Henning AK, Artati A, Krumsiek J, Völzke H, Adamski J, Lerch MM, Kühn JP, Nauck M, Friedrich N. Hepatic Steatosis Is Associated With Adverse Molecular Signatures in Subjects Without Diabetes. J Clin Endocrinol Metab 2018;103:3856-68. [PMID: 30060179 DOI: 10.1210/jc.2018-00999] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
75 Aw W, Fukuda S. Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach. Semin Immunopathol 2015;37:5-16. [PMID: 25338280 DOI: 10.1007/s00281-014-0456-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
76 Brennan L. Session 2: Personalised nutrition Metabolomic applications in nutritional research: Symposium on ‘The challenge of translating nutrition research into public health nutrition’. Proc Nutr Soc 2008;67:404-8. [DOI: 10.1017/s0029665108008719] [Cited by in Crossref: 34] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
77 Serino M. Molecular Paths Linking Metabolic Diseases, Gut Microbiota Dysbiosis and Enterobacteria Infections. J Mol Biol. 2018;430:581-590. [PMID: 29374557 DOI: 10.1016/j.jmb.2018.01.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
78 Dall'Oglio F, Milani M, Micali G. Effects of oral supplementation with FOS and GOS prebiotics in women with adult acne: the "S.O. Sweet" study: a proof-of-concept pilot trial. Clin Cosmet Investig Dermatol 2018;11:445-9. [PMID: 30349341 DOI: 10.2147/CCID.S179627] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Zhang LS, Davies SS. Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med. 2016;8:46. [PMID: 27102537 DOI: 10.1186/s13073-016-0296-x] [Cited by in Crossref: 238] [Cited by in F6Publishing: 221] [Article Influence: 39.7] [Reference Citation Analysis]
80 Zhang C, Yin A, Li H, Wang R, Wu G, Shen J, Zhang M, Wang L, Hou Y, Ouyang H, Zhang Y, Zheng Y, Wang J, Lv X, Wang Y, Zhang F, Zeng B, Li W, Yan F, Zhao Y, Pang X, Zhang X, Fu H, Chen F, Zhao N, Hamaker BR, Bridgewater LC, Weinkove D, Clement K, Dore J, Holmes E, Xiao H, Zhao G, Yang S, Bork P, Nicholson JK, Wei H, Tang H, Zhang X, Zhao L. Dietary Modulation of Gut Microbiota Contributes to Alleviation of Both Genetic and Simple Obesity in Children. EBioMedicine 2015;2:968-84. [PMID: 26425705 DOI: 10.1016/j.ebiom.2015.07.007] [Cited by in Crossref: 156] [Cited by in F6Publishing: 156] [Article Influence: 22.3] [Reference Citation Analysis]
81 Kessoku T, Kobayashi T, Imajo K, Tanaka K, Yamamoto A, Takahashi K, Kasai Y, Ozaki A, Iwaki M, Nogami A, Honda Y, Ogawa Y, Kato S, Higurashi T, Hosono K, Yoneda M, Okamoto T, Usuda H, Wada K, Kobayashi N, Saito S, Nakajima A. Endotoxins and Non-Alcoholic Fatty Liver Disease. Front Endocrinol (Lausanne) 2021;12:770986. [PMID: 34777261 DOI: 10.3389/fendo.2021.770986] [Reference Citation Analysis]
82 Fukui H. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far? Diseases. 2019;7. [PMID: 31726747 DOI: 10.3390/diseases7040058] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
83 Yin P, Wan D, Zhao C, Chen J, Zhao X, Wang W, Lu X, Yang S, Gu J, Xu G. A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry. Mol Biosyst 2009;5:868-76. [PMID: 19603122 DOI: 10.1039/b820224a] [Cited by in Crossref: 159] [Cited by in F6Publishing: 150] [Article Influence: 12.2] [Reference Citation Analysis]
84 Fava F, Gitau R, Griffin BA, Gibson GR, Tuohy KM, Lovegrove JA. The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome 'at-risk' population. Int J Obes (Lond). 2013;37:216-223. [PMID: 22410962 DOI: 10.1038/ijo.2012.33] [Cited by in Crossref: 223] [Cited by in F6Publishing: 190] [Article Influence: 22.3] [Reference Citation Analysis]
85 Sun Y, He Z, Li J, Gong S, Yuan S, Li T, Ning N, Xing L, Zhang L, Chen F, Li Z, Wang J, Luo D, Wang H. Gentamicin Induced Microbiome Adaptations Associate With Increased BCAA Levels and Enhance Severity of Influenza Infection. Front Immunol 2020;11:608895. [PMID: 33708192 DOI: 10.3389/fimmu.2020.608895] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Spagou K, Theodoridis G, Wilson I, Raikos N, Greaves P, Edwards R, Nolan B, Klapa MI. A GC-MS metabolic profiling study of plasma samples from mice on low- and high-fat diets. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879:1467-75. [PMID: 21388899 DOI: 10.1016/j.jchromb.2011.01.028] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
87 Canyelles M, Tondo M, Cedó L, Farràs M, Escolà-Gil JC, Blanco-Vaca F. Trimethylamine N-Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function. Int J Mol Sci 2018;19:E3228. [PMID: 30347638 DOI: 10.3390/ijms19103228] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 16.8] [Reference Citation Analysis]
88 Qin C, Gong L, Zhang X, Wang Y, Wang Y, Wang B, Li Y, Li W. Effect of Saccharomyces boulardii and Bacillus subtilis B10 on gut microbiota modulation in broilers. Anim Nutr 2018;4:358-66. [PMID: 30564755 DOI: 10.1016/j.aninu.2018.03.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
89 Gao X, Liu X, Xu J, Xue C, Xue Y, Wang Y. Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet. J Biosci Bioeng 2014;118:476-81. [PMID: 24721123 DOI: 10.1016/j.jbiosc.2014.03.001] [Cited by in Crossref: 152] [Cited by in F6Publishing: 148] [Article Influence: 19.0] [Reference Citation Analysis]
90 Portincasa P, Bonfrate L, Khalil M, Angelis MD, Calabrese FM, D’amato M, Wang DQ, Di Ciaula A. Intestinal Barrier and Permeability in Health, Obesity and NAFLD. Biomedicines 2022;10:83. [DOI: 10.3390/biomedicines10010083] [Reference Citation Analysis]
91 Migliozzi M, Thavarajah D, Thavarajah P, Smith P. Lentil and Kale: Complementary Nutrient-Rich Whole Food Sources to Combat Micronutrient and Calorie Malnutrition. Nutrients 2015;7:9285-98. [PMID: 26569296 DOI: 10.3390/nu7115471] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
92 Sharpton SR, Ajmera V, Loomba R. Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function. Clin Gastroenterol Hepatol 2019;17:296-306. [PMID: 30196156 DOI: 10.1016/j.cgh.2018.08.065] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 15.5] [Reference Citation Analysis]
93 Bang JW, Crockford DJ, Holmes E, Pazos F, Sternberg MJ, Muggleton SH, Nicholson JK. Integrative top-down system metabolic modeling in experimental disease states via data-driven Bayesian methods. J Proteome Res 2008;7:497-503. [PMID: 18179164 DOI: 10.1021/pr070350l] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
94 Kussmann M, Van Bladeren PJ. The Extended Nutrigenomics - Understanding the Interplay between the Genomes of Food, Gut Microbes, and Human Host. Front Genet 2011;2:21. [PMID: 22303317 DOI: 10.3389/fgene.2011.00021] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
95 Shrinet J, Shastri JS, Gaind R, Bhavesh NS, Sunil S. Serum metabolomics analysis of patients with chikungunya and dengue mono/co-infections reveals distinct metabolite signatures in the three disease conditions. Sci Rep 2016;6:36833. [PMID: 27845374 DOI: 10.1038/srep36833] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
96 Keun HC, Athersuch TJ. Application of metabonomics in drug development. Pharmacogenomics 2007;8:731-41. [DOI: 10.2217/14622416.8.7.731] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
97 Hazen SL, Smith JD. An antiatherosclerotic signaling cascade involving intestinal microbiota, microRNA-10b, and ABCA1/ABCG1-mediated reverse cholesterol transport. Circ Res 2012;111:948-50. [PMID: 23023503 DOI: 10.1161/CIRCRESAHA.112.277277] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
98 Corbin KD, Zeisel SH. The nutrigenetics and nutrigenomics of the dietary requirement for choline. Prog Mol Biol Transl Sci 2012;108:159-77. [PMID: 22656377 DOI: 10.1016/B978-0-12-398397-8.00007-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
99 Jiang C, Xie C, Li F, Zhang L, Nichols RG, Krausz KW, Cai J, Qi Y, Fang ZZ, Takahashi S, Tanaka N, Desai D, Amin SG, Albert I, Patterson AD, Gonzalez FJ. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. J Clin Invest. 2015;125:386-402. [PMID: 25500885 DOI: 10.1172/jci76738] [Cited by in Crossref: 330] [Cited by in F6Publishing: 216] [Article Influence: 41.3] [Reference Citation Analysis]
100 Liu CC, Wu YF, Feng GM, Gao XX, Zhou YZ, Hou WJ, Qin XM, Du GH, Tian JS. Plasma-metabolite-biomarkers for the therapeutic response in depressed patients by the traditional Chinese medicine formula Xiaoyaosan: A (1)H NMR-based metabolomics approach. J Affect Disord 2015;185:156-63. [PMID: 26186531 DOI: 10.1016/j.jad.2015.05.005] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 6.6] [Reference Citation Analysis]
101 Claus SP, Tsang TM, Wang Y, Cloarec O, Skordi E, Martin FP, Rezzi S, Ross A, Kochhar S, Holmes E. Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol Syst Biol. 2008;4:219. [PMID: 18854818 DOI: 10.1038/msb.2008.56] [Cited by in Crossref: 245] [Cited by in F6Publishing: 216] [Article Influence: 17.5] [Reference Citation Analysis]
102 Guo W, Jiang C, Yang L, Li T, Liu X, Jin M, Qu K, Chen H, Jin X, Liu H, Zhu H, Wang Y. Quantitative Metabolomic Profiling of Plasma, Urine, and Liver Extracts by 1H NMR Spectroscopy Characterizes Different Stages of Atherosclerosis in Hamsters. J Proteome Res 2016;15:3500-10. [PMID: 27570155 DOI: 10.1021/acs.jproteome.6b00179] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
103 Demir M, Lang S, Martin A, Farowski F, Wisplinghoff H, Vehreschild MJGT, Krawczyk M, Nowag A, Scholz CJ, Kretzschmar A, Roderburg C, Lammert F, Goeser T, Kasper P, Steffen HM. Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time? J Gastroenterol Hepatol 2020;35:1969-77. [PMID: 32267559 DOI: 10.1111/jgh.15071] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
104 Zhao L, Ni Y, Su M, Li H, Dong F, Chen W, Wei R, Zhang L, Guiraud SP, Martin FP, Rajani C, Xie G, Jia W. High Throughput and Quantitative Measurement of Microbial Metabolome by Gas Chromatography/Mass Spectrometry Using Automated Alkyl Chloroformate Derivatization. Anal Chem 2017;89:5565-77. [PMID: 28437060 DOI: 10.1021/acs.analchem.7b00660] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 10.6] [Reference Citation Analysis]
105 Bian HX, Wu ZY, Bao B, Cai J, Wang X, Jiang Y, Liu J, Qu W. 1H NMR-based metabolic study reveals the improvements of bitter melon (Momordica charantia) on energy metabolism in diet-induced obese mouse. Pharm Biol 2016;54:3103-12. [PMID: 27538854 DOI: 10.1080/13880209.2016.1211713] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
106 Kho ZY, Lal SK. The Human Gut Microbiome - A Potential Controller of Wellness and Disease. Front Microbiol 2018;9:1835. [PMID: 30154767 DOI: 10.3389/fmicb.2018.01835] [Cited by in Crossref: 285] [Cited by in F6Publishing: 221] [Article Influence: 71.3] [Reference Citation Analysis]
107 Krueger ES, Lloyd TS, Tessem JS. The Accumulation and Molecular Effects of Trimethylamine N-Oxide on Metabolic Tissues: It's Not All Bad. Nutrients 2021;13:2873. [PMID: 34445033 DOI: 10.3390/nu13082873] [Reference Citation Analysis]
108 Barton RH, Waterman D, Bonner FW, Holmes E, Clarke R, Nicholson JK, Lindon JC; Procardis Consortium. The influence of EDTA and citrate anticoagulant addition to human plasma on information recovery from NMR-based metabolic profiling studies. Mol Biosyst 2010;6:215-24. [PMID: 20024083 DOI: 10.1039/b907021d] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
109 Ong HS, Yim HCH. Microbial Factors in Inflammatory Diseases and Cancers. Adv Exp Med Biol 2017;1024:153-74. [PMID: 28921469 DOI: 10.1007/978-981-10-5987-2_7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
110 Solga SF. Breath volatile organic compounds for the gut-fatty liver axis: Promise, peril, and path forward. World J Gastroenterol 2014; 20(27): 9017-9025 [PMID: 25083075 DOI: 10.3748/wjg.v20.i27.9017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
111 Alkasir R, Li J, Li X, Jin M, Zhu B. Human gut microbiota: the links with dementia development. Protein Cell 2017;8:90-102. [PMID: 27866330 DOI: 10.1007/s13238-016-0338-6] [Cited by in Crossref: 100] [Cited by in F6Publishing: 99] [Article Influence: 16.7] [Reference Citation Analysis]
112 Allayee H, Hazen SL. Contribution of Gut Bacteria to Lipid Levels: Another Metabolic Role for Microbes? Circ Res 2015;117:750-4. [PMID: 26450886 DOI: 10.1161/CIRCRESAHA.115.307409] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
113 Boursier J, Diehl AM. Implication of gut microbiota in nonalcoholic fatty liver disease. PLoS Pathog. 2015;11:e1004559. [PMID: 25625278 DOI: 10.1371/journal.ppat.1004559] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 10.3] [Reference Citation Analysis]
114 Li M, Wang B, Zhang M, Rantalainen M, Wang S, Zhou H, Zhang Y, Shen J, Pang X, Zhang M, Wei H, Chen Y, Lu H, Zuo J, Su M, Qiu Y, Jia W, Xiao C, Smith LM, Yang S, Holmes E, Tang H, Zhao G, Nicholson JK, Li L, Zhao L. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A 2008;105:2117-22. [PMID: 18252821 DOI: 10.1073/pnas.0712038105] [Cited by in Crossref: 749] [Cited by in F6Publishing: 696] [Article Influence: 53.5] [Reference Citation Analysis]
115 Zha W, A J, Wang G, Yan B, Gu S, Zhu X, Hao H, Huang Q, Sun J, Zhang Y, Cao B, Ren H. Metabonomic characterization of early atherosclerosis in hamsters with induced cholesterol. Biomarkers 2009;14:372-80. [DOI: 10.1080/13547500903026401] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
116 Salzman NH, Bevins CL. Dysbiosis--a consequence of Paneth cell dysfunction. Semin Immunol 2013;25:334-41. [PMID: 24239045 DOI: 10.1016/j.smim.2013.09.006] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 5.9] [Reference Citation Analysis]
117 Rudzki L, Stone TW, Maes M, Misiak B, Samochowiec J, Szulc A. Gut microbiota-derived vitamins - underrated powers of a multipotent ally in psychiatric health and disease. Prog Neuropsychopharmacol Biol Psychiatry 2021;107:110240. [PMID: 33428888 DOI: 10.1016/j.pnpbp.2020.110240] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
118 Safari Z, Gérard P. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cell Mol Life Sci 2019;76:1541-58. [PMID: 30683985 DOI: 10.1007/s00018-019-03011-w] [Cited by in Crossref: 101] [Cited by in F6Publishing: 91] [Article Influence: 33.7] [Reference Citation Analysis]
119 [DOI: 10.1101/225581] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Dai X, Wang B. Role of gut barrier function in the pathogenesis of nonalcoholic Fatty liver disease. Gastroenterol Res Pract 2015;2015:287348. [PMID: 25945084 DOI: 10.1155/2015/287348] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
121 Eswaran S, Babbar A, Drescher HK, Hitch TCA, Clavel T, Muschaweck M, Ritz T, Kroy DC, Trautwein C, Wagner N, Schippers A. Upregulation of Anti-Oxidative Stress Response Improves Metabolic Changes in L-Selectin-Deficient Mice but Does Not Prevent NAFLD Progression or Fecal Microbiota Shifts. Int J Mol Sci 2021;22:7314. [PMID: 34298930 DOI: 10.3390/ijms22147314] [Reference Citation Analysis]
122 Ashrafian H, Li JV, Spagou K, Harling L, Masson P, Darzi A, Nicholson JK, Holmes E, Athanasiou T. Bariatric surgery modulates circulating and cardiac metabolites. J Proteome Res. 2014;13:570-580. [PMID: 24279706 DOI: 10.1021/pr400748f] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
123 Wang Z, Tang WH, Buffa JA, Fu X, Britt EB, Koeth RA, Levison BS, Fan Y, Wu Y, Hazen SL. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. Eur Heart J 2014;35:904-10. [PMID: 24497336 DOI: 10.1093/eurheartj/ehu002] [Cited by in Crossref: 321] [Cited by in F6Publishing: 304] [Article Influence: 40.1] [Reference Citation Analysis]
124 Neves AL, Chilloux J, Sarafian MH, Rahim MB, Boulangé CL, Dumas ME. The microbiome and its pharmacological targets: therapeutic avenues in cardiometabolic diseases. Curr Opin Pharmacol 2015;25:36-44. [PMID: 26531326 DOI: 10.1016/j.coph.2015.09.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
125 Hrncir T, Hrncirova L, Kverka M, Hromadka R, Machova V, Trckova E, Kostovcikova K, Kralickova P, Krejsek J, Tlaskalova-Hogenova H. Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions. Microorganisms 2021;9:957. [PMID: 33946843 DOI: 10.3390/microorganisms9050957] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
126 Scorletti E, Calder PC, Byrne CD. Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments. Endocrine 2011;40:332-43. [DOI: 10.1007/s12020-011-9530-x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
127 Li M, Rajani C, Zheng X, Jia W. The microbial metabolome in metabolic‐associated fatty liver disease. Journal of Gastroenterology and Hepatology. [DOI: 10.1111/jgh.15746] [Reference Citation Analysis]
128 Hartmann P, Schnabl B. New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease. Semin Liver Dis 2021;41:87-102. [PMID: 33957682 DOI: 10.1055/s-0040-1719174] [Reference Citation Analysis]
129 Gauguier D, Dumas M. Métabonomique et cartographie génétique. Med Sci (Paris) 2007;23:1091-4. [DOI: 10.1051/medsci/200723121091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
130 Shanahan F. From bugs to drugs—Mining the gut microbiota. Curr Gastroenterol Rep 2008;10:515-6. [DOI: 10.1007/s11894-008-0094-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
131 Forcisi S, Moritz F, Kanawati B, Tziotis D, Lehmann R, Schmitt-kopplin P. Liquid chromatography–mass spectrometry in metabolomics research: Mass analyzers in ultra high pressure liquid chromatography coupling. Journal of Chromatography A 2013;1292:51-65. [DOI: 10.1016/j.chroma.2013.04.017] [Cited by in Crossref: 114] [Cited by in F6Publishing: 91] [Article Influence: 12.7] [Reference Citation Analysis]
132 Fabbiano S, Suárez-Zamorano N, Trajkovski M. Host-Microbiota Mutualism in Metabolic Diseases. Front Endocrinol (Lausanne) 2017;8:267. [PMID: 29056925 DOI: 10.3389/fendo.2017.00267] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
133 Toye AA, Dumas ME, Blancher C, Rothwell AR, Fearnside JF, Wilder SP, Bihoreau MT, Cloarec O, Azzouzi I, Young S, Barton RH, Holmes E, McCarthy MI, Tatoud R, Nicholson JK, Scott J, Gauguier D. Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice. Diabetologia 2007;50:1867-79. [PMID: 17618414 DOI: 10.1007/s00125-007-0738-5] [Cited by in F6Publishing: 81] [Reference Citation Analysis]
134 Zhou XL, Yan BB, Xiao Y, Zhou YM, Liu TY. Tartary buckwheat protein prevented dyslipidemia in high-fat diet-fed mice associated with gut microbiota changes. Food Chem Toxicol 2018;119:296-301. [PMID: 29481895 DOI: 10.1016/j.fct.2018.02.052] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
135 Zhou C, Li G, Li Y, Gong L, Huang Y, Shi Z, Du S, Li Y, Wang M, Yin J, Sun C. A high-throughput metabolomic approach to explore the regulatory effect of mangiferin on metabolic network disturbances of hyperlipidemia rats. Mol BioSyst 2015;11:418-33. [DOI: 10.1039/c4mb00421c] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
136 Gu S, Cao B, Sun R, Tang Y, Paletta JL, Wu X, Liu L, Zha W, Zhao C, Li Y, Ridlon JM, Hylemon PB, Zhou H, Aa J, Wang G. A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine. Mol Biosyst 2015;11:463-74. [PMID: 25411028 DOI: 10.1039/c4mb00500g] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
137 Minami S, Miura K, Ishioka M, Morimoto N, Isoda N, Yamamoto H, Iijima K. Homocysteine supplementation ameliorates steatohepatitis induced by a choline-deficient diet in mice. Hepatol Res 2019;49:189-200. [PMID: 30048033 DOI: 10.1111/hepr.13234] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
138 Yadav M, Verma MK, Chauhan NS. A review of metabolic potential of human gut microbiome in human nutrition. Arch Microbiol 2018;200:203-17. [PMID: 29188341 DOI: 10.1007/s00203-017-1459-x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 57] [Article Influence: 18.2] [Reference Citation Analysis]
139 Heianza Y, Sun D, Li X, DiDonato JA, Bray GA, Sacks FM, Qi L. Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial. Gut 2019;68:263-70. [PMID: 29860242 DOI: 10.1136/gutjnl-2018-316155] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 12.5] [Reference Citation Analysis]
140 Wu J, Yang L, Li S, Huang P, Liu Y, Wang Y, Tang H. Metabolomics Insights into the Modulatory Effects of Long-Term Low Calorie Intake in Mice. J Proteome Res 2016;15:2299-308. [DOI: 10.1021/acs.jproteome.6b00336] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
141 Li JV, Saric J, Yap IKS, Utzinger J, Holmes E. Metabonomic investigations of age- and batch-related variations in female NMRI mice using proton nuclear magnetic resonance spectroscopy. Mol BioSyst 2013;9:3155. [DOI: 10.1039/c3mb70215d] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
142 Akhmedov VA, Gaus OV. Role of intestinal microbiota in the formation of non-alcoholic fatty liver disease. Terapevticheskii arkhiv 2019;91:143-8. [DOI: 10.26442/00403660.2019.02.000051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
143 Maher JJ, Leon P, Ryan JC. Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis. Hepatology. 2008;48:670-678. [PMID: 18666225 DOI: 10.1002/hep.22399] [Cited by in Crossref: 136] [Cited by in F6Publishing: 143] [Article Influence: 9.7] [Reference Citation Analysis]
144 Rak K, Rader DJ. The diet–microbe morbid union. Nature 2011;472:40-1. [DOI: 10.1038/472040a] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
145 Li JV, Wang Y, Saric J, Nicholson JK, Dirnhofer S, Singer BH, Tanner M, Wittlin S, Holmes E, Utzinger J. Global metabolic responses of NMRI mice to an experimental Plasmodium berghei infection. J Proteome Res 2008;7:3948-56. [PMID: 18646786 DOI: 10.1021/pr800209d] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 4.2] [Reference Citation Analysis]
146 Smith L, Klément W, Dopavogui L, de Bock F, Lasserre F, Barretto S, Lukowicz C, Fougerat A, Polizzi A, Schaal B, Patris B, Denis C, Feuillet G, Canlet C, Jamin EL, Debrauwer L, Mselli-Lakhal L, Loiseau N, Guillou H, Marchi N, Ellero-Simatos S, Gamet-Payrastre L. Perinatal exposure to a dietary pesticide cocktail does not increase susceptibility to high-fat diet-induced metabolic perturbations at adulthood but modifies urinary and fecal metabolic fingerprints in C57Bl6/J mice. Environ Int 2020;144:106010. [PMID: 32745781 DOI: 10.1016/j.envint.2020.106010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
147 Heinken A, Thiele I. Systems biology of host-microbe metabolomics. Wiley Interdiscip Rev Syst Biol Med 2015;7:195-219. [PMID: 25929487 DOI: 10.1002/wsbm.1301] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 7.3] [Reference Citation Analysis]
148 Rubio-aliaga I, Roos BD, Sailer M, Mcloughlin GA, Boekschoten MV, van Erk M, Bachmair E, van Schothorst EM, Keijer J, Coort SL, Evelo C, Gibney MJ, Daniel H, Muller M, Kleemann R, Brennan L. Alterations in hepatic one-carbon metabolism and related pathways following a high-fat dietary intervention. Physiological Genomics 2011;43:408-16. [DOI: 10.1152/physiolgenomics.00179.2010] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
149 Ganesan R, Vasantha-Srinivasan P, Sadhasivam DR, Subramanian R, Vimalraj S, Suk KT. Carbon Nanotubes Induce Metabolomic Profile Disturbances in Zebrafish: NMR-Based Metabolomics Platform. Front Mol Biosci 2021;8:688827. [PMID: 34277704 DOI: 10.3389/fmolb.2021.688827] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
150 Boulangé CL, Claus SP, Chou CJ, Collino S, Montoliu I, Kochhar S, Holmes E, Rezzi S, Nicholson JK, Dumas ME, Martin FP. Early metabolic adaptation in C57BL/6 mice resistant to high fat diet induced weight gain involves an activation of mitochondrial oxidative pathways. J Proteome Res 2013;12:1956-68. [PMID: 23473242 DOI: 10.1021/pr400051s] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
151 Jo JK, Seo SH, Park SE, Kim HW, Kim EJ, Kim JS, Pyo JY, Cho KM, Kwon SJ, Park DH, Son HS. Gut Microbiome and Metabolome Profiles Associated with High-Fat Diet in Mice. Metabolites 2021;11:482. [PMID: 34436423 DOI: 10.3390/metabo11080482] [Reference Citation Analysis]
152 Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG. Minireview: Gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014;28:1221-1238. [PMID: 24892638 DOI: 10.1210/me.2014-1108] [Cited by in Crossref: 476] [Cited by in F6Publishing: 418] [Article Influence: 59.5] [Reference Citation Analysis]
153 Hu L, Brito LF, Abbas Z, Sammad A, Kang L, Wang D, Wu H, Liu A, Qi G, Zhao M, Wang Y, Xu Q. Investigating the Short-Term Effects of Cold Stress on Metabolite Responses and Metabolic Pathways in Inner-Mongolia Sanhe Cattle. Animals (Basel) 2021;11:2493. [PMID: 34573458 DOI: 10.3390/ani11092493] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
154 González-Ramos S, Paz-García M, Fernández-García V, Portune KJ, Acosta-Medina EF, Sanz Y, Castrillo A, Martín-Sanz P, Obregon MJ, Boscá L. NOD1 deficiency promotes an imbalance of thyroid hormones and microbiota homeostasis in mice fed high fat diet. Sci Rep 2020;10:12317. [PMID: 32704052 DOI: 10.1038/s41598-020-69295-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
155 Haque TR, Barritt AS. Intestinal microbiota in liver disease. Best Practice & Research Clinical Gastroenterology 2016;30:133-42. [DOI: 10.1016/j.bpg.2016.02.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
156 Wang J, Yue H, Xia Z, Wu S, Zhang H, Ji F, Xu L, Qi G. Effect of dietary choline supplementation under different flavin-containing monooxygenase 3 genotypes on trimethylamine metabolism in laying hens. Poultry Science 2012;91:2221-8. [DOI: 10.3382/ps.2011-02074] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
157 Backman LRF, Funk MA, Dawson CD, Drennan CL. New tricks for the glycyl radical enzyme family. Crit Rev Biochem Mol Biol 2017;52:674-95. [PMID: 28901199 DOI: 10.1080/10409238.2017.1373741] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 7.6] [Reference Citation Analysis]
158 Gu H, Pan Z, Xi B, Hainline BE, Shanaiah N, Asiago V, Gowda GA, Raftery D. 1H NMR metabolomics study of age profiling in children. NMR Biomed 2009;22:826-33. [PMID: 19441074 DOI: 10.1002/nbm.1395] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 4.2] [Reference Citation Analysis]
159 Anand G, Zarrinpar A, Loomba R. Targeting Dysbiosis for the Treatment of Liver Disease. Semin Liver Dis. 2016;36:37-47. [PMID: 26870931 DOI: 10.1055/s-0035-1571276] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
160 Bäckhed F. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: the normal gut microbiota in health and disease. Clin Exp Immunol 2010;160:80-4. [PMID: 20415855 DOI: 10.1111/j.1365-2249.2010.04123.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
161 Martin FP, Collino S, Rezzi S, Kochhar S. Metabolomic applications to decipher gut microbial metabolic influence in health and disease. Front Physiol. 2012;3:113. [PMID: 22557976 DOI: 10.3389/fphys.2012.00113] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 6.2] [Reference Citation Analysis]
162 Verdugo-Meza A, Ye J, Dadlani H, Ghosh S, Gibson DL. Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites. Nutrients 2020;12:E1434. [PMID: 32429195 DOI: 10.3390/nu12051434] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
163 Jiang L, Zhao X, Huang C, Lei H, Tang H, Wang Y. Dynamic changes in metabolic profiles of rats subchronically exposed to mequindox. Mol BioSyst 2014;10:2914-22. [DOI: 10.1039/c4mb00218k] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
164 Brial F, Le Lay A, Dumas ME, Gauguier D. Implication of gut microbiota metabolites in cardiovascular and metabolic diseases. Cell Mol Life Sci 2018;75:3977-90. [PMID: 30101405 DOI: 10.1007/s00018-018-2901-1] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 15.5] [Reference Citation Analysis]
165 Brial F, Le Lay A, Hedjazi L, Tsang T, Fearnside JF, Otto GW, Alzaid F, Wilder SP, Venteclef N, Cazier JB, Nicholson JK, Day C, Burt AD, Gut IG, Lathrop M, Dumas ME, Gauguier D. Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment. Sci Rep 2019;9:3656. [PMID: 30842494 DOI: 10.1038/s41598-019-40153-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
166 Allaway D, Kamlage B, Gilham MS, Hewson-hughes AK, Wiemer JC, Colyer A, Rein D. Effects of dietary glucose supplementation on the fasted plasma metabolome in cats and dogs. Metabolomics 2013;9:1096-108. [DOI: 10.1007/s11306-013-0527-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
167 An X, Bao Q, Di S, Zhao Y, Zhao S, Zhang H, Lian F, Tong X. The interaction between the gut Microbiota and herbal medicines. Biomedicine & Pharmacotherapy 2019;118:109252. [DOI: 10.1016/j.biopha.2019.109252] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
168 Martínez-del Campo A, Bodea S, Hamer HA, Marks JA, Haiser HJ, Turnbaugh PJ, Balskus EP. Characterization and detection of a widely distributed gene cluster that predicts anaerobic choline utilization by human gut bacteria. mBio 2015;6:e00042-15. [PMID: 25873372 DOI: 10.1128/mBio.00042-15] [Cited by in Crossref: 95] [Cited by in F6Publishing: 63] [Article Influence: 13.6] [Reference Citation Analysis]
169 Wang LJ, Zhang HW, Zhou JY, Liu Y, Yang Y, Chen XL, Zhu CH, Zheng RD, Ling WH, Zhu HL. Betaine attenuates hepatic steatosis by reducing methylation of the MTTP promoter and elevating genomic methylation in mice fed a high-fat diet. J Nutr Biochem 2014;25:329-36. [PMID: 24456734 DOI: 10.1016/j.jnutbio.2013.11.007] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 8.4] [Reference Citation Analysis]
170 Lin H, An Y, Hao F, Wang Y, Tang H. Correlations of Fecal Metabonomic and Microbiomic Changes Induced by High-fat Diet in the Pre-Obesity State. Sci Rep 2016;6:21618. [PMID: 26916743 DOI: 10.1038/srep21618] [Cited by in Crossref: 70] [Cited by in F6Publishing: 76] [Article Influence: 11.7] [Reference Citation Analysis]
171 Yeoh BS, Vijay-kumar M. Altered Microbiota and Their Metabolism in Host Metabolic Diseases. In: Sun J, Dudeja PK, editors. Mechanisms Underlying Host-Microbiome Interactions in Pathophysiology of Human Diseases. Boston: Springer US; 2018. pp. 129-65. [DOI: 10.1007/978-1-4939-7534-1_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
172 Pereira H, Martin J, Joly C, Sébédio J, Pujos-guillot E. Development and validation of a UPLC/MS method for a nutritional metabolomic study of human plasma. Metabolomics 2010;6:207-18. [DOI: 10.1007/s11306-009-0188-9] [Cited by in Crossref: 54] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
173 Inamine T, Schnabl B. Immunoglobulin A and liver diseases. J Gastroenterol 2018;53:691-700. [PMID: 29075899 DOI: 10.1007/s00535-017-1400-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
174 Madrid-gambin F, Llorach R, Vázquez-fresno R, Urpi-sarda M, Almanza-aguilera E, Garcia-aloy M, Estruch R, Corella D, Andres-lacueva C. Urinary 1 H Nuclear Magnetic Resonance Metabolomic Fingerprinting Reveals Biomarkers of Pulse Consumption Related to Energy-Metabolism Modulation in a Subcohort from the PREDIMED study. J Proteome Res 2017;16:1483-91. [DOI: 10.1021/acs.jproteome.6b00860] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
175 Xu X, He S, Zhang X. New food safety concerns associated with gut microbiota. Trends in Food Science & Technology 2013;34:62-6. [DOI: 10.1016/j.tifs.2013.07.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
176 Lindskog Jonsson A, Caesar R, Akrami R, Reinhardt C, Fåk Hållenius F, Borén J, Bäckhed F. Impact of Gut Microbiota and Diet on the Development of Atherosclerosis in Apoe-/- Mice. Arterioscler Thromb Vasc Biol 2018;38:2318-26. [PMID: 29903735 DOI: 10.1161/ATVBAHA.118.311233] [Cited by in Crossref: 62] [Cited by in F6Publishing: 36] [Article Influence: 20.7] [Reference Citation Analysis]
177 Tabbaa M, Golubic M, Roizen MF, Bernstein AM. Docosahexaenoic acid, inflammation, and bacterial dysbiosis in relation to periodontal disease, inflammatory bowel disease, and the metabolic syndrome. Nutrients 2013;5:3299-310. [PMID: 23966110 DOI: 10.3390/nu5083299] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
178 Delzenne NM, Cani PD, Neyrinck AM. Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data. J Nutr 2007;137:2547S-51S. [PMID: 17951500 DOI: 10.1093/jn/137.11.2547S] [Cited by in Crossref: 127] [Cited by in F6Publishing: 49] [Article Influence: 8.5] [Reference Citation Analysis]
179 Rawls JF, Mahowald MA, Goodman AL, Trent CM, Gordon JI. In vivo imaging and genetic analysis link bacterial motility and symbiosis in the zebrafish gut. Proc Natl Acad Sci U S A 2007;104:7622-7. [PMID: 17456593 DOI: 10.1073/pnas.0702386104] [Cited by in Crossref: 106] [Cited by in F6Publishing: 102] [Article Influence: 7.1] [Reference Citation Analysis]
180 Romick-Rosendale LE, Goodpaster AM, Hanwright PJ, Patel NB, Wheeler ET, Chona DL, Kennedy MA. NMR-based metabonomics analysis of mouse urine and fecal extracts following oral treatment with the broad-spectrum antibiotic enrofloxacin (Baytril). Magn Reson Chem. 2009;47 Suppl 1:S36-S46. [PMID: 19768747 DOI: 10.1002/mrc.2511] [Cited by in Crossref: 79] [Cited by in F6Publishing: 78] [Article Influence: 6.6] [Reference Citation Analysis]
181 Blaise BJ, Giacomotto J, Elena B, Dumas ME, Toulhoat P, Ségalat L, Emsley L. Metabotyping of Caenorhabditis elegans reveals latent phenotypes. Proc Natl Acad Sci U S A 2007;104:19808-12. [PMID: 18077412 DOI: 10.1073/pnas.0707393104] [Cited by in Crossref: 92] [Cited by in F6Publishing: 79] [Article Influence: 6.1] [Reference Citation Analysis]
182 Al-Asmakh M, Anuar F, Zadjali F, Rafter J, Pettersson S. Gut microbial communities modulating brain development and function. Gut Microbes 2012;3:366-73. [PMID: 22743758 DOI: 10.4161/gmic.21287] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 5.7] [Reference Citation Analysis]
183 Jichitu A, Bungau S, Stanescu AMA, Vesa CM, Toma MM, Bustea C, Iurciuc S, Rus M, Bacalbasa N, Diaconu CC. Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management. Diagnostics (Basel) 2021;11:689. [PMID: 33921359 DOI: 10.3390/diagnostics11040689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
184 Zhuang R, Ge X, Han L, Yu P, Gong X, Meng Q, Zhang Y, Fan H, Zheng L, Liu Z, Zhou X. Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: A systematic review and dose-response meta-analysis. Obes Rev 2019;20:883-94. [PMID: 30868721 DOI: 10.1111/obr.12843] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 12.7] [Reference Citation Analysis]
185 Prot JM, Leclerc E. The Current Status of Alternatives to Animal Testing and Predictive Toxicology Methods Using Liver Microfluidic Biochips. Ann Biomed Eng 2012;40:1228-43. [DOI: 10.1007/s10439-011-0480-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
186 Thompson HJ. Vegetable and Fruit Intake and the Development of Cancer. Bioactive Foods in Promoting Health. Elsevier; 2010. pp. 19-36. [DOI: 10.1016/b978-0-12-374628-3.00002-5] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
187 Castaño-Rodríguez N, Mitchell HM, Kaakoush NO. NAFLD, Helicobacter species and the intestinal microbiome. Best Pract Res Clin Gastroenterol 2017;31:657-68. [PMID: 29566909 DOI: 10.1016/j.bpg.2017.09.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
188 Bifari F, Manfrini R, Dei Cas M, Berra C, Siano M, Zuin M, Paroni R, Folli F. Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Pharmacol Res 2018;137:219-29. [PMID: 30359962 DOI: 10.1016/j.phrs.2018.09.025] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
189 Xu J, Cheng A, Song B, Zhao M, Xue J, Wang A, Dai L, Jing J, Meng X, Li H, Zheng L, Wang Y. Trimethylamine N-Oxide and Stroke Recurrence Depends on Ischemic Stroke Subtypes. Stroke 2021;:STROKEAHA120031443. [PMID: 34794334 DOI: 10.1161/STROKEAHA.120.031443] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
190 Shore SA. The Metabolic Response to Ozone. Front Immunol 2019;10:2890. [PMID: 31867021 DOI: 10.3389/fimmu.2019.02890] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
191 Shanahan F. The colonic microflora and probiotic therapy in health and disease. Curr Opin Gastroenterol 2011;27:61-5. [PMID: 20885319 DOI: 10.1097/MOG.0b013e328340076f] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
192 Hashemian M, Merat S, Poustchi H, Jafari E, Radmard AR, Kamangar F, Freedman N, Hekmatdoost A, Sheikh M, Boffetta P, Sinha R, Dawsey SM, Abnet CC, Malekzadeh R, Etemadi A. Red Meat Consumption and Risk of Nonalcoholic Fatty Liver Disease in a Population With Low Meat Consumption: The Golestan Cohort Study. Am J Gastroenterol 2021;116:1667-75. [PMID: 33767101 DOI: 10.14309/ajg.0000000000001229] [Reference Citation Analysis]
193 Kim JH, Yamaori S, Tanabe T, Johnson CH, Krausz KW, Kato S, Gonzalez FJ. Implication of intestinal VDR deficiency in inflammatory bowel disease. Biochim Biophys Acta 2013;1830:2118-28. [PMID: 23041070 DOI: 10.1016/j.bbagen.2012.09.020] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
194 Oresic M, Gopalacharyulu P, Mykkänen J, Lietzen N, Mäkinen M, Nygren H, Simell S, Simell V, Hyöty H, Veijola R, Ilonen J, Sysi-Aho M, Knip M, Hyötyläinen T, Simell O. Cord serum lipidome in prediction of islet autoimmunity and type 1 diabetes. Diabetes 2013;62:3268-74. [PMID: 23630305 DOI: 10.2337/db13-0159] [Cited by in Crossref: 62] [Cited by in F6Publishing: 52] [Article Influence: 6.9] [Reference Citation Analysis]
195 Wu C, Li C, Zhao W, Xie N, Yan F, Lian Y, Zhou L, Xu X, Liang Y, Wang L, Ren M, Li S, Cheng X, Zhang L, Ma Q, Song H, Meng R, Ji X. Elevated trimethylamine N-oxide related to ischemic brain lesions after carotid artery stenting. Neurology 2018;90:e1283-90. [PMID: 29540587 DOI: 10.1212/WNL.0000000000005298] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
196 Zou B, Yang W, Tang Y, Hou Y, Tang T, Qu S. Intestinal microbiota-farnesoid X receptor axis in metabolic diseases. Clinica Chimica Acta 2020;509:167-71. [DOI: 10.1016/j.cca.2020.06.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
197 Qamar AA. Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis. J Clin Gastroenterol. 2015;49 Suppl 1:S28-S32. [PMID: 26447961 DOI: 10.1097/mcg.0000000000000347] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
198 Park G, Jung S, Wellen KE, Jang C. The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease. Exp Mol Med 2021;53:809-22. [PMID: 34017059 DOI: 10.1038/s12276-021-00614-x] [Reference Citation Analysis]
199 Marchesi J, Shanahan F. The normal intestinal microbiota. Curr Opin Infect Dis 2007;20:508-13. [PMID: 17762785 DOI: 10.1097/QCO.0b013e3282a56a99] [Cited by in Crossref: 91] [Cited by in F6Publishing: 38] [Article Influence: 6.1] [Reference Citation Analysis]
200 Gandhi S, Devi MM, Pal S, Tripathi RP, Khushu S. Metabolic regulatory variations in rats due to acute cold stress & Tinospora Cordifolia intervention: high resolution 1H NMR approach. Metabolomics 2012;8:444-53. [DOI: 10.1007/s11306-011-0326-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
201 Kirpich IA, Solovieva NV, Leikhter SN, Shidakova NA, Lebedeva OV, Sidorov PI, Bazhukova TA, Soloviev AG, Barve SS, McClain CJ, Cave M. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol. 2008;42:675-682. [PMID: 19038698 DOI: 10.1016/j.alcohol.2008.08.006] [Cited by in Crossref: 252] [Cited by in F6Publishing: 238] [Article Influence: 19.4] [Reference Citation Analysis]
202 Brial F, Matsuda F, Gauguier D. Diet dependent impact of benzoate on diabetes and obesity in mice. Biochimie 2021;194:35-42. [PMID: 34965461 DOI: 10.1016/j.biochi.2021.12.010] [Reference Citation Analysis]
203 Mokhtari Z, Gibson DL, Hekmatdoost A. Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet. Adv Nutr 2017;8:240-52. [PMID: 28298269 DOI: 10.3945/an.116.013151] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 14.0] [Reference Citation Analysis]
204 Tian J, Peng G, Gao X, Zhou Y, Xing J, Qin X, Du G. Dynamic analysis of the endogenous metabolites in depressed patients treated with TCM formula Xiaoyaosan using urinary 1H NMR-based metabolomics. Journal of Ethnopharmacology 2014;158:1-10. [DOI: 10.1016/j.jep.2014.10.005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
205 Machado MV, Cortez-Pinto H. Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet. Int J Mol Sci. 2016;17:481. [PMID: 27043550 DOI: 10.3390/ijms17040481] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 8.8] [Reference Citation Analysis]
206 Matsumoto M, Inoue R, Tsuruta T, Hara H, Yajima T. Long-term oral administration of cows' milk improves insulin sensitivity in rats fed a high-sucrose diet. Br J Nutr 2009;102:1324-33. [PMID: 19566967 DOI: 10.1017/S0007114509990365] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
207 Swann JR, Tuohy KM, Lindfors P, Brown DT, Gibson GR, Wilson ID, Sidaway J, Nicholson JK, Holmes E. Variation in antibiotic-induced microbial recolonization impacts on the host metabolic phenotypes of rats. J Proteome Res. 2011;10:3590-3603. [PMID: 21591676 DOI: 10.1021/pr200243t] [Cited by in Crossref: 97] [Cited by in F6Publishing: 94] [Article Influence: 8.8] [Reference Citation Analysis]
208 Craciun S, Balskus EP. Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proc Natl Acad Sci U S A 2012;109:21307-12. [PMID: 23151509 DOI: 10.1073/pnas.1215689109] [Cited by in Crossref: 358] [Cited by in F6Publishing: 334] [Article Influence: 35.8] [Reference Citation Analysis]
209 Moran-Ramos S, He X, Chin EL, Tovar AR, Torres N, Slupsky CM, Raybould HE. Nopal feeding reduces adiposity, intestinal inflammation and shifts the cecal microbiota and metabolism in high-fat fed rats. PLoS One 2017;12:e0171672. [PMID: 28196086 DOI: 10.1371/journal.pone.0171672] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
210 Rodriguez-Nunez I, Caluag T, Kirby K, Rudick CN, Dziarski R, Gupta D. Nod2 and Nod2-regulated microbiota protect BALB/c mice from diet-induced obesity and metabolic dysfunction. Sci Rep 2017;7:548. [PMID: 28373658 DOI: 10.1038/s41598-017-00484-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
211 Zhang S, Nagana Gowda GA, Asiago V, Shanaiah N, Barbas C, Raftery D. Correlative and quantitative 1H NMR-based metabolomics reveals specific metabolic pathway disturbances in diabetic rats. Anal Biochem 2008;383:76-84. [PMID: 18775407 DOI: 10.1016/j.ab.2008.07.041] [Cited by in Crossref: 123] [Cited by in F6Publishing: 115] [Article Influence: 8.8] [Reference Citation Analysis]
212 Madrid-Gambin F, Brunius C, Garcia-Aloy M, Estruel-Amades S, Landberg R, Andres-Lacueva C. Untargeted 1H NMR-Based Metabolomics Analysis of Urine and Serum Profiles after Consumption of Lentils, Chickpeas, and Beans: An Extended Meal Study To Discover Dietary Biomarkers of Pulses. J Agric Food Chem 2018;66:6997-7005. [PMID: 29920085 DOI: 10.1021/acs.jafc.8b00047] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
213 Shyu P Jr, Ng BSH, Ho N, Chaw R, Seah YL, Marvalim C, Thibault G. Membrane phospholipid alteration causes chronic ER stress through early degradation of homeostatic ER-resident proteins. Sci Rep 2019;9:8637. [PMID: 31201345 DOI: 10.1038/s41598-019-45020-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
214 Kigerl KA, Zane K, Adams K, Sullivan MB, Popovich PG. The spinal cord-gut-immune axis as a master regulator of health and neurological function after spinal cord injury. Exp Neurol. 2020;323:113085. [PMID: 31654639 DOI: 10.1016/j.expneurol.2019.113085] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
215 Camp JG, Kanther M, Semova I, Rawls JF. Patterns and scales in gastrointestinal microbial ecology. Gastroenterology 2009;136:1989-2002. [PMID: 19457423 DOI: 10.1053/j.gastro.2009.02.075] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
216 Leboucher A, Pisani DF, Martinez-Gili L, Chilloux J, Bermudez-Martin P, Van Dijck A, Ganief T, Macek B, Becker JAJ, Le Merrer J, Kooy RF, Amri EZ, Khandjian EW, Dumas ME, Davidovic L. The translational regulator FMRP controls lipid and glucose metabolism in mice and humans. Mol Metab 2019;21:22-35. [PMID: 30686771 DOI: 10.1016/j.molmet.2019.01.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
217 Barbuti RC, Schiavon LL, Oliveira CP, Alvares-DA-Silva MR, Sassaki LY, Passos MDCF, Farias AQ, Barros LL, Barreto BP, Albuquerque GBML, Alves AM, Navarro-Rodriguez T, Bittencourt PL. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FBG). Arq Gastroenterol 2020;57:381-98. [PMID: 33331485 DOI: 10.1590/S0004-2803.202000000-72] [Reference Citation Analysis]
218 Thibodeaux CJ, van der Donk WA. Converging on a mechanism for choline degradation. Proc Natl Acad Sci U S A 2012;109:21184-5. [PMID: 23243142 DOI: 10.1073/pnas.1219534110] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
219 Sun L, Hu W, Liu Q, Hao Q, Sun B, Zhang Q, Mao S, Qiao J, Yan X. Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients. J Proteome Res 2012;11:2937-46. [PMID: 22428626 DOI: 10.1021/pr3000317] [Cited by in Crossref: 84] [Cited by in F6Publishing: 81] [Article Influence: 8.4] [Reference Citation Analysis]
220 Kijmanawat A, Panburana P, Reutrakul S, Tangshewinsirikul C. Effects of probiotic supplements on insulin resistance in gestational diabetes mellitus: A double-blind randomized controlled trial. J Diabetes Investig 2019;10:163-70. [PMID: 29781243 DOI: 10.1111/jdi.12863] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 9.5] [Reference Citation Analysis]
221 Hattori M, Taylor TD. The human intestinal microbiome: a new frontier of human biology. DNA Res 2009;16:1-12. [PMID: 19147530 DOI: 10.1093/dnares/dsn033] [Cited by in Crossref: 168] [Cited by in F6Publishing: 144] [Article Influence: 12.9] [Reference Citation Analysis]
222 Thavarajah D, Thavarajah P, Abare A, Basnagala S, Lacher C, Smith P, Combs GF. Mineral micronutrient and prebiotic carbohydrate profiles of USA-grown kale (Brassica oleracea L. var. acephala). Journal of Food Composition and Analysis 2016;52:9-15. [DOI: 10.1016/j.jfca.2016.07.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
223 Zhou R, Fan X, Schnabl B. Role of the intestinal microbiome in liver fibrosis development and new treatment strategies. Transl Res 2019;209:22-38. [PMID: 30853445 DOI: 10.1016/j.trsl.2019.02.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
224 Kim SY. Production of Fermented Kale Juices with Lactobacillus Strains and Nutritional Composition. Prev Nutr Food Sci 2017;22:231-6. [PMID: 29043222 DOI: 10.3746/pnf.2017.22.3.231] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
225 [DOI: 10.1101/437731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
226 Rosberg-Cody E, Stanton C, O’Mahony L, Wall R, Shanahan F, Quigley EM, Fitzgerald GF, Ross RP. Recombinant lactobacilli expressing linoleic acid isomerase can modulate the fatty acid composition of host adipose tissue in mice. Microbiology. 2011;157:609-615. [PMID: 21178166 DOI: 10.1099/mic.0.043406-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
227 Gomez-Santos L, Luka Z, Wagner C, Fernandez-Alvarez S, Lu SC, Mato JM, Martinez-Chantar ML, Beraza N. Inhibition of natural killer cells protects the liver against acute injury in the absence of glycine N-methyltransferase. Hepatology. 2012;56:747-759. [PMID: 22392635 DOI: 10.1002/hep.25694] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
228 Nishitsuji K, Xiao J, Nagatomo R, Umemoto H, Morimoto Y, Akatsu H, Inoue K, Tsuneyama K. Analysis of the gut microbiome and plasma short-chain fatty acid profiles in a spontaneous mouse model of metabolic syndrome. Sci Rep 2017;7:15876. [PMID: 29158587 DOI: 10.1038/s41598-017-16189-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 9.6] [Reference Citation Analysis]
229 Tashiro H, Cho Y, Kasahara DI, Brand JD, Bry L, Yeliseyev V, Abu-Ali G, Huttenhower C, Shore SA. Microbiota Contribute to Obesity-related Increases in the Pulmonary Response to Ozone. Am J Respir Cell Mol Biol 2019;61:702-12. [PMID: 31144984 DOI: 10.1165/rcmb.2019-0144OC] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
230 Xia Y, Chen H, Zhang M, Jiang Y, Hang X, Qin H. Effect of Lactobacillus plantarum LP-Onlly on gut flora and colitis in interleukin-10 knockout mice: Probiotic therapy in colitis. Journal of Gastroenterology and Hepatology 2011;26:405-11. [DOI: 10.1111/j.1440-1746.2010.06498.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
231 Riedl RA, Burnett CML, Pearson NA, Reho JJ, Mokadem M, Edwards RA, Kindel TL, Kirby JR, Grobe JL. Gut Microbiota Represent a Major Thermogenic Biomass. Function (Oxf) 2021;2:zqab019. [PMID: 33939772 DOI: 10.1093/function/zqab019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
232 Wu X, Li N, Li H, Tang H. An optimized method for NMR-based plant seed metabolomic analysis with maximized polar metabolite extraction efficiency, signal-to-noise ratio, and chemical shift consistency. Analyst 2014;139:1769-78. [DOI: 10.1039/c3an02100a] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
233 Arthur JC, Jobin C. The struggle within: microbial influences on colorectal cancer. Inflamm Bowel Dis. 2011;17:396-409. [PMID: 20848537 DOI: 10.1002/ibd.21354] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 7.1] [Reference Citation Analysis]
234 Nicoletti A, Ponziani FR, Biolato M, Valenza V, Marrone G, Sganga G, Gasbarrini A, Miele L, Grieco A. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation. World J Gastroenterol 2019; 25(33): 4814-4834 [PMID: 31543676 DOI: 10.3748/wjg.v25.i33.4814] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 26] [Article Influence: 10.3] [Reference Citation Analysis]
235 Reddy SK, Zhan M, Alexander HR, El-Kamary SS. Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders. World J Gastroenterol 2013; 19(45): 8301-8311 [PMID: 24363521 DOI: 10.3748/wjg.v19.i45.8301] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
236 Nagalingam NA, Lynch SV. Role of the microbiota in inflammatory bowel diseases. Inflamm Bowel Dis. 2012;18:968-984. [PMID: 21936031 DOI: 10.1002/ibd.21866] [Cited by in Crossref: 181] [Cited by in F6Publishing: 170] [Article Influence: 16.5] [Reference Citation Analysis]
237 Chu H, Duan Y, Yang L, Schnabl B. Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease. Gut. 2019;68:359-370. [PMID: 30171065 DOI: 10.1136/gutjnl-2018-316307] [Cited by in Crossref: 115] [Cited by in F6Publishing: 116] [Article Influence: 28.8] [Reference Citation Analysis]
238 Shintu L, Baudoin R, Navratil V, Prot JM, Pontoizeau C, Defernez M, Blaise BJ, Domange C, Péry AR, Toulhoat P, Legallais C, Brochot C, Leclerc E, Dumas ME. Metabolomics-on-a-chip and predictive systems toxicology in microfluidic bioartificial organs. Anal Chem 2012;84:1840-8. [PMID: 22242722 DOI: 10.1021/ac2011075] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 7.5] [Reference Citation Analysis]
239 Zhou J, Tripathi M, Sinha RA, Singh BK, Yen PM. Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease. Hepatoma Res 2021;7:11. [PMID: 33490737 DOI: 10.20517/2394-5079.2020.134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
240 Xu W, Wu J, An Y, Xiao C, Hao F, Liu H, Wang Y, Tang H. Streptozotocin-induced dynamic metabonomic changes in rat biofluids. J Proteome Res 2012;11:3423-35. [PMID: 22563680 DOI: 10.1021/pr300280t] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
241 Ma BW, Bokulich NA, Castillo PA, Kananurak A, Underwood MA, Mills DA, Bevins CL. Routine habitat change: a source of unrecognized transient alteration of intestinal microbiota in laboratory mice. PLoS One 2012;7:e47416. [PMID: 23082164 DOI: 10.1371/journal.pone.0047416] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
242 Zhou D, Fan JG. Microbial metabolites in non-alcoholic fatty liver disease. World J Gastroenterol 2019; 25(17): 2019-2028 [PMID: 31114130 DOI: 10.3748/wjg.v25.i17.2019] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 23] [Article Influence: 9.3] [Reference Citation Analysis]
243 Sati J, Mohanty BP, Garg ML, Koul A. Pro-Oxidant Role of Silibinin in DMBA/TPA Induced Skin Cancer: 1H NMR Metabolomic and Biochemical Study. PLoS One 2016;11:e0158955. [PMID: 27414401 DOI: 10.1371/journal.pone.0158955] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
244 Vitlic A, Sadiq S, Ahmed HI, Ale EC, Binetti AG, Collett A, Humpreys PN, Laws AP. Isolation and characterization of a high molecular mass β-glucan from Lactobacillus fermentum Lf2 and evaluation of its immunomodulatory activity. Carbohydrate Research 2019;476:44-52. [DOI: 10.1016/j.carres.2019.03.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
245 Koutsos A, Lovegrove JA. An Apple a Day Keeps the Doctor Away – Inter-Relationship Between Apple Consumption, the Gut Microbiota and Cardiometabolic Disease Risk Reduction. Diet-Microbe Interactions in the Gut. Elsevier; 2015. pp. 173-94. [DOI: 10.1016/b978-0-12-407825-3.00012-5] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
246 He Q, Tang H, Ren P, Kong X, Wu G, Yin Y, Wang Y. Dietary supplementation with l-arginine partially counteracts serum metabonome induced by weaning stress in piglets. J Proteome Res 2011;10:5214-21. [PMID: 21942754 DOI: 10.1021/pr200688u] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
247 Vernocchi P, Vannini L, Gottardi D, Del Chierico F, Serrazanetti DI, Ndagijimana M, Guerzoni ME. Integration of datasets from different analytical techniques to assess the impact of nutrition on human metabolome. Front Cell Infect Microbiol 2012;2:156. [PMID: 23248777 DOI: 10.3389/fcimb.2012.00156] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
248 Scalbert A, Brennan L, Fiehn O, Hankemeier T, Kristal BS, van Ommen B, Pujos-Guillot E, Verheij E, Wishart D, Wopereis S. Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics. 2009;5:435-458. [PMID: 20046865 DOI: 10.1007/s11306-009-0168-0] [Cited by in Crossref: 380] [Cited by in F6Publishing: 341] [Article Influence: 29.2] [Reference Citation Analysis]
249 Libiger O, Schork NJ. Partial Least Squares Regression Can Aid in Detecting Differential Abundance of Multiple Features in Sets of Metagenomic Samples. Front Genet 2015;6:350. [PMID: 26734061 DOI: 10.3389/fgene.2015.00350] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
250 Dai X, Lv ZS. Role of gut barrier function in the pathogenesis of nonalcoholic fatty liver disease. Shijie Huaren Xiaohua Zazhi 2012; 20(8): 656-661 [DOI: 10.11569/wcjd.v20.i8.656] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
251 Cao H, Huang H, Xu W, Chen D, Yu J, Li J, Li L. Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometry. Anal Chim Acta. 2011;691:68-75. [PMID: 21458633 DOI: 10.1016/j.aca.2011.02.038] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 6.7] [Reference Citation Analysis]
252 Jenab M, Slimani N, Bictash M, Ferrari P, Bingham SA. Biomarkers in nutritional epidemiology: applications, needs and new horizons. Hum Genet 2009;125:507-25. [DOI: 10.1007/s00439-009-0662-5] [Cited by in Crossref: 297] [Cited by in F6Publishing: 257] [Article Influence: 22.8] [Reference Citation Analysis]
253 Martins dos Santos V, Müller M, de Vos WM. Systems biology of the gut: the interplay of food, microbiota and host at the mucosal interface. Curr Opin Biotechnol 2010;21:539-50. [PMID: 20817507 DOI: 10.1016/j.copbio.2010.08.003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
254 Tian JS, Xia XT, Wu YF, Zhao L, Xiang H, Du GH, Zhang X, Qin XM. Discovery, screening and evaluation of a plasma biomarker panel for subjects with psychological suboptimal health state using (1)H-NMR-based metabolomics profiles. Sci Rep 2016;6:33820. [PMID: 27650680 DOI: 10.1038/srep33820] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
255 Canani RB, Di Costanzo M, Leone L, Bedogni G, Brambilla P, Cianfarani S, Nobili V, Pietrobelli A, Agostoni C. Epigenetic mechanisms elicited by nutrition in early life. Nutr Res Rev 2011;24:198-205. [DOI: 10.1017/s0954422411000102] [Cited by in Crossref: 143] [Cited by in F6Publishing: 55] [Article Influence: 13.0] [Reference Citation Analysis]
256 Macpherson AJ, Heikenwalder M, Ganal-Vonarburg SC. The Liver at the Nexus of Host-Microbial Interactions. Cell Host Microbe 2016;20:561-71. [PMID: 27832587 DOI: 10.1016/j.chom.2016.10.016] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
257 Zhang X, Shen D, Fang Z, Jie Z, Qiu X, Zhang C, Chen Y, Ji L. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One. 2013;8:e71108. [PMID: 24013136 DOI: 10.1371/journal.pone.0071108] [Cited by in Crossref: 374] [Cited by in F6Publishing: 353] [Article Influence: 41.6] [Reference Citation Analysis]
258 Kinross J, Warren O, Basson S, Holmes E, Silk D, Darzi A, Nicholson JK. Intestinal ischemia/reperfusion injury: defining the role of the gut microbiome. Biomarkers in Medicine 2009;3:175-92. [DOI: 10.2217/bmm.09.11] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
259 Huo X, Li J, Cao YF, Li SN, Shao P, Leng J, Li W, Liu J, Yang K, Ma RCW, Hu G, Fang ZZ, Yang X. Trimethylamine N-Oxide Metabolites in Early Pregnancy and Risk of Gestational Diabetes: A Nested Case-Control Study. J Clin Endocrinol Metab. 2019;104:5529-5539. [PMID: 31373635 DOI: 10.1210/jc.2019-00710] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
260 Sun J, Schnackenberg LK, Khare S, Yang X, Greenhaw J, Salminen W, Mendrick DL, Beger RD. Evaluating effects of penicillin treatment on the metabolome of rats. J Chromatogr B Analyt Technol Biomed Life Sci 2013;932:134-43. [PMID: 23831706 DOI: 10.1016/j.jchromb.2013.05.030] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
261 Miyata M, Yamakawa H, Hamatsu M, Kuribayashi H, Takamatsu Y, Yamazoe Y. Enterobacteria modulate intestinal bile acid transport and homeostasis through apical sodium-dependent bile acid transporter (SLC10A2) expression. J Pharmacol Exp Ther. 2011;336:188-196. [PMID: 20884752 DOI: 10.1124/jpet.110.171736] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
262 Collison M, Hirt RP, Wipat A, Nakjang S, Sanseau P, Brown JR. Data mining the human gut microbiota for therapeutic targets. Briefings in Bioinformatics 2012;13:751-68. [DOI: 10.1093/bib/bbs002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
263 Lavelle A, Lennon G, Docherty N, Balfe A, Mulcahy HE, Doherty G, O Donoghue D, Hyland JM, Shanahan F, Sheahan K, Coffey JC, Winter DC, O Connell PR. Depth-dependent differences in community structure of the human colonic microbiota in health. PLoS One 2013;8:e78835. [PMID: 24223167 DOI: 10.1371/journal.pone.0078835] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
264 Barrea L, Di Somma C, Muscogiuri G, Tarantino G, Tenore GC, Orio F, Colao A, Savastano S. Nutrition, inflammation and liver-spleen axis. Critical Reviews in Food Science and Nutrition 2018;58:3141-58. [DOI: 10.1080/10408398.2017.1353479] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
265 Fardet A, Chardigny J. Plant-Based Foods as a Source of Lipotropes for Human Nutrition: A Survey of In Vivo Studies. Critical Reviews in Food Science and Nutrition 2013;53:535-90. [DOI: 10.1080/10408398.2010.549596] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
266 Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012;489:242-9. [PMID: 22972297 DOI: 10.1038/nature11552] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
267 Martin FP, Wang Y, Sprenger N, Yap IK, Rezzi S, Ramadan Z, Peré-Trepat E, Rochat F, Cherbut C, van Bladeren P, Fay LB, Kochhar S, Lindon JC, Holmes E, Nicholson JK. Top-down systems biology integration of conditional prebiotic modulated transgenomic interactions in a humanized microbiome mouse model. Mol Syst Biol 2008;4:205. [PMID: 18628745 DOI: 10.1038/msb.2008.40] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 5.3] [Reference Citation Analysis]
268 Corbin KD, Driscoll KA, Pratley RE, Smith SR, Maahs DM, Mayer-davis EJ; Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON). Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms. Endocrine Reviews 2018;39:629-63. [DOI: 10.1210/er.2017-00191] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 15.0] [Reference Citation Analysis]
269 Domange C, Canlet C, Traoré A, Biélicki G, Keller C, Paris A, Priymenko N. Orthologous Metabonomic Qualification of a Rodent Model Combined with Magnetic Resonance Imaging for an Integrated Evaluation of the Toxicity of Hypochœris radicata. Chem Res Toxicol 2008;21:2082-96. [DOI: 10.1021/tx800159x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
270 Quigley EM, Stanton C, Murphy EF. The gut microbiota and the liver. Pathophysiological and clinical implications. J Hepatol. 2013;58:1020-1027. [PMID: 23183530 DOI: 10.1016/j.jhep.2012.11.023] [Cited by in Crossref: 75] [Cited by in F6Publishing: 68] [Article Influence: 7.5] [Reference Citation Analysis]
271 Leser TD, Mølbak L. Better living through microbial action: the benefits of the mammalian gastrointestinal microbiota on the host. Environmental Microbiology 2009;11:2194-206. [DOI: 10.1111/j.1462-2920.2009.01941.x] [Cited by in Crossref: 182] [Cited by in F6Publishing: 170] [Article Influence: 14.0] [Reference Citation Analysis]
272 Geamanu A, Goja A, Saadat N, Khosla P, Gupta SV. ProAlgaZyme subfraction improves the lipoprotein profile of hypercholesterolemic hamsters, while inhibiting production of betaine, carnitine, and choline metabolites. Nutr Metab (Lond) 2013;10:55. [PMID: 23981691 DOI: 10.1186/1743-7075-10-55] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
273 Péan N, Doignon I, Tordjmann T. Gut microbiota and bile acids: an old story revisited (again). Clin Res Hepatol Gastroenterol 2014;38:129-31. [PMID: 23916556 DOI: 10.1016/j.clinre.2013.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
274 Xie B, Liu A, Zhan X, Ye X, Wei J. Alteration of gut bacteria and metabolomes after glucaro-1,4-lactone treatment contributes to the prevention of hypercholesterolemia. J Agric Food Chem 2014;62:7444-51. [PMID: 24972288 DOI: 10.1021/jf501744d] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
275 Alkasir R, Li J, Li X, Jin M, Zhu B. Human gut microbiota: the links with dementia development. Protein Cell. 2017;8:90-102. [PMID: 27866330 DOI: 10.1007/s13238-016-0338-691] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
276 Friedman SL. Focus. J Hepatol 2014;60:1-2. [PMID: 24121095 DOI: 10.1016/j.jhep.2013.10.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
277 Shortt C, Hasselwander O, Meynier A, Nauta A, Fernández EN, Putz P, Rowland I, Swann J, Türk J, Vermeiren J, Antoine JM. Systematic review of the effects of the intestinal microbiota on selected nutrients and non-nutrients. Eur J Nutr 2018;57:25-49. [PMID: 29086061 DOI: 10.1007/s00394-017-1546-4] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 12.4] [Reference Citation Analysis]
278 Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L, Chilloux J, Ottman N, Duparc T, Lichtenstein L, Myridakis A, Delzenne NM, Klievink J, Bhattacharjee A, van der Ark KC, Aalvink S, Martinez LO, Dumas ME, Maiter D, Loumaye A, Hermans MP, Thissen JP, Belzer C, de Vos WM, Cani PD. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2017;23:107-113. [PMID: 27892954 DOI: 10.1038/nm.4236] [Cited by in Crossref: 685] [Cited by in F6Publishing: 617] [Article Influence: 114.2] [Reference Citation Analysis]
279 Loman BR, Hernández-Saavedra D, An R, Rector RS. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Nutr Rev 2018;76:822-39. [PMID: 30113661 DOI: 10.1093/nutrit/nuy031] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 12.7] [Reference Citation Analysis]
280 Yap IKS, Kho MT, Lim SHE, Ismail NH, Yam WK, Chong CW. Acclimatisation-induced stress influenced host metabolic and gut microbial composition change. Mol BioSyst 2015;11:297-306. [DOI: 10.1039/c4mb00463a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
281 Hyun CK. Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:9139. [PMID: 34502047 DOI: 10.3390/ijms22179139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
282 Wei Y, Liang M, Mai K, Zheng K, Xu H. The effect of ultrafiltered fish protein hydrolysate levels on the liver and muscle metabolic profile of juvenile turbot ( Scophthalmus maximus L.) by 1 H NMR-based metabolomics studies. Aquac Res 2017;48:3515-27. [DOI: 10.1111/are.13178] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
283 Howitt MR, Garrett WS. A complex microworld in the gut: gut microbiota and cardiovascular disease connectivity. Nat Med 2012;18:1188-9. [PMID: 22869188 DOI: 10.1038/nm.2895] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
284 Chen J, Zhang J, Wu X, Chen J, Dai Y, Ma X, Yu Y, Zhang L, Liu C. Disordered Metabolic Profiling in Plasma and Tissues of Mice Infected with Artemisinin-Sensitive and -Resistant Plasmodium berghei K173 Determined by 1H NMR Spectroscopy. J Proteome Res 2019;18:1970-93. [PMID: 30931571 DOI: 10.1021/acs.jproteome.8b00782] [Reference Citation Analysis]
285 Prot JM, Bunescu A, Elena-Herrmann B, Aninat C, Snouber LC, Griscom L, Razan F, Bois FY, Legallais C, Brochot C, Corlu A, Dumas ME, Leclerc E. Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol 2012;259:270-80. [PMID: 22230336 DOI: 10.1016/j.taap.2011.12.017] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
286 Won EY, Yoon MK, Kim SW, Jung Y, Bae HW, Lee D, Park SG, Lee CH, Hwang GS, Chi SW. Gender-specific metabolomic profiling of obesity in leptin-deficient ob/ob mice by 1H NMR spectroscopy. PLoS One 2013;8:e75998. [PMID: 24098417 DOI: 10.1371/journal.pone.0075998] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
287 Flint H, Duncan S, Louis P. Gut microbial ecology. Designing Functional Foods. Elsevier; 2009. pp. 38-67. [DOI: 10.1533/9781845696603.1.38] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
288 Abu-Shanab A, Quigley EM. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2010;7:691-701. [PMID: 21045794 DOI: 10.1038/nrgastro.2010.172] [Cited by in Crossref: 298] [Cited by in F6Publishing: 273] [Article Influence: 24.8] [Reference Citation Analysis]
289 Zhang P, Wang S, He Y, Xu Y, Shi D, Yang F, Yu W, Zhu W, He L. Identifying Metabolic Perturbations and Toxic Effects of Rac-Metalaxyl and Metalaxyl-M in Mice Using Integrative NMR and UPLC-MS/MS Based Metabolomics. Int J Mol Sci 2019;20:E5457. [PMID: 31683916 DOI: 10.3390/ijms20215457] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
290 Vajro P, Paolella G, Fasano A. Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease. J Pediatr Gastroenterol Nutr 2013;56:461-8. [PMID: 23287807 DOI: 10.1097/MPG.0b013e318284abb5] [Cited by in Crossref: 117] [Cited by in F6Publishing: 59] [Article Influence: 13.0] [Reference Citation Analysis]
291 Klein MS, Dorn C, Saugspier M, Hellerbrand C, Oefner PJ, Gronwald W. Discrimination of steatosis and NASH in mice using nuclear magnetic resonance spectroscopy. Metabolomics 2011;7:237-46. [DOI: 10.1007/s11306-010-0243-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
292 Neuschwander-Tetri BA. Fatty liver and the metabolic syndrome. Curr Opin Gastroenterol 2007;23:193-8. [PMID: 17268250 DOI: 10.1097/MOG.0b013e32801421a9] [Cited by in Crossref: 77] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
293 Agus A, Massier S, Darfeuille-Michaud A, Billard E, Barnich N. Understanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies. Biomed Res Int 2014;2014:567929. [PMID: 25580435 DOI: 10.1155/2014/567929] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
294 Wang X, Zhang A, Miao J, Sun H, Yan G, Wu F, Wang X. Gut microbiota as important modulator of metabolism in health and disease. RSC Adv 2018;8:42380-9. [DOI: 10.1039/c8ra08094a] [Cited by in Crossref: 37] [Cited by in F6Publishing: 1] [Article Influence: 9.3] [Reference Citation Analysis]
295 Wang Y, Holmes E, Comelli EM, Fotopoulos G, Dorta G, Tang H, Rantalainen MJ, Lindon JC, Corthésy-Theulaz IE, Fay LB, Kochhar S, Nicholson JK. Topographical variation in metabolic signatures of human gastrointestinal biopsies revealed by high-resolution magic-angle spinning 1H NMR spectroscopy. J Proteome Res 2007;6:3944-51. [PMID: 17711324 DOI: 10.1021/pr0702565] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
296 Ramireddy L, Tsen HY, Chiang YC, Hung CY, Chen FC, Yen HT. The gene expression and bioinformatic analysis of choline trimethylamine-lyase (CutC) and its activating enzyme (CutD) for gut microbes and comparison with their TMA production levels. Curr Res Microb Sci 2021;2:100043. [PMID: 34841334 DOI: 10.1016/j.crmicr.2021.100043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
297 Marušić M, Paić M, Knobloch M, Liberati Pršo AM. NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2. Can J Gastroenterol Hepatol 2021;2021:6613827. [PMID: 33681089 DOI: 10.1155/2021/6613827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
298 Fujimura KE, Slusher NA, Cabana MD, Lynch SV. Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther. 2010;8:435-454. [PMID: 20377338 DOI: 10.1586/eri.10.14] [Cited by in Crossref: 242] [Cited by in F6Publishing: 224] [Article Influence: 20.2] [Reference Citation Analysis]
299 Chang C, Lin H. Dysbiosis in gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2016;30:3-15. [PMID: 27048892 DOI: 10.1016/j.bpg.2016.02.001] [Cited by in F6Publishing: 46] [Reference Citation Analysis]
300 Boulangé CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med 2016;8:42. [PMID: 27098727 DOI: 10.1186/s13073-016-0303-2] [Cited by in Crossref: 552] [Cited by in F6Publishing: 511] [Article Influence: 92.0] [Reference Citation Analysis]
301 [DOI: 10.1101/178947] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
302 Yang X, Yin F, Yang Y, Lepp D, Yu H, Ruan Z, Yang C, Yin Y, Hou Y, Leeson S, Gong J. Dietary butyrate glycerides modulate intestinal microbiota composition and serum metabolites in broilers. Sci Rep 2018;8:4940. [PMID: 29563518 DOI: 10.1038/s41598-018-22565-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
303 Cobbold J, Anstee Q, Goldin R, Williams H, Matthews H, North B, Absalom N, Thomas H, Thursz M, Cox R, Taylor-robinson S, Cox I. Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissue. Clinical Science 2009;116:403-13. [DOI: 10.1042/cs20080159] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
304 Ilan Y. Leaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitis. World J Gastroenterol 2012; 18(21): 2609-2618 [PMID: 22690069 DOI: 10.3748/wjg.v18.i21.2609] [Cited by in CrossRef: 112] [Cited by in F6Publishing: 104] [Article Influence: 11.2] [Reference Citation Analysis]
305 Suk KT, Kim DJ. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol. 2019;13:193-204. [PMID: 30791767 DOI: 10.1080/17474124.2019.1569513] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
306 Xie G, Zhong W, Li H, Li Q, Qiu Y, Zheng X, Chen H, Zhao X, Zhang S, Zhou Z, Zeisel SH, Jia W. Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption. FASEB J. 2013;27:3583-3593. [PMID: 23709616 DOI: 10.1096/fj.13-231860] [Cited by in Crossref: 108] [Cited by in F6Publishing: 106] [Article Influence: 12.0] [Reference Citation Analysis]
307 Thompson MD, Thompson HJ. Chapter 1 Biomedical Agriculture. Elsevier; 2009. pp. 1-54. [DOI: 10.1016/s0065-2113(09)01001-3] [Cited by in Crossref: 8] [Article Influence: 0.6] [Reference Citation Analysis]
308 Joyce SA, Gahan CG. The gut microbiota and the metabolic health of the host. Curr Opin Gastroenterol. 2014;30:120-127. [PMID: 24468803 DOI: 10.1097/mog.0000000000000039] [Cited by in Crossref: 93] [Cited by in F6Publishing: 49] [Article Influence: 11.6] [Reference Citation Analysis]
309 Oresic M, Simell S, Sysi-Aho M, Näntö-Salonen K, Seppänen-Laakso T, Parikka V, Katajamaa M, Hekkala A, Mattila I, Keskinen P, Yetukuri L, Reinikainen A, Lähde J, Suortti T, Hakalax J, Simell T, Hyöty H, Veijola R, Ilonen J, Lahesmaa R, Knip M, Simell O. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med 2008;205:2975-84. [PMID: 19075291 DOI: 10.1084/jem.20081800] [Cited by in Crossref: 299] [Cited by in F6Publishing: 271] [Article Influence: 21.4] [Reference Citation Analysis]
310 Di Ciaula A, Baj J, Garruti G, Celano G, De Angelis M, Wang HH, Di Palo DM, Bonfrate L, Wang DQ, Portincasa P. Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk. J Clin Med 2020;9:E2648. [PMID: 32823983 DOI: 10.3390/jcm9082648] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
311 Sun Q, Li M, Yang X, Xu X, Wang J, Zhang J. Dietary salecan reverts partially the metabolic gene expressions and NMR-based metabolomic profiles from high-fat-diet-induced obese rats. The Journal of Nutritional Biochemistry 2017;47:53-62. [DOI: 10.1016/j.jnutbio.2017.04.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
312 Aron-wisnewsky J, Vigliotti C, Witjes J, Le P, Holleboom AG, Verheij J, Nieuwdorp M, Clément K. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nat Rev Gastroenterol Hepatol 2020;17:279-97. [DOI: 10.1038/s41575-020-0269-9] [Cited by in Crossref: 103] [Cited by in F6Publishing: 103] [Article Influence: 51.5] [Reference Citation Analysis]
313 Zhao ZH, Lai JK, Qiao L, Fan JG. Role of gut microbial metabolites in nonalcoholic fatty liver disease. J Dig Dis. 2019;20:181-188. [PMID: 30706694 DOI: 10.1111/1751-2980.12709] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
314 Orman M, Bodea S, Funk MA, Campo AM, Bollenbach M, Drennan CL, Balskus EP. Structure-Guided Identification of a Small Molecule That Inhibits Anaerobic Choline Metabolism by Human Gut Bacteria. J Am Chem Soc 2019;141:33-7. [PMID: 30557011 DOI: 10.1021/jacs.8b04883] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
315 Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, Siuzdak G. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA. 2009;106:3698-3703. [PMID: 19234110 DOI: 10.1073/pnas.0812874106] [Cited by in Crossref: 1466] [Cited by in F6Publishing: 1322] [Article Influence: 112.8] [Reference Citation Analysis]
316 Li R, Mao Z, Ye X, Zuo T. Human Gut Microbiome and Liver Diseases: From Correlation to Causation. Microorganisms 2021;9:1017. [PMID: 34066850 DOI: 10.3390/microorganisms9051017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
317 Wang D, Zhang P, Wang X, Wang Y, Zhou Z, Zhu W. NMR- and LC-MS/MS-based urine metabolomic investigation of the subacute effects of hexabromocyclododecane in mice. Environ Sci Pollut Res Int 2016;23:8500-7. [PMID: 26786581 DOI: 10.1007/s11356-015-5940-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
318 Icaza-Chávez ME. [Gut microbiota in health and disease]. Rev Gastroenterol Mex 2013;78:240-8. [PMID: 24290319 DOI: 10.1016/j.rgmx.2013.04.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
319 Blander JM, Longman RS, Iliev ID, Sonnenberg GF, Artis D. Regulation of inflammation by microbiota interactions with the host. Nat Immunol 2017;18:851-60. [PMID: 28722709 DOI: 10.1038/ni.3780] [Cited by in Crossref: 263] [Cited by in F6Publishing: 243] [Article Influence: 52.6] [Reference Citation Analysis]
320 Zhang Z, Zhang XX, Wu B, Yin J, Yu Y, Yang L. Comprehensive insights into microcystin-LR effects on hepatic lipid metabolism using cross-omics technologies. J Hazard Mater 2016;315:126-34. [PMID: 27208774 DOI: 10.1016/j.jhazmat.2016.05.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
321 Dong TS, Jacobs JP. Nonalcoholic fatty liver disease and the gut microbiome: Are bacteria responsible for fatty liver? Exp Biol Med (Maywood) 2019;244:408-18. [PMID: 30871368 DOI: 10.1177/1535370219836739] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
322 Zabek A, Paslawski R, Paslawska U, Wojtowicz W, Drozdz K, Polakof S, Podhorska M, Dziegiel P, Mlynarz P, Szuba A. The influence of different diets on metabolism and atherosclerosis processes-A porcine model: Blood serum, urine and tissues 1H NMR metabolomics targeted analysis. PLoS One 2017;12:e0184798. [PMID: 28991897 DOI: 10.1371/journal.pone.0184798] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
323 Chénard T, Prévost K, Dubé J, Massé E. Immune System Modulations by Products of the Gut Microbiota. Vaccines (Basel) 2020;8:E461. [PMID: 32825559 DOI: 10.3390/vaccines8030461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
324 Feng WW, Liu J, Cheng H, Peng C. Integration of Gut Microbiota and Metabolomics for Chinese Medicines Research: Opportunities and Challenges. Chin J Integr Med 2021. [PMID: 34755290 DOI: 10.1007/s11655-021-3305-x] [Reference Citation Analysis]
325 Mohamed Ahmed IA, Eltayeb ME, Mori N, Arima J, Tanaka H, Taniguchi T, Yamanaka N. Proteomic analysis of homocholine catabolic pathway in Pseudomonas sp. strain A9. Process Biochemistry 2015;50:1735-47. [DOI: 10.1016/j.procbio.2015.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
326 Jia W, Rajani C. The Influence of Gut Microbial Metabolism on the Development and Progression of Non-alcoholic Fatty Liver Disease. Adv Exp Med Biol 2018;1061:95-110. [PMID: 29956209 DOI: 10.1007/978-981-10-8684-7_8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
327 Wong BW, Meredith A, Lin D, McManus BM. The biological role of inflammation in atherosclerosis. Can J Cardiol. 2012;28:631-641. [PMID: 22985787 DOI: 10.1016/j.cjca.2012.06.023] [Cited by in Crossref: 109] [Cited by in F6Publishing: 103] [Article Influence: 10.9] [Reference Citation Analysis]
328 Gkolfakis P, Dimitriadis G, Triantafyllou K. Gut microbiota and non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int 2015;14:572-81. [PMID: 26663004 DOI: 10.1016/s1499-3872(15)60026-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
329 Collins D, Winter DC, Hogan AM, Schirmer L, Baird AW, Stewart GS. Differential protein abundance and function of UT-B urea transporters in human colon. Am J Physiol Gastrointest Liver Physiol 2010;298:G345-51. [PMID: 19926813 DOI: 10.1152/ajpgi.00405.2009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
330 Rojo D, Gosalbes MJ, Ferrari R, Pérez-Cobas AE, Hernández E, Oltra R, Buesa J, Latorre A, Barbas C, Ferrer M, Moya A. Clostridium difficile heterogeneously impacts intestinal community architecture but drives stable metabolome responses. ISME J 2015;9:2206-20. [PMID: 25756679 DOI: 10.1038/ismej.2015.32] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
331 Dao MC, Sokolovska N, Brazeilles R, Affeldt S, Pelloux V, Prifti E, Chilloux J, Verger EO, Kayser BD, Aron-Wisnewsky J, Ichou F, Pujos-Guillot E, Hoyles L, Juste C, Doré J, Dumas ME, Rizkalla SW, Holmes BA, Zucker JD, Clément K; MICRO-Obes Consortium. A Data Integration Multi-Omics Approach to Study Calorie Restriction-Induced Changes in Insulin Sensitivity. Front Physiol 2018;9:1958. [PMID: 30804813 DOI: 10.3389/fphys.2018.01958] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
332 Lu K, Mahbub R, Fox JG. Xenobiotics: Interaction with the Intestinal Microflora. ILAR J 2015;56:218-27. [PMID: 26323631 DOI: 10.1093/ilar/ilv018] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 9.5] [Reference Citation Analysis]
333 Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M, Clément K. Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity? Gastroenterology 2020;158:1881-98. [PMID: 32044317 DOI: 10.1053/j.gastro.2020.01.049] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 12.5] [Reference Citation Analysis]
334 Francque SM, van der Graaff D, Kwanten WJ. Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications. J Hepatol. 2016;65:425-443. [PMID: 27091791 DOI: 10.1016/j.jhep.2016.04.005] [Cited by in Crossref: 190] [Cited by in F6Publishing: 185] [Article Influence: 31.7] [Reference Citation Analysis]
335 Chen EB, Cason C, Gilbert JA, Ho KJ. Current State of Knowledge on Implications of Gut Microbiome for Surgical Conditions. J Gastrointest Surg 2018;22:1112-23. [PMID: 29623674 DOI: 10.1007/s11605-018-3755-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
336 Fardet A. New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre? Nutr Res Rev. 2010;23:65-134. [PMID: 20565994 DOI: 10.1017/s0954422410000041] [Cited by in Crossref: 592] [Cited by in F6Publishing: 147] [Article Influence: 49.3] [Reference Citation Analysis]
337 Barton RH. A decade of advances in metabonomics. Expert Opin Drug Metab Toxicol. 2011;7:129-136. [PMID: 21219245 DOI: 10.1517/17425255.2011.547473] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
338 Jennison E, Byrne CD. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease. Clin Mol Hepatol 2021;27:22-43. [PMID: 33291863 DOI: 10.3350/cmh.2020.0129] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
339 Fukui H. Gut Microbiota and Host Reaction in Liver Diseases. Microorganisms. 2015;3:759-791. [PMID: 27682116 DOI: 10.3390/microorganisms3040759] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
340 Bain JR, Stevens RD, Wenner BR, Ilkayeva O, Muoio DM, Newgard CB. Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes 2009;58:2429-43. [PMID: 19875619 DOI: 10.2337/db09-0580] [Cited by in Crossref: 244] [Cited by in F6Publishing: 220] [Article Influence: 20.3] [Reference Citation Analysis]
341 Cui HX, Hu YN, Li JW, Yuan K. Hypoglycemic Mechanism of the Berberine Organic Acid Salt under the Synergistic Effect of Intestinal Flora and Oxidative Stress. Oxid Med Cell Longev. 2018;2018:8930374. [PMID: 30662584 DOI: 10.1155/2018/8930374] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
342 Krautkramer KA, Dhillon RS, Denu JM, Carey HV. Metabolic programming of the epigenome: host and gut microbial metabolite interactions with host chromatin. Transl Res 2017;189:30-50. [PMID: 28919341 DOI: 10.1016/j.trsl.2017.08.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
343 Aguirre M, Venema K. Does the Gut Microbiota Contribute to Obesity? Going beyond the Gut Feeling. Microorganisms 2015;3:213-35. [PMID: 27682087 DOI: 10.3390/microorganisms3020213] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
344 Contopoulos-Ioannidis DG, Ley C, Wang W, Ma T, Olson C, Shi X, Luft HS, Hastie T, Parsonnet J. Effect of long-term antibiotic use on weight in adolescents with acne. J Antimicrob Chemother 2016;71:1098-105. [PMID: 26782773 DOI: 10.1093/jac/dkv455] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
345 Marra F, Lotersztajn S. Pathophysiology of NASH: perspectives for a targeted treatment. Curr Pharm Des. 2013;19:5250-5269. [PMID: 23394092 DOI: 10.2174/1381612811399990344] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
346 He X, Ji G, Jia W, Li H. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics. Int J Mol Sci. 2016;17:300. [PMID: 26999104 DOI: 10.3390/ijms17030300] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
347 Patel DP, Krausz KW, Xie C, Beyoğlu D, Gonzalez FJ, Idle JR. Metabolic profiling by gas chromatography-mass spectrometry of energy metabolism in high-fat diet-fed obese mice. PLoS One 2017;12:e0177953. [PMID: 28520815 DOI: 10.1371/journal.pone.0177953] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 6.4] [Reference Citation Analysis]
348 Diamant M, Blaak EE, de Vos WM. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev. 2011;12:272-281. [PMID: 20804522 DOI: 10.1111/j.1467-789x.2010.00797.x] [Cited by in Crossref: 182] [Cited by in F6Publishing: 97] [Article Influence: 15.2] [Reference Citation Analysis]
349 Hui ST, Parks BW, Org E, Norheim F, Che N, Pan C, Castellani LW, Charugundla S, Dirks DL, Psychogios N, Neuhaus I, Gerszten RE, Kirchgessner T, Gargalovic PS, Lusis AJ. The genetic architecture of NAFLD among inbred strains of mice. Elife 2015;4:e05607. [PMID: 26067236 DOI: 10.7554/eLife.05607] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 8.3] [Reference Citation Analysis]
350 Tell G, Vascotto C, Tiribelli C. Alterations in the redox state and liver damage: hints from the EASL Basic School of Hepatology. J Hepatol 2013;58:365-74. [PMID: 23023012 DOI: 10.1016/j.jhep.2012.09.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
351 Li M, Wu T, Ji G, Zheng PY. Applications of metabolomics technology in traditional Chinese medicine treatment of non-alcoholic fatty liver disease. Shijie Huaren Xiaohua Zazhi 2015; 23(7): 1045-1051 [DOI: 10.11569/wcjd.v23.i7.1045] [Reference Citation Analysis]
352 Zhang S, Nagana Gowda GA, Ye T, Raftery D. Advances in NMR-based biofluid analysis and metabolite profiling. Analyst 2010;135:1490-8. [PMID: 20379603 DOI: 10.1039/c000091d] [Cited by in Crossref: 85] [Cited by in F6Publishing: 74] [Article Influence: 7.1] [Reference Citation Analysis]
353 Ming X, Stein TP, Barnes V, Rhodes N, Guo L. Metabolic perturbance in autism spectrum disorders: a metabolomics study. J Proteome Res 2012;11:5856-62. [PMID: 23106572 DOI: 10.1021/pr300910n] [Cited by in Crossref: 140] [Cited by in F6Publishing: 131] [Article Influence: 14.0] [Reference Citation Analysis]
354 Teng M, Zhu W, Wang D, Qi S, Wang Y, Yan J, Dong K, Zheng M, Wang C. Metabolomics and transcriptomics reveal the toxicity of difenoconazole to the early life stages of zebrafish (Danio rerio). Aquatic Toxicology 2018;194:112-20. [DOI: 10.1016/j.aquatox.2017.11.009] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
355 Zhao X, Huang C, Lei H, Nie X, Tang H, Wang Y. Dynamic Metabolic Response of Mice to Acute Mequindox Exposure. J Proteome Res 2011;10:5183-90. [DOI: 10.1021/pr2006457] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
356 Fabian E, Bordag N, Herold M, Kamp H, Krennrich G, Looser R, Ma-Hock L, Mellert W, Montoya G, Peter E, Prokudin A, Spitzer M, Strauss V, Walk T, Zbranek R, van Ravenzwaay B. Metabolite profiles of rats in repeated dose toxicological studies after oral and inhalative exposure. Toxicol Lett 2016;255:11-23. [PMID: 27153797 DOI: 10.1016/j.toxlet.2016.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
357 Shanahan F. The colonic microbiota in health and disease. Curr Opin Gastroenterol. 2013;29:49-54. [PMID: 23041677 DOI: 10.1097/mog.0b013e32835a3493] [Cited by in Crossref: 61] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
358 Bahr SM, Weidemann BJ, Castro AN, Walsh JW, deLeon O, Burnett CM, Pearson NA, Murry DJ, Grobe JL, Kirby JR. Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure. EBioMedicine 2015;2:1725-34. [PMID: 26870798 DOI: 10.1016/j.ebiom.2015.10.018] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 11.7] [Reference Citation Analysis]
359 Kinross JM, von Roon AC, Holmes E, Darzi A, Nicholson JK. The human gut microbiome: implications for future health care. Curr Gastroenterol Rep. 2008;10:396-403. [PMID: 18627653 DOI: 10.1007/s11894-008-0075-y] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 6.1] [Reference Citation Analysis]
360 Harris K, Kassis A, Major G, Chou CJ. Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J Obes 2012;2012:879151. [PMID: 22315672 DOI: 10.1155/2012/879151] [Cited by in Crossref: 34] [Cited by in F6Publishing: 87] [Article Influence: 3.4] [Reference Citation Analysis]
361 Martin FP, Collino S, Rezzi S. 1H NMR-based metabonomic applications to decipher gut microbial metabolic influence on mammalian health. Magn Reson Chem 2011;49 Suppl 1:S47-54. [PMID: 22290709 DOI: 10.1002/mrc.2810] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
362 Harakeh SM, Khan I, Kumosani T, Barbour E, Almasaudi SB, Bahijri SM, Alfadul SM, Ajabnoor GM, Azhar EI. Gut Microbiota: A Contributing Factor to Obesity. Front Cell Infect Microbiol 2016;6:95. [PMID: 27625997 DOI: 10.3389/fcimb.2016.00095] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 7.7] [Reference Citation Analysis]
363 Singh V, Yeoh BS, Ntambi JM, Vijay-kumar M. Influence of Gut Microbiota on Hepatic Lipogenesis and Disease Pathogenesis. In: Ntambi JM, editor. Hepatic De Novo Lipogenesis and Regulation of Metabolism. Cham: Springer International Publishing; 2016. pp. 189-209. [DOI: 10.1007/978-3-319-25065-6_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
364 Noecker C, Chiu HC, McNally CP, Borenstein E. Defining and Evaluating Microbial Contributions to Metabolite Variation in Microbiome-Metabolome Association Studies. mSystems 2019;4:e00579-19. [PMID: 31848305 DOI: 10.1128/mSystems.00579-19] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
365 Wang L, Chen J, Chen L, Deng P, Bu Q, Xiang P, Li M, Lu W, Xu Y, Lin H. 1H-NMR based metabonomic profiling of human esophageal cancer tissue. Mol Cancer. 2013;12:25. [PMID: 23556477 DOI: 10.1186/1476-4598-12-25] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
366 Ebrahimzadeh Leylabadlo H, Ghotaslou R, Samadi Kafil H, Feizabadi MM, Moaddab SY, Farajnia S, Sheykhsaran E, Sanaie S, Shanehbandi D, Bannazadeh Baghi H. Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies. Eur J Clin Microbiol Infect Dis 2020;39:613-27. [PMID: 31828683 DOI: 10.1007/s10096-019-03746-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
367 Fouts DE, Torralba M, Nelson KE, Brenner DA, Schnabl B. Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease. J Hepatol. 2012;56:1283-1292. [PMID: 22326468 DOI: 10.1016/j.jhep.2012.01.019] [Cited by in Crossref: 187] [Cited by in F6Publishing: 184] [Article Influence: 18.7] [Reference Citation Analysis]
368 Fang C, Du H, Zheng X, Zhao A, Jia W, Xu Y. Solid-state fermented Chinese alcoholic beverage (baijiu) and ethanol resulted in distinct metabolic and microbiome responses. FASEB J 2019;33:7274-88. [PMID: 30857422 DOI: 10.1096/fj.201802306R] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
369 Wang D, Cui Y, Cao Y, He Y, Chen H. Human Microbe-Disease Association Prediction by a Novel Double-Ended Random Walk with Restart. Biomed Res Int 2020;2020:3978702. [PMID: 32851068 DOI: 10.1155/2020/3978702] [Reference Citation Analysis]
370 Sun P, Jin M, Ding L, Lu Y, Ma H, Yuan Y, Zhou Q. Dietary lipid levels could improve growth and intestinal microbiota of juvenile swimming crab, Portunus trituberculatus. Aquaculture 2018;490:208-16. [DOI: 10.1016/j.aquaculture.2018.02.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
371 Prakash S, Rodes L, Coussa-Charley M, Tomaro-Duchesneau C. Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics. 2011;5:71-86. [PMID: 21847343 DOI: 10.2147/btt.s19099] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 5.0] [Reference Citation Analysis]
372 Machado MV, Cortez-pinto H. Gut microbiota and nonalcoholic fatty liver disease. Annals of Hepatology 2012;11:440-9. [DOI: 10.1016/s1665-2681(19)31457-7] [Cited by in Crossref: 99] [Article Influence: 9.9] [Reference Citation Analysis]
373 Safari Z, Bruneau A, Monnoye M, Mariadassou M, Philippe C, Zatloukal K, Gérard P. Murine Genetic Background Overcomes Gut Microbiota Changes to Explain Metabolic Response to High-Fat Diet. Nutrients 2020;12:E287. [PMID: 31973214 DOI: 10.3390/nu12020287] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
374 Huang H, Zhang A, Cao H, Lu H, Wang B, Xie Q, Xu W, Li L. Metabolomic analyses of faeces reveals malabsorption in cirrhotic patients. Digestive and Liver Disease 2013;45:677-82. [DOI: 10.1016/j.dld.2013.01.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
375 Mohammed A, Guda C. Application of a hierarchical enzyme classification method reveals the role of gut microbiome in human metabolism. BMC Genomics 2015;16 Suppl 7:S16. [PMID: 26099921 DOI: 10.1186/1471-2164-16-S7-S16] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
376 Li D, Wang P, Wang P, Hu X, Chen F. The gut microbiota: A treasure for human health. Biotechnology Advances 2016;34:1210-24. [DOI: 10.1016/j.biotechadv.2016.08.003] [Cited by in Crossref: 91] [Cited by in F6Publishing: 79] [Article Influence: 15.2] [Reference Citation Analysis]
377 Reigstad CS, Bäckhed F. Microbial regulation of SAA3 expression in mouse colon and adipose tissue. Gut Microbes 2010;1:55-7. [PMID: 21327118 DOI: 10.4161/gmic.1.1.10514] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
378 Dumas M, Wilder SP, Bihoreau M, Barton RH, Fearnside JF, Argoud K, D'amato L, Wallis RH, Blancher C, Keun HC, Baunsgaard D, Scott J, Sidelmann UG, Nicholson JK, Gauguier D. Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models. Nat Genet 2007;39:666-72. [DOI: 10.1038/ng2026] [Cited by in Crossref: 118] [Cited by in F6Publishing: 107] [Article Influence: 7.9] [Reference Citation Analysis]
379 Spencer MD, Hamp TJ, Reid RW, Fischer LM, Zeisel SH, Fodor AA. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 2011;140:976-86. [PMID: 21129376 DOI: 10.1053/j.gastro.2010.11.049] [Cited by in Crossref: 378] [Cited by in F6Publishing: 349] [Article Influence: 31.5] [Reference Citation Analysis]
380 Su Q, Guan T, He Y, Lv H. Siderophore Biosynthesis Governs the Virulence of Uropathogenic Escherichia coli by Coordinately Modulating the Differential Metabolism. J Proteome Res 2016;15:1323-32. [DOI: 10.1021/acs.jproteome.6b00061] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
381 Smallwood T, Allayee H, Bennett BJ. Choline metabolites: gene by diet interactions. Curr Opin Lipidol. 2016;27:33-39. [PMID: 26655287 DOI: 10.1097/mol.0000000000000259] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
382 Dunn WB, Goodacre R, Neyses L, Mamas M. Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook. Bioanalysis 2011;3:2205-22. [DOI: 10.4155/bio.11.223] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
383 Daliry A, Pereira ENGDS. Role of Maternal Microbiota and Nutrition in Early-Life Neurodevelopmental Disorders. Nutrients 2021;13:3533. [PMID: 34684534 DOI: 10.3390/nu13103533] [Reference Citation Analysis]
384 Leung C, Rivera L, Furness JB, Angus PW. The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol. 2016;13:412-425. [PMID: 27273168 DOI: 10.1038/nrgastro.2016.85] [Cited by in Crossref: 362] [Cited by in F6Publishing: 339] [Article Influence: 60.3] [Reference Citation Analysis]
385 Fan L, Zhao X, Tong Q, Zhou X, Chen J, Xiong W, Fang J, Wang W, Shi C. Interactions of Dihydromyricetin, a Flavonoid from Vine Tea (Ampelopsis grossedentata) with Gut Microbiota. J Food Sci 2018;83:1444-53. [PMID: 29660761 DOI: 10.1111/1750-3841.14128] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
386 Salzman NH, Underwood MA, Bevins CL. Paneth cells, defensins, and the commensal microbiota: A hypothesis on intimate interplay at the intestinal mucosa. Seminars in Immunology 2007;19:70-83. [DOI: 10.1016/j.smim.2007.04.002] [Cited by in Crossref: 262] [Cited by in F6Publishing: 240] [Article Influence: 17.5] [Reference Citation Analysis]
387 Carotti S, Guarino MPL, Vespasiani-Gentilucci U, Morini S. Starring role of toll-like receptor-4 activation in the gut-liver axis. World J Gastrointest Pathophysiol 2015; 6(4): 99-109 [PMID: 26600967 DOI: 10.4291/wjgp.v6.i4.99] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
388 Leong KSW, Jayasinghe TN, Derraik JGB, Albert BB, Chiavaroli V, Svirskis DM, Beck KL, Conlon CA, Jiang Y, Schierding W, Vatanen T, Holland DJ, O'Sullivan JM, Cutfield WS. Protocol for the Gut Bugs Trial: a randomised double-blind placebo-controlled trial of gut microbiome transfer for the treatment of obesity in adolescents. BMJ Open 2019;9:e026174. [PMID: 31005929 DOI: 10.1136/bmjopen-2018-026174] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
389 Nilsson Å, Duan RD. Pancreatic and mucosal enzymes in choline phospholipid digestion. Am J Physiol Gastrointest Liver Physiol 2019;316:G425-45. [PMID: 30576217 DOI: 10.1152/ajpgi.00320.2018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
390 Chen P, Liu J. Metabonomics and diabetes mellitus. Adv Therapy 2007;24:1036-45. [DOI: 10.1007/bf02877709] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
391 Palma M, Hernández-Castellano LE, Castro N, Arguëllo A, Capote J, Matzapetakis M, de Almeida AM. NMR-metabolomics profiling of mammary gland secretory tissue and milk serum in two goat breeds with different levels of tolerance to seasonal weight loss. Mol Biosyst 2016;12:2094-107. [PMID: 27001028 DOI: 10.1039/c5mb00851d] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 4.2] [Reference Citation Analysis]
392 Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R. Publisher Correction: The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol 2018;15:785. [PMID: 29785003 DOI: 10.1038/s41575-018-0031-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
393 Milan AM, Cameron-smith D. Digestion and Postprandial Metabolism in the Elderly. Elsevier; 2015. pp. 79-124. [DOI: 10.1016/bs.afnr.2015.09.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
394 Carroll IM, Threadgill DW, Threadgill DS. The gastrointestinal microbiome: a malleable, third genome of mammals. Mamm Genome 2009;20:395-403. [PMID: 19629594 DOI: 10.1007/s00335-009-9204-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
395 Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008;3:213-23. [PMID: 18407065 DOI: 10.1016/j.chom.2008.02.015] [Cited by in Crossref: 1777] [Cited by in F6Publishing: 1634] [Article Influence: 126.9] [Reference Citation Analysis]
396 Hernández-Alonso P, Cañueto D, Giardina S, Salas-Salvadó J, Cañellas N, Correig X, Bulló M. Effect of pistachio consumption on the modulation of urinary gut microbiota-related metabolites in prediabetic subjects. J Nutr Biochem 2017;45:48-53. [PMID: 28432876 DOI: 10.1016/j.jnutbio.2017.04.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
397 Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, Wu Y, Schauer P, Smith JD, Allayee H, Tang WH, DiDonato JA, Lusis AJ, Hazen SL. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57-63. [PMID: 21475195 DOI: 10.1038/nature09922] [Cited by in Crossref: 2773] [Cited by in F6Publishing: 2552] [Article Influence: 252.1] [Reference Citation Analysis]
398 Fu ZD, Cui JY. Remote Sensing between Liver and Intestine: Importance of Microbial Metabolites. Curr Pharmacol Rep 2017;3:101-13. [PMID: 28983453 DOI: 10.1007/s40495-017-0087-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
399 Murdoch TB, Fu H, MacFarlane S, Sydora BC, Fedorak RN, Slupsky CM. Urinary metabolic profiles of inflammatory bowel disease in interleukin-10 gene-deficient mice. Anal Chem. 2008;80:5524-5531. [PMID: 18558774 DOI: 10.1021/ac8005236] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
400 Schnackenberg LK, Beger RD. The role of metabolic biomarkers in drug toxicity studies. Toxicol Mech Methods 2008;18:301-11. [PMID: 20020895 DOI: 10.1080/15376510701623193] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
401 Elliott P, Posma JM, Chan Q, Garcia-Perez I, Wijeyesekera A, Bictash M, Ebbels TM, Ueshima H, Zhao L, van Horn L, Daviglus M, Stamler J, Holmes E, Nicholson JK. Urinary metabolic signatures of human adiposity. Sci Transl Med 2015;7:285ra62. [PMID: 25925681 DOI: 10.1126/scitranslmed.aaa5680] [Cited by in Crossref: 132] [Cited by in F6Publishing: 110] [Article Influence: 18.9] [Reference Citation Analysis]
402 Li X, Chen Y, Liu J, Yang G, Zhao J, Liao G, Shi M, Yuan Y, He S, Lu Y, Cheng J. Serum metabolic variables associated with impaired glucose tolerance induced by high-fat-high-cholesterol diet in Macaca mulatta. Exp Biol Med (Maywood). 2012;237:1310-1321. [PMID: 23239442 DOI: 10.1258/ebm.2012.012157] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
403 Albhaisi SAM, Bajaj JS, Sanyal AJ. Role of gut microbiota in liver disease. Am J Physiol Gastrointest Liver Physiol 2020;318:G84-98. [PMID: 31657225 DOI: 10.1152/ajpgi.00118.2019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
404 He X, Qi Z, Hou H, Gao J, Zhang X. Effects of chronic cadmium exposure at food limitation-relevant levels on energy metabolism in mice. Journal of Hazardous Materials 2020;388:121791. [DOI: 10.1016/j.jhazmat.2019.121791] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
405 Ivanovic N, Minic R, Djuricic I, Dimitrijevic L, Sobajic S, Zivkovic I, Djordjevic B. Brain and liver fatty acid composition changes upon consumption of Lactobacillus rhamnosus LA68. Int J Food Sci Nutr 2015;66:93-7. [PMID: 25431181 DOI: 10.3109/09637486.2014.979313] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
406 Craciun S, Marks JA, Balskus EP. Characterization of choline trimethylamine-lyase expands the chemistry of glycyl radical enzymes. ACS Chem Biol 2014;9:1408-13. [PMID: 24854437 DOI: 10.1021/cb500113p] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 9.3] [Reference Citation Analysis]
407 Torres N, Guevara-cruz M, Velázquez-villegas LA, Tovar AR. Nutrition and Atherosclerosis. Archives of Medical Research 2015;46:408-26. [DOI: 10.1016/j.arcmed.2015.05.010] [Cited by in Crossref: 102] [Cited by in F6Publishing: 78] [Article Influence: 14.6] [Reference Citation Analysis]
408 Schwimmer JB, Johnson JS, Angeles JE, Behling C, Belt PH, Borecki I, Bross C, Durelle J, Goyal NP, Hamilton G, Holtz ML, Lavine JE, Mitreva M, Newton KP, Pan A, Simpson PM, Sirlin CB, Sodergren E, Tyagi R, Yates KP, Weinstock GM, Salzman NH. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease. Gastroenterology 2019;157:1109-22. [PMID: 31255652 DOI: 10.1053/j.gastro.2019.06.028] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 22.7] [Reference Citation Analysis]
409 Chen J, Zhao X, Fritsche J, Yin P, Schmitt-kopplin P, Wang W, Lu X, Häring HU, Schleicher ED, Lehmann R, Xu G. Practical Approach for the Identification and Isomer Elucidation of Biomarkers Detected in a Metabonomic Study for the Discovery of Individuals at Risk for Diabetes by Integrating the Chromatographic and Mass Spectrometric Information. Anal Chem 2008;80:1280-9. [DOI: 10.1021/ac702089h] [Cited by in Crossref: 147] [Cited by in F6Publishing: 134] [Article Influence: 10.5] [Reference Citation Analysis]
410 Brochot A, Azalbert V, Landrier JF, Tourniaire F, Serino M. A Two-Week Treatment with Plant Extracts Changes Gut Microbiota, Caecum Metabolome, and Markers of Lipid Metabolism in ob/ob Mice. Mol Nutr Food Res 2019;63:e1900403. [PMID: 31206248 DOI: 10.1002/mnfr.201900403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
411 Aron-wisnewsky J, Gaborit B, Dutour A, Clement K. Gut microbiota and non-alcoholic fatty liver disease: new insights. Clinical Microbiology and Infection 2013;19:338-48. [DOI: 10.1111/1469-0691.12140] [Cited by in Crossref: 141] [Cited by in F6Publishing: 134] [Article Influence: 15.7] [Reference Citation Analysis]
412 Bennett BJ, de Aguiar Vallim TQ, Wang Z, Shih DM, Meng Y, Gregory J, Allayee H, Lee R, Graham M, Crooke R, Edwards PA, Hazen SL, Lusis AJ. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013;17:49-60. [PMID: 23312283 DOI: 10.1016/j.cmet.2012.12.011] [Cited by in Crossref: 508] [Cited by in F6Publishing: 486] [Article Influence: 56.4] [Reference Citation Analysis]
413 Koontz JM, Dancy BCR, Horton CL, Stallings JD, DiVito VT, Lewis JA. The Role of the Human Microbiome in Chemical Toxicity. Int J Toxicol 2019;38:251-64. [PMID: 31220972 DOI: 10.1177/1091581819849833] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
414 Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, Sidaway JE, Nicholson JK, Holmes E. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci USA. 2011;108 Suppl 1:4523-4530. [PMID: 20837534 DOI: 10.1073/pnas.1006734107] [Cited by in Crossref: 425] [Cited by in F6Publishing: 404] [Article Influence: 35.4] [Reference Citation Analysis]
415 Bajaj JS, Hylemon PB, Younossi Z. The Intestinal Microbiota and Liver Disease. Am J Gastroenterol Suppl 2012;1:9-14. [DOI: 10.1038/ajgsup.2012.3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
416 Dumas ME. The microbial-mammalian metabolic axis: beyond simple metabolism. Cell Metab 2011;13:489-90. [PMID: 21531329 DOI: 10.1016/j.cmet.2011.04.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
417 Ruan Z, Yang Y, Wen Y, Zhou Y, Fu X, Ding S, Liu G, Yao K, Wu X, Deng Z, Wu G, Yin Y. Metabolomic analysis of amino acid and fat metabolism in rats with l-tryptophan supplementation. Amino Acids 2014;46:2681-91. [DOI: 10.1007/s00726-014-1823-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
418 Yamamoto M, Pinto-Sanchez MI, Bercik P, Britz-McKibbin P. Metabolomics reveals elevated urinary excretion of collagen degradation and epithelial cell turnover products in irritable bowel syndrome patients. Metabolomics 2019;15:82. [PMID: 31111238 DOI: 10.1007/s11306-019-1543-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
419 El-Sayed A, Aleya L, Kamel M. Microbiota and epigenetics: promising therapeutic approaches? Environ Sci Pollut Res Int 2021. [PMID: 34319520 DOI: 10.1007/s11356-021-15623-6] [Reference Citation Analysis]
420 Xue C, Lv H, Li Y, Dong N, Wang Y, Zhou J, Shi B, Shan A. Oleanolic acid reshapes the gut microbiota and alters immune-related gene expression of intestinal epithelial cells. J Sci Food Agric 2021. [PMID: 34227118 DOI: 10.1002/jsfa.11410] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
421 Nicolas S, Blasco-Baque V, Fournel A, Gilleron J, Klopp P, Waget A, Ceppo F, Marlin A, Padmanabhan R, Iacovoni JS, Tercé F, Cani PD, Tanti JF, Burcelin R, Knauf C, Cormont M, Serino M. Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism. Mol Syst Biol 2017;13:921. [PMID: 28302863 DOI: 10.15252/msb.20167356] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
422 Wijarnpreecha K, Lou S, Watthanasuntorn K, Kroner PT, Cheungpasitporn W, Lukens FJ, Pungpapong S, Keaveny AP, Ungprasert P. Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2020;32:601-8. [PMID: 31567712 DOI: 10.1097/MEG.0000000000001541] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
423 Zeng H, Liu J, Jackson MI, Zhao FQ, Yan L, Combs GF Jr. Fatty liver accompanies an increase in lactobacillus species in the hind gut of C57BL/6 mice fed a high-fat diet. J Nutr 2013;143:627-31. [PMID: 23486979 DOI: 10.3945/jn.112.172460] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 6.2] [Reference Citation Analysis]
424 Tong X, Sun H, Yan GL, Dong W, Sun WJ, Yu Y, Wang P, Han Y, Wang XJ. Evaluation study on urine metabolomics in yinhuang rat model induced by triplet factors of rhubarb, ethanol, and α-nephthylisothiolyanate. Chin J Integr Med. 2011;17:369-375. [PMID: 21611901 DOI: 10.1007/s11655-011-0728-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
425 Adamovsky O, Buerger AN, Wormington AM, Ector N, Griffitt RJ, Bisesi JH, Martyniuk CJ. The gut microbiome and aquatic toxicology: An emerging concept for environmental health: The microbiome and aquatic toxicology. Environ Toxicol Chem 2018;37:2758-75. [DOI: 10.1002/etc.4249] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 10.5] [Reference Citation Analysis]
426 Walker A, Pfitzner B, Neschen S, Kahle M, Harir M, Lucio M, Moritz F, Tziotis D, Witting M, Rothballer M, Engel M, Schmid M, Endesfelder D, Klingenspor M, Rattei T, Castell WZ, de Angelis MH, Hartmann A, Schmitt-Kopplin P. Distinct signatures of host-microbial meta-metabolome and gut microbiome in two C57BL/6 strains under high-fat diet. ISME J 2014;8:2380-96. [PMID: 24906017 DOI: 10.1038/ismej.2014.79] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 10.4] [Reference Citation Analysis]
427 Yap IKS, Li JV, Saric J, Martin F, Davies H, Wang Y, Wilson ID, Nicholson JK, Utzinger J, Marchesi JR, Holmes E. Metabonomic and Microbiological Analysis of the Dynamic Effect of Vancomycin-Induced Gut Microbiota Modification in the Mouse. J Proteome Res 2008;7:3718-28. [DOI: 10.1021/pr700864x] [Cited by in Crossref: 174] [Cited by in F6Publishing: 163] [Article Influence: 12.4] [Reference Citation Analysis]
428 Li D, Kirsop J, Tang WH. Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes Pathogenesis. Curr Diab Rep 2015;15:63. [PMID: 26208694 DOI: 10.1007/s11892-015-0634-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
429 Bao Q, Feng J, Chen L, Chen F, Liu Z, Jiang B, Liu C. A robust automatic phase correction method for signal dense spectra. Journal of Magnetic Resonance 2013;234:82-9. [DOI: 10.1016/j.jmr.2013.06.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
430 Ding L, Oligschlaeger Y, Shiri-Sverdlov R, Houben T. Nonalcoholic Fatty Liver Disease. Handb Exp Pharmacol 2020. [PMID: 32185502 DOI: 10.1007/164_2020_352] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
431 Tang WHW, Li DY, Hazen SL. Dietary metabolism, the gut microbiome, and heart failure. Nat Rev Cardiol 2019;16:137-54. [PMID: 30410105 DOI: 10.1038/s41569-018-0108-7] [Cited by in Crossref: 146] [Cited by in F6Publishing: 136] [Article Influence: 73.0] [Reference Citation Analysis]
432 Gauguier D. Application of quantitative metabolomics in systems genetics in rodent models of complex phenotypes. Archives of Biochemistry and Biophysics 2016;589:158-67. [DOI: 10.1016/j.abb.2015.09.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
433 Russell WR, Hoyles L, Flint HJ, Dumas ME. Colonic bacterial metabolites and human health. Curr Opin Microbiol. 2013;16:246-254. [PMID: 23880135 DOI: 10.1016/j.mib.2013.07.002] [Cited by in Crossref: 213] [Cited by in F6Publishing: 196] [Article Influence: 23.7] [Reference Citation Analysis]
434 Pieper IA, Bertau M. Predictive tools for the evaluation of microbial effects on drugs during gastrointestinal passage. Expert Opinion on Drug Metabolism & Toxicology 2010;6:747-60. [DOI: 10.1517/17425251003769859] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
435 Pomié C, Blasco-Baque V, Klopp P, Nicolas S, Waget A, Loubières P, Azalbert V, Puel A, Lopez F, Dray C, Valet P, Lelouvier B, Servant F, Courtney M, Amar J, Burcelin R, Garidou L. Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia. Mol Metab 2016;5:392-403. [PMID: 27257599 DOI: 10.1016/j.molmet.2016.03.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
436 Munshi SU, Taneja S, Bhavesh NS, Shastri J, Aggarwal R, Jameel S. Metabonomic analysis of hepatitis E patients shows deregulated metabolic cycles and abnormalities in amino acid metabolism: Hepatitis E metabonomics. Journal of Viral Hepatitis 2011;18:e591-602. [DOI: 10.1111/j.1365-2893.2011.01488.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
437 Misra P, Singh S. Site specific microbiome of Leishmania parasite and its cross-talk with immune milieu. Immunol Lett 2019;216:79-88. [PMID: 31678358 DOI: 10.1016/j.imlet.2019.10.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
438 Ametaj BN, Zebeli Q, Saleem F, Psychogios N, Lewis MJ, Dunn SM, Xia J, Wishart DS. Metabolomics reveals unhealthy alterations in rumen metabolism with increased proportion of cereal grain in the diet of dairy cows. Metabolomics 2010;6:583-94. [DOI: 10.1007/s11306-010-0227-6] [Cited by in Crossref: 112] [Cited by in F6Publishing: 44] [Article Influence: 9.3] [Reference Citation Analysis]
439 Feng W, Ao H, Peng C, Yan D. Gut microbiota, a new frontier to understand traditional Chinese medicines. Pharmacol Res 2019;142:176-91. [PMID: 30818043 DOI: 10.1016/j.phrs.2019.02.024] [Cited by in Crossref: 86] [Cited by in F6Publishing: 83] [Article Influence: 28.7] [Reference Citation Analysis]
440 Griffin JL, Wang X, Stanley E. Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics. Circ Cardiovasc Genet 2015;8:187-91. [PMID: 25691688 DOI: 10.1161/CIRCGENETICS.114.000219] [Cited by in Crossref: 57] [Cited by in F6Publishing: 26] [Article Influence: 8.1] [Reference Citation Analysis]
441 Gabr MT, Machalz D, Pach S, Wolber G. A benzoxazole derivative as an inhibitor of anaerobic choline metabolism by human gut microbiota. RSC Med Chem 2020;11:1402-12. [PMID: 34095847 DOI: 10.1039/d0md00218f] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
442 Burcelin R, Serino M, Chabo C, Blasco-Baque V, Amar J. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol. 2011;48:257-273. [PMID: 21964884 DOI: 10.1007/s00592-011-0333-6] [Cited by in Crossref: 149] [Cited by in F6Publishing: 136] [Article Influence: 13.5] [Reference Citation Analysis]
443 Ciavarella A, Gnocchi D, Custodero C, Lenato GM, Fiore G, Sabbà C, Mazzocca A. Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease. Thromb Res 2021;198:139-50. [PMID: 33340925 DOI: 10.1016/j.thromres.2020.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
444 Martin FP, Dumas ME, Wang Y, Legido-Quigley C, Yap IKS, Tang H, Zirah S, Murphy GM, Cloarec O, Lindon JC. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol. 2007;3:112. [PMID: 17515922 DOI: 10.1038/msb4100153] [Cited by in Crossref: 343] [Cited by in F6Publishing: 317] [Article Influence: 22.9] [Reference Citation Analysis]
445 Han S, Van Treuren W, Fischer CR, Merrill BD, Defelice BC, Sanchez JM, Higginbottom SK, Guthrie L, Fall LA, Dodd D, Fischbach MA, Sonnenburg JL. A metabolomics pipeline for the mechanistic interrogation of the gut microbiome. Nature 2021;595:415-20. [DOI: 10.1038/s41586-021-03707-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
446 Maher JJ. Pathogenesis of NAFLD and NASH. In: Chalasani N, Szabo G, editors. Alcoholic and Non-Alcoholic Fatty Liver Disease. Cham: Springer International Publishing; 2016. pp. 71-101. [DOI: 10.1007/978-3-319-20538-0_4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
447 Shanab AA, Scully P, Crosbie O, Buckley M, O’mahony L, Shanahan F, Gazareen S, Murphy E, Quigley EMM. Small Intestinal Bacterial Overgrowth in Nonalcoholic Steatohepatitis: Association with Toll-Like Receptor 4 Expression and Plasma Levels of Interleukin 8. Dig Dis Sci 2011;56:1524-34. [DOI: 10.1007/s10620-010-1447-3] [Cited by in Crossref: 119] [Cited by in F6Publishing: 116] [Article Influence: 9.9] [Reference Citation Analysis]
448 Celarain N, Tomas-Roig J. Aberrant DNA methylation profile exacerbates inflammation and neurodegeneration in multiple sclerosis patients. J Neuroinflammation 2020;17:21. [PMID: 31937331 DOI: 10.1186/s12974-019-1667-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
449 Xie G, Zhang S, Zheng X, Jia W. Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes. Electrophoresis 2013;34:2787-98. [PMID: 23775228 DOI: 10.1002/elps.201300017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
450 Serino M, Blasco-Baque V, Nicolas S, Burcelin R. Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences. Curr Cardiol Rep 2014;16:540. [PMID: 25303894 DOI: 10.1007/s11886-014-0540-1] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 8.6] [Reference Citation Analysis]
451 Sun S, Yang M, Fu H, Ge X, Zou J. Altered intestinal microbiota induced by chronic hypoxia drives the effects on lipid metabolism and the immune response of oriental river prawn Macrobrachium nipponense. Aquaculture 2020;526:735431. [DOI: 10.1016/j.aquaculture.2020.735431] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
452 Luo L, Hu M, Li Y, Chen Y, Zhang S, Chen J, Wang Y, Lu B, Xie Z, Liao Q. Association between metabolic profile and microbiomic changes in rats with functional dyspepsia. RSC Adv 2018;8:20166-81. [DOI: 10.1039/c8ra01432a] [Cited by in Crossref: 17] [Article Influence: 4.3] [Reference Citation Analysis]
453 Jiang Y, Chowdhury S, Xu BH, Meybodi MA, Damiris K, Devalaraju S, Pyrsopoulos N. Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection. World J Hepatol 2021; 13(11): 1777-1790 [PMID: 34904045 DOI: 10.4254/wjh.v13.i11.1777] [Reference Citation Analysis]
454 Zhou JW, Jia AQ, Tan XJ, Chen H, Sun B, Huang TZ, He Y, Li PL, Liu EQ. 1-(4-Amino-2-Hydroxyphenyl)Ethenone Suppresses Agrobacterium tumefaciens Virulence and Metabolism. Front Microbiol 2020;11:584767. [PMID: 33281779 DOI: 10.3389/fmicb.2020.584767] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
455 Ushiroda C, Naito Y, Takagi T, Uchiyama K, Mizushima K, Higashimura Y, Yasukawa Z, Okubo T, Inoue R, Honda A, Matsuzaki Y, Itoh Y. Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice. J Clin Biochem Nutr. 2019;65:34-46. [PMID: 31379412 DOI: 10.3164/jcbn.18-116] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 12.7] [Reference Citation Analysis]
456 Li Z, Vance DE. Thematic Review Series: Glycerolipids. Phosphatidylcholine and choline homeostasis. Journal of Lipid Research 2008;49:1187-94. [DOI: 10.1194/jlr.r700019-jlr200] [Cited by in Crossref: 349] [Cited by in F6Publishing: 162] [Article Influence: 24.9] [Reference Citation Analysis]
457 Aygün C, Tözün N. Hepatocellular Cancer and Gut Microbiome: Time to Untie Gordian's Knot. J Gastrointest Cancer 2021. [PMID: 34750696 DOI: 10.1007/s12029-021-00736-5] [Reference Citation Analysis]
458 Cho Y, Shore SA. Obesity, Asthma, and the Microbiome. Physiology (Bethesda) 2016;31:108-16. [PMID: 26889016 DOI: 10.1152/physiol.00045.2015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
459 Zeng M, Xiao Y, Liang Y, Wang B, Chen X, Cao D, Li H, Wang M, Zhou Z. Metabolic alterations of impaired fasting glucose by GC/MS based plasma metabolic profiling combined with chemometrics. Metabolomics 2010;6:303-11. [DOI: 10.1007/s11306-009-0193-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
460 Kolodziejczyk AA, Zheng D, Shibolet O, Elinav E. The role of the microbiome in NAFLD and NASH. EMBO Mol Med. 2019;11: e9302. [PMID: 30591521 DOI: 10.15252/emmm.201809302] [Cited by in Crossref: 131] [Cited by in F6Publishing: 121] [Article Influence: 43.7] [Reference Citation Analysis]
461 Tuohy KM, Fava F, Viola R. ‘The way to a man’s heart is through his gut microbiota’--dietary pro- and prebiotics for the management of cardiovascular risk. Proc Nutr Soc. 2014;73:172-185. [PMID: 24495527 DOI: 10.1017/s0029665113003911] [Cited by in Crossref: 80] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
462 Bifari F, Ruocco C, Decimo I, Fumagalli G, Valerio A, Nisoli E. Amino acid supplements and metabolic health: a potential interplay between intestinal microbiota and systems control. Genes Nutr 2017;12:27. [PMID: 29043007 DOI: 10.1186/s12263-017-0582-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
463 Wang C, Zhu C, Shao L, Ye J, Shen Y, Ren Y. Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease. Mediators Inflamm. 2019;2019:7659509. [PMID: 31341422 DOI: 10.1155/2019/7659509] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
464 Tommasi S, Besaratinia A. DNA Hydroxymethylation at the Interface of the Environment and Nonalcoholic Fatty Liver Disease. Int J Environ Res Public Health 2019;16:E2791. [PMID: 31387232 DOI: 10.3390/ijerph16152791] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
465 Noerman S, Kolehmainen M, Hanhineva K. Profiling of Endogenous and Gut Microbial Metabolites to Indicate Metabotype-Specific Dietary Responses: A Systematic Review. Adv Nutr 2020;11:1237-54. [PMID: 32271864 DOI: 10.1093/advances/nmaa031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
466 Sagami S, Ueno Y, Tanaka S, Fujita A, Niitsu H, Hayashi R, Hyogo H, Hinoi T, Kitadai Y, Chayama K. Choline Deficiency Causes Colonic Type II Natural Killer T (NKT) Cell Loss and Alleviates Murine Colitis under Type I NKT Cell Deficiency. PLoS One 2017;12:e0169681. [PMID: 28095507 DOI: 10.1371/journal.pone.0169681] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
467 Wang T, Sun HG, Hua YL, Li PL, Wei YM. Urine metabonomic study for blood-replenishing mechanism of Angelica sinensis in a blood-deficient mouse model. Chin J Nat Med 2016;14:210-9. [PMID: 27025368 DOI: 10.1016/S1875-5364(16)30018-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
468 Blasco-Baque V, Coupé B, Fabre A, Handgraaf S, Gourdy P, Arnal JF, Courtney M, Schuster-Klein C, Guardiola B, Tercé F, Burcelin R, Serino M. Associations between hepatic miRNA expression, liver triacylglycerols and gut microbiota during metabolic adaptation to high-fat diet in mice. Diabetologia 2017;60:690-700. [PMID: 28105518 DOI: 10.1007/s00125-017-4209-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
469 Fearnside JF, Dumas ME, Rothwell AR, Wilder SP, Cloarec O, Toye A, Blancher C, Holmes E, Tatoud R, Barton RH, Scott J, Nicholson JK, Gauguier D. Phylometabonomic patterns of adaptation to high fat diet feeding in inbred mice. PLoS One 2008;3:e1668. [PMID: 18301746 DOI: 10.1371/journal.pone.0001668] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 5.7] [Reference Citation Analysis]
470 Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368:1575-1584. [PMID: 23614584 DOI: 10.1056/nejmoa1109400] [Cited by in Crossref: 1632] [Cited by in F6Publishing: 925] [Article Influence: 181.3] [Reference Citation Analysis]
471 Wei Y, Liang M, Mai K, Zheng K, Xu H. 1 H NMR-based metabolomics studies on the effect of size-fractionated fish protein hydrolysate, fish meal and plant protein in diet for juvenile turbot ( Scophthalmus maximus L.). Aquacult Nutr 2017;23:523-36. [DOI: 10.1111/anu.12420] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
472 Faber JH, Malmodin D, Toft H, Maher AD, Crockford D, Holmes E, Nicholson JK, Dumas ME, Baunsgaard D. Metabonomics in diabetes research. J Diabetes Sci Technol 2007;1:549-57. [PMID: 19885118 DOI: 10.1177/193229680700100413] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
473 El Aidy S, Merrifield CA, Derrien M, van Baarlen P, Hooiveld G, Levenez F, Doré J, Dekker J, Holmes E, Claus SP. The gut microbiota elicits a profound metabolic reorientation in the mouse jejunal mucosa during conventionalisation. Gut. 2013;62:1306-1314. [PMID: 22722618 DOI: 10.1136/gutjnl-2011-301955] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 7.8] [Reference Citation Analysis]
474 Chen HQ, Gao D, Wang B, Zhao RF, Guan M, Zheng LN, Zhou XY, Chai ZF, Feng WY. Graphene oxide as an anaerobic membrane scaffold for the enhancement of B. adolescentis proliferation and antagonistic effects against pathogens E. coli and S. aureus. Nanotechnology 2014;25:165101. [PMID: 24670485 DOI: 10.1088/0957-4484/25/16/165101] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
475 Shanahan F. Therapeutic implications of manipulating and mining the microbiota. J Physiol 2009;587:4175-9. [PMID: 19505978 DOI: 10.1113/jphysiol.2009.174649] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
476 Corbin KD, Zeisel SH. Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr Opin Gastroenterol. 2012;28:159-165. [PMID: 22134222 DOI: 10.1097/mog.0b013e32834e7b4b] [Cited by in Crossref: 225] [Cited by in F6Publishing: 119] [Article Influence: 22.5] [Reference Citation Analysis]
477 Garcia-Perez I, Villaseñor A, Wijeyesekera A, Posma JM, Jiang Z, Stamler J, Aronson P, Unwin R, Barbas C, Elliott P, Nicholson J, Holmes E. Urinary metabolic phenotyping the slc26a6 (chloride-oxalate exchanger) null mouse model. J Proteome Res 2012;11:4425-35. [PMID: 22594923 DOI: 10.1021/pr2012544] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
478 Miao J, Wang D, Yan J, Wang Y, Teng M, Zhou Z, Zhu W. Comparison of subacute effects of two types of pyrethroid insecticides using metabolomics methods. Pesticide Biochemistry and Physiology 2017;143:161-7. [DOI: 10.1016/j.pestbp.2017.08.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
479 Guo Y, Hwang LD, Li J, Eades J, Yu CW, Mansfield C, Burdick-Will A, Chang X, Chen Y, Duke FF, Zhang J, Fakharzadeh S, Fennessey P, Keating BJ, Jiang H, Hakonarson H, Reed DR, Preti G. Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing. BMC Med Genet 2017;18:11. [PMID: 28196478 DOI: 10.1186/s12881-017-0369-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
480 Robertson DG, Watkins PB, Reily MD. Metabolomics in toxicology: preclinical and clinical applications. Toxicol Sci 2011;120 Suppl 1:S146-70. [PMID: 21127352 DOI: 10.1093/toxsci/kfq358] [Cited by in Crossref: 147] [Cited by in F6Publishing: 123] [Article Influence: 12.3] [Reference Citation Analysis]
481 Lu J, Fang B, Ren M, Huang G, Zhang S, Wang Y, Deng X, Guan S. Nonalcoholic fatty liver disease induced by 13-week oral administration of 1,3-dichloro-2-propanol in C57BL/6J mice. Environmental Toxicology and Pharmacology 2015;39:1115-21. [DOI: 10.1016/j.etap.2015.04.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
482 Gao X, Xu J, Jiang C, Zhang Y, Xue Y, Li Z, Wang J, Xue C, Wang Y. Fish oil ameliorates trimethylamine N-oxide-exacerbated glucose intolerance in high-fat diet-fed mice. Food Funct 2015;6:1117-25. [DOI: 10.1039/c5fo00007f] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 4.1] [Reference Citation Analysis]
483 Yin X, Peng J, Zhao L, Yu Y, Zhang X, Liu P, Feng Q, Hu Y, Pang X. Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula. Syst Appl Microbiol. 2013;36:188-196. [PMID: 23453736 DOI: 10.1016/j.syapm.2012.12.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
484 Yu L, Liu T, Fu S, Li L, Meng X, Su X, Xie Z, Ren J, Meng Y, Lv X, Du Y. Physiological functions of urea transporter B. Pflugers Arch 2019;471:1359-68. [PMID: 31734718 DOI: 10.1007/s00424-019-02323-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
485 Jin C, Zeng Z, Fu Z, Jin Y. Oral imazalil exposure induces gut microbiota dysbiosis and colonic inflammation in mice. Chemosphere 2016;160:349-58. [DOI: 10.1016/j.chemosphere.2016.06.105] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 10.5] [Reference Citation Analysis]
486 Dong X, Zhou Z, Saremi B, Helmbrecht A, Wang Z, Loor JJ. Varying the ratio of Lys:Met while maintaining the ratios of Thr:Phe, Lys:Thr, Lys:His, and Lys:Val alters mammary cellular metabolites, mammalian target of rapamycin signaling, and gene transcription. J Dairy Sci 2018;101:1708-18. [PMID: 29248224 DOI: 10.3168/jds.2017-13351] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
487 McClain CJ, Barve S, Deaciuc I. Good fat/bad fat. Hepatology. 2007;45:1343-1346. [PMID: 17538963 DOI: 10.1002/hep.21788] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 4.3] [Reference Citation Analysis]
488 Narahara H, Sakai E, Katayama M, Ohtomo Y, Yamamoto K, Takemoto M, Aso H, Ohwada S, Mohri Y, Nishimori K, Isogai E, Yamaguchi T, Fukuda T. Immunological characteristics and response to lipopolysaccharide of mouse lines selectively bred with natural and acquired immunities. Anim Sci J 2012;83:367-74. [PMID: 22574788 DOI: 10.1111/j.1740-0929.2011.00980.x] [Reference Citation Analysis]
489 Blaise BJ, Gouel-Chéron A, Floccard B, Monneret G, Plaisant F, Chassard D, Javouhey E, Claris O, Allaouchiche B. [Nuclear magnetic resonance based metabolic phenotyping for patient evaluations in operating rooms and intensive care units]. Ann Fr Anesth Reanim 2014;33:167-75. [PMID: 24456616 DOI: 10.1016/j.annfar.2013.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
490 Zhang X, Zheng X, Yuan Y. Treatment of insulin resistance: straight from the gut. Drug Discovery Today 2016;21:1284-90. [DOI: 10.1016/j.drudis.2016.06.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
491 Yang B, Yan S, Chen Y, Ross RP, Stanton C, Zhao J, Zhang H, Chen W. Diversity of Gut Microbiota and Bifidobacterial Community of Chinese Subjects of Different Ages and from Different Regions. Microorganisms 2020;8:E1108. [PMID: 32722057 DOI: 10.3390/microorganisms8081108] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
492 Lade A, Noon LA, Friedman SL. Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer. Curr Opin Oncol 2014;26:100-7. [PMID: 24275855 DOI: 10.1097/CCO.0000000000000042] [Cited by in Crossref: 60] [Cited by in F6Publishing: 33] [Article Influence: 7.5] [Reference Citation Analysis]
493 Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014;146:1513-1524. [PMID: 24440671 DOI: 10.1053/j.gastro.2014.01.020] [Cited by in Crossref: 487] [Cited by in F6Publishing: 468] [Article Influence: 60.9] [Reference Citation Analysis]
494 Xie G, Zhong W, Zheng X, Li Q, Qiu Y, Li H, Chen H, Zhou Z, Jia W. Chronic ethanol consumption alters mammalian gastrointestinal content metabolites. J Proteome Res. 2013;12:3297-3306. [PMID: 23763674 DOI: 10.1021/pr400362z] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 7.8] [Reference Citation Analysis]
495 Gainetdinov RR, Hoener MC, Berry MD. Trace Amines and Their Receptors.Pharmacol Rev. 2018;70:549-620. [PMID: 29941461 DOI: 10.1124/pr.117.015305] [Cited by in Crossref: 98] [Cited by in F6Publishing: 82] [Article Influence: 24.5] [Reference Citation Analysis]
496 Imajo K, Yoneda M, Ogawa Y, Wada K, Nakajima A. Microbiota and nonalcoholic steatohepatitis. Semin Immunopathol. 2014;36:115-132. [PMID: 24337650 DOI: 10.1007/s00281-013-0404-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
497 Schabussova I, Wiedermann U. Lactic acid bacteria as novel adjuvant systems for prevention and treatment of atopic diseases. Current Opinion in Allergy & Clinical Immunology 2008;8:557-64. [DOI: 10.1097/aci.0b013e328317b88b] [Cited by in Crossref: 30] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
498 Reeves HL, Zaki MYW, Day CP. Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD. Dig Dis Sci 2016;61:1234-45. [DOI: 10.1007/s10620-016-4085-6] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 11.8] [Reference Citation Analysis]
499 Gabr M, Świderek K. Discovery of a Histidine-Based Scaffold as an Inhibitor of Gut Microbial Choline Trimethylamine-Lyase. ChemMedChem 2020;15:2273-9. [PMID: 32827245 DOI: 10.1002/cmdc.202000571] [Reference Citation Analysis]
500 Yang Y, Zhang H, Yan B, Zhang T, Gao Y, Shi Y, Le G. Health Effects of Dietary Oxidized Tyrosine and Dityrosine Administration in Mice with Nutrimetabolomic Strategies. J Agric Food Chem 2017;65:6957-71. [PMID: 28742334 DOI: 10.1021/acs.jafc.7b02003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
501 Palau-Rodriguez M, Tulipani S, Isabel Queipo-Ortuño M, Urpi-Sarda M, Tinahones FJ, Andres-Lacueva C. Metabolomic insights into the intricate gut microbial-host interaction in the development of obesity and type 2 diabetes. Front Microbiol 2015;6:1151. [PMID: 26579078 DOI: 10.3389/fmicb.2015.01151] [Cited by in F6Publishing: 62] [Reference Citation Analysis]
502 Micó-Carnero M, Rojano-Alfonso C, Álvarez-Mercado AI, Gracia-Sancho J, Casillas-Ramírez A, Peralta C. Effects of Gut Metabolites and Microbiota in Healthy and Marginal Livers Submitted to Surgery. Int J Mol Sci 2020;22:E44. [PMID: 33375200 DOI: 10.3390/ijms22010044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
503 Levin BJ, Huang YY, Peck SC, Wei Y, Martínez-Del Campo A, Marks JA, Franzosa EA, Huttenhower C, Balskus EP. A prominent glycyl radical enzyme in human gut microbiomes metabolizes trans-4-hydroxy-l-proline. Science 2017;355:eaai8386. [PMID: 28183913 DOI: 10.1126/science.aai8386] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 14.6] [Reference Citation Analysis]
504 Nyangale EP, Mottram DS, Gibson GR. Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. J Proteome Res. 2012;11:5573-5585. [PMID: 23116228 DOI: 10.1021/pr300637d] [Cited by in Crossref: 162] [Cited by in F6Publishing: 138] [Article Influence: 16.2] [Reference Citation Analysis]
505 Nakanishi Y, Fukuda S, Chikayama E, Kimura Y, Ohno H, Kikuchi J. Dynamic omics approach identifies nutrition-mediated microbial interactions. J Proteome Res 2011;10:824-36. [PMID: 21058740 DOI: 10.1021/pr100989c] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
506 Mitchell SC, Smith RL. Trimethylamine—The Extracorporeal Envoy. CHEMSE 2016;41:275-9. [DOI: 10.1093/chemse/bjw001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
507 Bäckhed F, Crawford PA. Coordinated regulation of the metabolome and lipidome at the host-microbial interface. Biochim Biophys Acta 2010;1801:240-5. [PMID: 19782151 DOI: 10.1016/j.bbalip.2009.09.009] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
508 Vespasiani-Gentilucci U, Gallo P, Picardi A. The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention. Arch Med Sci 2018;14:701-6. [PMID: 29765460 DOI: 10.5114/aoms.2016.58831] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
509 Iruzubieta P, Medina JM, Fernández-López R, Crespo J, de la Cruz F. A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression. J Clin Med 2020;9:E1369. [PMID: 32392712 DOI: 10.3390/jcm9051369] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
510 Hartiala J, Schwartzman WS, Gabbay J, Ghazalpour A, Bennett BJ, Allayee H. The Genetic Architecture of Coronary Artery Disease: Current Knowledge and Future Opportunities. Curr Atheroscler Rep 2017;19:6. [PMID: 28130654 DOI: 10.1007/s11883-017-0641-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
511 Hocking S, Samocha-Bonet D, Milner KL, Greenfield JR, Chisholm DJ. Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots. Endocr Rev. 2013;34:463-500. [PMID: 23550081 DOI: 10.1210/er.2012-1041] [Cited by in Crossref: 133] [Cited by in F6Publishing: 124] [Article Influence: 14.8] [Reference Citation Analysis]
512 Patel NR, McPhail MJ, Shariff MI, Keun HC, Taylor-Robinson SD. Biofluid metabonomics using (1)H NMR spectroscopy: the road to biomarker discovery in gastroenterology and hepatology. Expert Rev Gastroenterol Hepatol. 2012;6:239-251. [PMID: 22375528 DOI: 10.1586/egh.12.1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
513 Shek D, Chen D, Read SA, Ahlenstiel G. Examining the gut-liver axis in liver cancer using organoid models. Cancer Lett 2021;510:48-58. [PMID: 33891996 DOI: 10.1016/j.canlet.2021.04.008] [Reference Citation Analysis]
514 Nokoff N, Rewers M. Pathogenesis of type 1 diabetes: lessons from natural history studies of high-risk individuals. Ann N Y Acad Sci. 2013;1281:1-15. [PMID: 23360422 DOI: 10.1111/nyas.12021] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
515 Zhao XJ, Hao F, Huang C, Rantalainen M, Lei H, Tang H, Wang Y. Systems responses of rats to mequindox revealed by metabolic and transcriptomic profiling. J Proteome Res 2012;11:4712-21. [PMID: 22845897 DOI: 10.1021/pr300533a] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
516 Xie B, Waters MJ, Schirra HJ. Investigating potential mechanisms of obesity by metabolomics. J Biomed Biotechnol 2012;2012:805683. [PMID: 22665992 DOI: 10.1155/2012/805683] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 6.9] [Reference Citation Analysis]
517 Hanhineva K, Aura AM, Rogachev I, Matero S, Skov T, Aharoni A, Poutanen K, Mykkänen H. In vitro microbiotic fermentation causes an extensive metabolite turnover of rye bran phytochemicals. PLoS One 2012;7:e39322. [PMID: 22745732 DOI: 10.1371/journal.pone.0039322] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
518 Jia W, Li H, Zhao L, Nicholson JK. Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov 2008;7:123-9. [DOI: 10.1038/nrd2505] [Cited by in Crossref: 304] [Cited by in F6Publishing: 279] [Article Influence: 21.7] [Reference Citation Analysis]
519 Irague R, Massou S, Moulis C, Saurel O, Milon A, Monsan P, Remaud-Siméon M, Portais JC, Potocki-Véronèse G. NMR-based structural glycomics for high-throughput screening of carbohydrate-active enzyme specificity. Anal Chem 2011;83:1202-6. [PMID: 21271685 DOI: 10.1021/ac1032148] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
520 Dumas M, Kinross J, Nicholson JK. Metabolic Phenotyping and Systems Biology Approaches to Understanding Metabolic Syndrome and Fatty Liver Disease. Gastroenterology 2014;146:46-62. [DOI: 10.1053/j.gastro.2013.11.001] [Cited by in Crossref: 115] [Cited by in F6Publishing: 100] [Article Influence: 14.4] [Reference Citation Analysis]
521 Abdul Rahim MBH, Chilloux J, Martinez-Gili L, Neves AL, Myridakis A, Gooderham N, Dumas ME. Diet-induced metabolic changes of the human gut microbiome: importance of short-chain fatty acids, methylamines and indoles. Acta Diabetol 2019;56:493-500. [PMID: 30903435 DOI: 10.1007/s00592-019-01312-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 11.7] [Reference Citation Analysis]
522 Qian LL, Li HT, Zhang L, Fang QC, Jia WP. Effect of the Gut Microbiota on Obesity and Its Underlying Mechanisms: an Update. Biomedical and Environmental Sciences 2015;28:839-47. [DOI: 10.1016/s0895-3988(15)30116-1] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
523 Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology. 2009;136:2003-2014. [PMID: 19457424 DOI: 10.1053/j.gastro.2009.01.075] [Cited by in Crossref: 333] [Cited by in F6Publishing: 306] [Article Influence: 25.6] [Reference Citation Analysis]
524 Nicholson JK. Global systems biology, personalized medicine and molecular epidemiology. Mol Syst Biol 2006;2:52. [PMID: 17016518 DOI: 10.1038/msb4100095] [Cited by in Crossref: 277] [Cited by in F6Publishing: 229] [Article Influence: 17.3] [Reference Citation Analysis]
525 Sanchez-Rodriguez E, Egea-Zorrilla A, Plaza-Díaz J, Aragón-Vela J, Muñoz-Quezada S, Tercedor-Sánchez L, Abadia-Molina F. The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases. Nutrients 2020;12:E605. [PMID: 32110880 DOI: 10.3390/nu12030605] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 16.5] [Reference Citation Analysis]
526 Zhang X, Wang Y, Hao F, Zhou X, Han X, Tang H, Ji L. Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statuses. J Proteome Res 2009;8:5188-95. [PMID: 19697961 DOI: 10.1021/pr900524z] [Cited by in Crossref: 106] [Cited by in F6Publishing: 101] [Article Influence: 8.8] [Reference Citation Analysis]
527 Albert CL, Tang WHW. Metabolic Biomarkers in Heart Failure. Heart Fail Clin 2018;14:109-18. [PMID: 29153196 DOI: 10.1016/j.hfc.2017.08.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
528 Collins SM, Denou E, Verdu EF, Bercik P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig Liver Dis. 2009;41:850-853. [PMID: 19740713 DOI: 10.1016/j.dld.2009.07.023] [Cited by in Crossref: 64] [Cited by in F6Publishing: 70] [Article Influence: 4.9] [Reference Citation Analysis]
529 Mischke M, Plösch T. The Gut Microbiota and their Metabolites: Potential Implications for the Host Epigenome. Adv Exp Med Biol 2016;902:33-44. [PMID: 27161349 DOI: 10.1007/978-3-319-31248-4_3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
530 Gonzalez FJ, Jiang C, Patterson AD. An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease. Gastroenterology. 2016;151:845-859. [PMID: 27639801 DOI: 10.1053/j.gastro.2016.08.057] [Cited by in Crossref: 125] [Cited by in F6Publishing: 120] [Article Influence: 20.8] [Reference Citation Analysis]
531 Cotter DG, Schugar RC, Crawford PA. Ketone body metabolism and cardiovascular disease. Am J Physiol Heart Circ Physiol 2013;304:H1060-76. [PMID: 23396451 DOI: 10.1152/ajpheart.00646.2012] [Cited by in Crossref: 203] [Cited by in F6Publishing: 188] [Article Influence: 22.6] [Reference Citation Analysis]
532 Erejuwa OO, Sulaiman SA, Wahab MS. Oligosaccharides might contribute to the antidiabetic effect of honey: a review of the literature. Molecules 2011;17:248-66. [PMID: 22205091 DOI: 10.3390/molecules17010248] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
533 Mencarelli A, Cipriani S, Renga B, Bruno A, D'Amore C, Distrutti E, Fiorucci S. VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation. PLoS One. 2012;7:e45425. [PMID: 23029000 DOI: 10.1371/journal.pone.0045425] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 6.2] [Reference Citation Analysis]
534 Al-humadi H, Zarros A, Kyriakaki A, Al-saigh R, Liapi C. Choline deprivation: An overview of the major hepatic metabolic response pathways. Scandinavian Journal of Gastroenterology 2012;47:874-86. [DOI: 10.3109/00365521.2012.685755] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
535 Chen B, Sun L, Zhang X. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases. Journal of Autoimmunity 2017;83:31-42. [DOI: 10.1016/j.jaut.2017.03.009] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 13.2] [Reference Citation Analysis]
536 Massey W, Brown JM. The Gut Microbial Endocrine Organ in Type 2 Diabetes. Endocrinology 2021;162:bqaa235. [PMID: 33373432 DOI: 10.1210/endocr/bqaa235] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
537 Korecka A, Arulampalam V. The gut microbiome: scourge, sentinel or spectator? J Oral Microbiol. 2012;4. [PMID: 22368769 DOI: 10.3402/jom.v4i0.9367] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
538 Senn T, Hazen SL, Tang WH. Translating metabolomics to cardiovascular biomarkers. Prog Cardiovasc Dis 2012;55:70-6. [PMID: 22824112 DOI: 10.1016/j.pcad.2012.06.004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
539 Chen C, Shah YM, Morimura K, Krausz KW, Miyazaki M, Richardson TA, Morgan ET, Ntambi JM, Idle JR, Gonzalez FJ. Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell Metab. 2008;7:135-147. [PMID: 18249173 DOI: 10.1016/j.cmet.2007.12.003] [Cited by in Crossref: 119] [Cited by in F6Publishing: 111] [Article Influence: 8.5] [Reference Citation Analysis]
540 Lee SH, An JH, Park HM, Jung BH. Investigation of endogenous metabolic changes in the urine of pseudo germ-free rats using a metabolomic approach. J Chromatogr B Analyt Technol Biomed Life Sci 2012;887-888:8-18. [PMID: 22300547 DOI: 10.1016/j.jchromb.2011.12.030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
541 Zhao E, Zhang W, Geng B, You B, Wang W, Li X. Intestinal dysbacteriosis leads to kidney stone disease. Mol Med Rep 2021;23:180. [PMID: 33655334 DOI: 10.3892/mmr.2020.11819] [Reference Citation Analysis]
542 Zeisel SH. Nutrigenomics and metabolomics will change clinical nutrition and public health practice: insights from studies on dietary requirements for choline. Am J Clin Nutr 2007;86:542-8. [PMID: 17823415 DOI: 10.1093/ajcn/86.3.542] [Cited by in Crossref: 58] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
543 Kil DY, Swanson KS. Companion animals symposium: role of microbes in canine and feline health. J Anim Sci 2011;89:1498-505. [PMID: 21036940 DOI: 10.2527/jas.2010-3498] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
544 Marra F, Lotersztajn S. Pathophysiology of NASH: perspectives for a targeted treatment. Curr Pharm Des 2013;19:5250-69. [PMID: 23394092 DOI: 10.2174/13816128113199990344] [Cited by in Crossref: 94] [Cited by in F6Publishing: 96] [Article Influence: 11.8] [Reference Citation Analysis]
545 Xie C, Halegoua-DeMarzio D. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter? Nutrients. 2019;11. [PMID: 31752378 DOI: 10.3390/nu11112837] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
546 Phetcharaburanin J, Lees H, Marchesi JR, Nicholson JK, Holmes E, Seyfried F, Li JV. Systemic Characterization of an Obese Phenotype in the Zucker Rat Model Defining Metabolic Axes of Energy Metabolism and Host–Microbial Interactions. J Proteome Res 2016;15:1897-906. [DOI: 10.1021/acs.jproteome.6b00090] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
547 Cani PD, Hoste S, Guiot Y, Delzenne NM. Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr. 2007;98:32-37. [PMID: 17367575 DOI: 10.1017/s0007114507691648] [Cited by in Crossref: 169] [Cited by in F6Publishing: 69] [Article Influence: 11.3] [Reference Citation Analysis]
548 He J, Li G, Chen J, Lin J, Zeng C, Chen J, Deng J, Xie P. Prolonged exposure to low-dose microcystin induces nonalcoholic steatohepatitis in mice: a systems toxicology study. Arch Toxicol 2017;91:465-80. [PMID: 26984711 DOI: 10.1007/s00204-016-1681-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
549 Cӑtoi AF, Vodnar DC, Corina A, Nikolic D, Citarrella R, Pérez-Martínez P, Rizzo M. Gut Microbiota, Obesity and Bariatric Surgery: Current Knowledge and Future Perspectives. Curr Pharm Des 2019;25:2038-50. [PMID: 31298152 DOI: 10.2174/1381612825666190708190437] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
550 Chikayama E, Sekiyama Y, Okamoto M, Nakanishi Y, Tsuboi Y, Akiyama K, Saito K, Shinozaki K, Kikuchi J. Statistical indices for simultaneous large-scale metabolite detections for a single NMR spectrum. Anal Chem 2010;82:1653-8. [PMID: 20128615 DOI: 10.1021/ac9022023] [Cited by in Crossref: 100] [Cited by in F6Publishing: 92] [Article Influence: 8.3] [Reference Citation Analysis]
551 Dornas W, Lagente V. Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis. Pharmacol Res. 2019;141:418-428. [PMID: 30658094 DOI: 10.1016/j.phrs.2019.01.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
552 Ghazalpour A, Cespedes I, Bennett BJ, Allayee H. Expanding role of gut microbiota in lipid metabolism. Curr Opin Lipidol 2016;27:141-7. [PMID: 26855231 DOI: 10.1097/MOL.0000000000000278] [Cited by in Crossref: 68] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
553 Wree A, Broderick L, Canbay A, Hoffman HM, Feldstein AE. From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. Nat Rev Gastroenterol Hepatol. 2013;10:627-636. [PMID: 23958599 DOI: 10.1038/nrgastro.2013.149] [Cited by in Crossref: 335] [Cited by in F6Publishing: 320] [Article Influence: 37.2] [Reference Citation Analysis]
554 An Y, Xu W, Li H, Lei H, Zhang L, Hao F, Duan Y, Yan X, Zhao Y, Wu J, Wang Y, Tang H. High-fat diet induces dynamic metabolic alterations in multiple biological matrices of rats. J Proteome Res 2013;12:3755-68. [PMID: 23746045 DOI: 10.1021/pr400398b] [Cited by in Crossref: 99] [Cited by in F6Publishing: 90] [Article Influence: 11.0] [Reference Citation Analysis]
555 Fianchi F, Liguori A, Gasbarrini A, Grieco A, Miele L. Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut-Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy. Int J Mol Sci 2021;22:6485. [PMID: 34204274 DOI: 10.3390/ijms22126485] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
556 Sharpton SR, Yong GJM, Terrault NA, Lynch SV. Gut Microbial Metabolism and Nonalcoholic Fatty Liver Disease. Hepatol Commun 2019;3:29-43. [PMID: 30619992 DOI: 10.1002/hep4.1284] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
557 Boursier J, Diehl AM. Nonalcoholic Fatty Liver Disease and the Gut Microbiome. Clin Liver Dis 2016;20:263-75. [PMID: 27063268 DOI: 10.1016/j.cld.2015.10.012] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 7.1] [Reference Citation Analysis]
558 Cho CE, Caudill MA. Trimethylamine- N -Oxide: Friend, Foe, or Simply Caught in the Cross-Fire? Trends in Endocrinology & Metabolism 2017;28:121-30. [DOI: 10.1016/j.tem.2016.10.005] [Cited by in Crossref: 84] [Cited by in F6Publishing: 78] [Article Influence: 16.8] [Reference Citation Analysis]
559 Yang Y, Wang Y, Zhang J, Han Z, Chen A, Pan S, Liang S, Wang S. System responses to chronic cold stress probed via 1 H NMR spectroscopy in plasma and urine matrices. Mol BioSyst 2015;11:1425-33. [DOI: 10.1039/c5mb00033e] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
560 Wei L, Liao P, Wu H, Li X, Pei F, Li W, Wu Y. Toxicological effects of cinnabar in rats by NMR-based metabolic profiling of urine and serum. Toxicol Appl Pharmacol 2008;227:417-29. [PMID: 18164359 DOI: 10.1016/j.taap.2007.11.015] [Cited by in Crossref: 93] [Cited by in F6Publishing: 86] [Article Influence: 6.2] [Reference Citation Analysis]
561 Siva N, Johnson CR, Richard V, Jesch ED, Whiteside W, Abood AA, Thavarajah P, Duckett S, Thavarajah D. Lentil ( Lens culinaris Medikus) Diet Affects the Gut Microbiome and Obesity Markers in Rat. J Agric Food Chem 2018;66:8805-13. [DOI: 10.1021/acs.jafc.8b03254] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
562 Hoyles L, Jiménez-Pranteda ML, Chilloux J, Brial F, Myridakis A, Aranias T, Magnan C, Gibson GR, Sanderson JD, Nicholson JK, Gauguier D, McCartney AL, Dumas ME. Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota. Microbiome 2018;6:73. [PMID: 29678198 DOI: 10.1186/s40168-018-0461-0] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 15.3] [Reference Citation Analysis]
563 Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R. The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018;15:397-411. [PMID: 29748586 DOI: 10.1038/s41575-018-0011-z] [Cited by in Crossref: 301] [Cited by in F6Publishing: 300] [Article Influence: 100.3] [Reference Citation Analysis]
564 Zamboni N, Saghatelian A, Patti GJ. Defining the metabolome: size, flux, and regulation. Mol Cell 2015;58:699-706. [PMID: 26000853 DOI: 10.1016/j.molcel.2015.04.021] [Cited by in Crossref: 160] [Cited by in F6Publishing: 139] [Article Influence: 22.9] [Reference Citation Analysis]
565 Ponziani FR, Pecere S, Gasbarrini A, Ojetti V. Physiology and pathophysiology of liver lipid metabolism. Expert Review of Gastroenterology & Hepatology 2015;9:1055-67. [DOI: 10.1586/17474124.2015.1056156] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
566 Caspani G, Kennedy S, Foster JA, Swann J. Gut microbial metabolites in depression: understanding the biochemical mechanisms. Microb Cell 2019;6:454-81. [PMID: 31646148 DOI: 10.15698/mic2019.10.693] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 16.0] [Reference Citation Analysis]
567 Kussmann M, Rezzi S, Daniel H. Profiling techniques in nutrition and health research. Current Opinion in Biotechnology 2008;19:83-99. [DOI: 10.1016/j.copbio.2008.02.003] [Cited by in Crossref: 56] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
568 Lazar V, Ditu LM, Pircalabioru GG, Picu A, Petcu L, Cucu N, Chifiriuc MC. Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity. Front Nutr 2019;6:21. [PMID: 30931309 DOI: 10.3389/fnut.2019.00021] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 20.7] [Reference Citation Analysis]
569 Kuang L, Zhou W, Jiang Y. Association of small intestinal bacterial overgrowth with nonalcoholic fatty liver disease in children: A meta-analysis. PLoS One 2021;16:e0260479. [PMID: 34855819 DOI: 10.1371/journal.pone.0260479] [Reference Citation Analysis]
570 Schwabe RF, Greten TF. Gut microbiome in HCC - Mechanisms, diagnosis and therapy. J Hepatol. 2020;72:230-238. [PMID: 31954488 DOI: 10.1016/j.jhep.2019.08.016] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 51.0] [Reference Citation Analysis]
571 Cassard AM, Gérard P, Perlemuter G. Microbiota, Liver Diseases, and Alcohol. Microbiol Spectr 2017;5. [PMID: 28840806 DOI: 10.1128/microbiolspec.BAD-0007-2016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
572 Li H, An Y, Zhang L, Lei H, Zhang L, Wang Y, Tang H. Combined NMR and GC–MS Analyses Revealed Dynamic Metabolic Changes Associated with the Carrageenan-Induced Rat Pleurisy. J Proteome Res 2013;12:5520-34. [DOI: 10.1021/pr400440d] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
573 Org E, Blum Y, Kasela S, Mehrabian M, Kuusisto J, Kangas AJ, Soininen P, Wang Z, Ala-Korpela M, Hazen SL, Laakso M, Lusis AJ. Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort. Genome Biol 2017;18:70. [PMID: 28407784 DOI: 10.1186/s13059-017-1194-2] [Cited by in Crossref: 131] [Cited by in F6Publishing: 126] [Article Influence: 26.2] [Reference Citation Analysis]
574 Zhao Y, He Z, Hao W, Zhu H, Liu J, Ma KY, He WS, Chen ZY. Cholesterol-lowering activity of protocatechuic acid is mediated by increasing the excretion of bile acids and modulating gut microbiota and producing short-chain fatty acids. Food Funct 2021;12:11557-67. [PMID: 34709262 DOI: 10.1039/d1fo02906a] [Reference Citation Analysis]
575 Rajani C, Jia W. Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders. Clin Sci (Lond) 2018;132:791-811. [PMID: 29661926 DOI: 10.1042/CS20171328] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
576 Cho K, Moon JS, Kang JH, Jang HB, Lee HJ, Park SI, Yu KS, Cho JY. Combined untargeted and targeted metabolomic profiling reveals urinary biomarkers for discriminating obese from normal-weight adolescents. Pediatr Obes 2017;12:93-101. [PMID: 26910390 DOI: 10.1111/ijpo.12114] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
577 Brown JM, Hazen SL. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu Rev Med. 2015;66:343-359. [PMID: 25587655 DOI: 10.1146/annurev-med-060513-093205] [Cited by in Crossref: 198] [Cited by in F6Publishing: 181] [Article Influence: 28.3] [Reference Citation Analysis]
578 Jiang L, Schnabl B. Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know? Physiology (Bethesda) 2020;35:261-74. [PMID: 32490750 DOI: 10.1152/physiol.00005.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
579 Jiang T, Gao X, Wu C, Tian F, Lei Q, Bi J, Xie B, Wang HY, Chen S, Wang X. Apple-Derived Pectin Modulates Gut Microbiota, Improves Gut Barrier Function, and Attenuates Metabolic Endotoxemia in Rats with Diet-Induced Obesity. Nutrients 2016;8:126. [PMID: 26938554 DOI: 10.3390/nu8030126] [Cited by in Crossref: 92] [Cited by in F6Publishing: 82] [Article Influence: 15.3] [Reference Citation Analysis]
580 Gonzalez-Franquesa A, Burkart AM, Isganaitis E, Patti ME. What Have Metabolomics Approaches Taught Us About Type 2 Diabetes? Curr Diab Rep. 2016;16:74. [PMID: 27319324 DOI: 10.1007/s11892-016-0763-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
581 Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: Pathophysiological basis for therapy. J Hepatol. 2020;72:558-577. [PMID: 31622696 DOI: 10.1016/j.jhep.2019.10.003] [Cited by in Crossref: 141] [Cited by in F6Publishing: 151] [Article Influence: 47.0] [Reference Citation Analysis]
582 Costa JSR, Fonseca GFAC, Ottone NCDS, Silva PA, Antonaccio RF, Silva G, Rocha MDSA, Coimbra CC, Esteves EA, Mang ZA, Amorim FT, Magalhães FC. Strength training improves insulin resistance and differently affects mitochondria in skeletal muscle and visceral adipose tissue in high-fat fed mice. Life Sci 2021;278:119639. [PMID: 34043987 DOI: 10.1016/j.lfs.2021.119639] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
583 Schenkel LC, Sivanesan S, Zhang J, Wuyts B, Taylor A, Verbrugghe A, Bakovic M. Choline supplementation restores substrate balance and alleviates complications of Pcyt2 deficiency. J Nutr Biochem 2015;26:1221-34. [PMID: 26242921 DOI: 10.1016/j.jnutbio.2015.05.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
584 Chao J, Huo TI, Cheng HY, Tsai JC, Liao JW, Lee MS, Qin XM, Hsieh MT, Pao LH, Peng WH. Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice. PLoS One. 2014;9:e96969. [PMID: 24918580 DOI: 10.1371/journal.pone.0096969] [Cited by in Crossref: 94] [Cited by in F6Publishing: 89] [Article Influence: 11.8] [Reference Citation Analysis]
585 Cerreto M, Santopaolo F, Gasbarrini A, Pompili M, Ponziani FR. Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut-Liver Axis. Nutrients 2021;13:2649. [PMID: 34444807 DOI: 10.3390/nu13082649] [Reference Citation Analysis]
586 Tang WH, Wang Z, Shrestha K, Borowski AG, Wu Y, Troughton RW, Klein AL, Hazen SL. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure. J Card Fail 2015;21:91-6. [PMID: 25459686 DOI: 10.1016/j.cardfail.2014.11.006] [Cited by in Crossref: 193] [Cited by in F6Publishing: 174] [Article Influence: 24.1] [Reference Citation Analysis]
587 Emwas AH, Luchinat C, Turano P, Tenori L, Roy R, Salek RM, Ryan D, Merzaban JS, Kaddurah-Daouk R, Zeri AC, Nagana Gowda GA, Raftery D, Wang Y, Brennan L, Wishart DS. Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review. Metabolomics 2015;11:872-94. [PMID: 26109927 DOI: 10.1007/s11306-014-0746-7] [Cited by in Crossref: 134] [Cited by in F6Publishing: 123] [Article Influence: 16.8] [Reference Citation Analysis]
588 Pinnick KE, Collins SC, Londos C, Gauguier D, Clark A, Fielding BA. Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity (Silver Spring). 2008;16:522-530. [PMID: 18239594 DOI: 10.1038/oby.2007.110] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 8.4] [Reference Citation Analysis]
589 Zhu Y, Bai J, Zhang Y, Xiao X, Dong Y. Effects of bitter melon (Momordica charantia L.) on the gut microbiota in high fat diet and low dose streptozocin-induced rats. Int J Food Sci Nutr. 2016;67:686-695. [PMID: 27352776 DOI: 10.1080/09637486.2016.1197185] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
590 Stock J. Gut microbiota: an environmental risk factor for cardiovascular disease. Atherosclerosis 2013;229:440-2. [PMID: 23880200 DOI: 10.1016/j.atherosclerosis.2013.05.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
591 Sévin DC, Kuehne A, Zamboni N, Sauer U. Biological insights through nontargeted metabolomics. Curr Opin Biotechnol 2015;34:1-8. [PMID: 25461505 DOI: 10.1016/j.copbio.2014.10.001] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 9.5] [Reference Citation Analysis]
592 Maulidiani, Abas F, Khatib A, Perumal V, Suppaiah V, Ismail A, Hamid M, Shaari K, Lajis N. Metabolic alteration in obese diabetes rats upon treatment with Centella asiatica extract. Journal of Ethnopharmacology 2016;180:60-9. [DOI: 10.1016/j.jep.2016.01.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
593 Miele L, Giorgio V, Alberelli MA, De Candia E, Gasbarrini A, Grieco A. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk. Curr Cardiol Rep. 2015;17:120. [PMID: 26497040 DOI: 10.1007/s11886-015-0671-z] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 13.7] [Reference Citation Analysis]
594 Torres-Fuentes C, Schellekens H, Dinan TG, Cryan JF. The microbiota-gut-brain axis in obesity. Lancet Gastroenterol Hepatol 2017;2:747-56. [PMID: 28844808 DOI: 10.1016/S2468-1253(17)30147-4] [Cited by in Crossref: 185] [Cited by in F6Publishing: 100] [Article Influence: 37.0] [Reference Citation Analysis]
595 Janssen AWF, Houben T, Katiraei S, Dijk W, Boutens L, van der Bolt N, Wang Z, Brown JM, Hazen SL, Mandard S, Shiri-Sverdlov R, Kuipers F, Willems van Dijk K, Vervoort J, Stienstra R, Hooiveld GJEJ, Kersten S. Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids. J Lipid Res. 2017;58:1399-1416. [PMID: 28533304 DOI: 10.1194/jlr.m075713] [Cited by in Crossref: 56] [Cited by in F6Publishing: 35] [Article Influence: 11.2] [Reference Citation Analysis]
596 Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012;489:242-9. [DOI: 10.1038/nature11552] [Cited by in Crossref: 2354] [Cited by in F6Publishing: 2126] [Article Influence: 235.4] [Reference Citation Analysis]
597 Zhang S, Zheng C, Lanza IR, Nair KS, Raftery D, Vitek O. Interdependence of signal processing and analysis of urine 1H NMR spectra for metabolic profiling. Anal Chem 2009;81:6080-8. [PMID: 19950923 DOI: 10.1021/ac900424c] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
598 Bluemel S, Williams B, Knight R, Schnabl B. Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota. Am J Physiol Gastrointest Liver Physiol 2016;311:G1018-36. [PMID: 27686615 DOI: 10.1152/ajpgi.00245.2016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 7.7] [Reference Citation Analysis]
599 Dixon LJ, Barnes M, Tang H, Pritchard MT, Nagy LE. Kupffer cells in the liver. Compr Physiol. 2013;3:785-797. [PMID: 23720329 DOI: 10.1002/cphy.c120026] [Cited by in Crossref: 90] [Cited by in F6Publishing: 171] [Article Influence: 10.0] [Reference Citation Analysis]
600 Dumas ME, Rothwell AR, Hoyles L, Aranias T, Chilloux J, Calderari S, Noll EM, Péan N, Boulangé CL, Blancher C, Barton RH, Gu Q, Fearnside JF, Deshayes C, Hue C, Scott J, Nicholson JK, Gauguier D. Microbial-Host Co-metabolites Are Prodromal Markers Predicting Phenotypic Heterogeneity in Behavior, Obesity, and Impaired Glucose Tolerance. Cell Rep 2017;20:136-48. [PMID: 28683308 DOI: 10.1016/j.celrep.2017.06.039] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 12.8] [Reference Citation Analysis]
601 Barra NG, Palanivel R, Denou E, Chew MV, Gillgrass A, Walker TD, Kong J, Richards CD, Jordana M, Collins SM, Trigatti BL, Holloway AC, Raha S, Steinberg GR, Ashkar AA. Interleukin-15 modulates adipose tissue by altering mitochondrial mass and activity. PLoS One 2014;9:e114799. [PMID: 25517731 DOI: 10.1371/journal.pone.0114799] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
602 Brestoff JR, Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol. 2013;14:676-684. [PMID: 23778795 DOI: 10.1038/ni.2640] [Cited by in Crossref: 500] [Cited by in F6Publishing: 450] [Article Influence: 55.6] [Reference Citation Analysis]
603 Mellert W, Kapp M, Strauss V, Wiemer J, Kamp H, Walk T, Looser R, Prokoudine A, Fabian E, Krennrich G, Herold M, van Ravenzwaay B. Nutritional impact on the plasma metabolome of rats. Toxicol Lett 2011;207:173-81. [PMID: 21907771 DOI: 10.1016/j.toxlet.2011.08.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
604 Loscalzo J. Lipid metabolism by gut microbes and atherosclerosis. Circ Res 2011;109:127-9. [PMID: 21737814 DOI: 10.1161/RES.0b013e3182290620] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
605 Jänis MT, Laaksonen R, Oresic M. Metabolomic strategies to identify tissue-specific effects of cardiovascular drugs. Expert Opin Drug Metab Toxicol 2008;4:665-80. [PMID: 18611110 DOI: 10.1517/17425255.4.6.665] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
606 Moco S, Ross AB. Can We Use Metabolomics to Understand Changes to Gut Microbiota Populations and Function? A Nutritional Perspective. In: Kochhar S, Martin F, editors. Metabonomics and Gut Microbiota in Nutrition and Disease. London: Springer; 2015. pp. 83-108. [DOI: 10.1007/978-1-4471-6539-2_5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
607 Bakhshimoghaddam F, Alizadeh M. Contribution of gut microbiota to nonalcoholic fatty liver disease: Pathways of mechanisms. Clin Nutr ESPEN 2021;44:61-8. [PMID: 34330514 DOI: 10.1016/j.clnesp.2021.05.012] [Reference Citation Analysis]
608 Zeisel SH. A grand challenge for nutrigenomics. Front Genet 2010;1:2. [PMID: 22303299 DOI: 10.3389/fgene.2010.00002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
609 Vajro P, Paolella G, Fasano A. Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease. J Pediatr Gastroenterol Nutr. 2013;56:461-468. [PMID: 23287807 DOI: 10.1016/j.numecd.2012.02.007] [Cited by in Crossref: 229] [Cited by in F6Publishing: 235] [Article Influence: 25.4] [Reference Citation Analysis]
610 Schewe M, Fodde R. Multitasking Paneth Cells in the Intestinal Stem Cell Niche. Intestinal Stem Cell Niche. Elsevier; 2018. pp. 41-75. [DOI: 10.1016/bs.asn.2017.12.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
611 Meyer KA, Bennett BJ. Diet and Gut Microbial Function in Metabolic and Cardiovascular Disease Risk. Curr Diab Rep 2016;16:93. [PMID: 27541295 DOI: 10.1007/s11892-016-0791-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
612 Sherriff JL, O'Sullivan TA, Properzi C, Oddo JL, Adams LA. Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes. Adv Nutr. 2016;7:5-13. [PMID: 26773011 DOI: 10.3945/an.114.007955] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 12.3] [Reference Citation Analysis]
613 Holmes E, Loo RL, Cloarec O, Coen M, Tang H, Maibaum E, Bruce S, Chan Q, Elliott P, Stamler J, Wilson ID, Lindon JC, Nicholson JK. Detection of urinary drug metabolite (xenometabolome) signatures in molecular epidemiology studies via statistical total correlation (NMR) spectroscopy. Anal Chem 2007;79:2629-40. [PMID: 17323917 DOI: 10.1021/ac062305n] [Cited by in Crossref: 95] [Cited by in F6Publishing: 83] [Article Influence: 6.3] [Reference Citation Analysis]
614 Yu LX, Schwabe RF. The gut microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol 2017;14:527-39. [PMID: 28676707 DOI: 10.1038/nrgastro.2017.72] [Cited by in Crossref: 176] [Cited by in F6Publishing: 168] [Article Influence: 35.2] [Reference Citation Analysis]
615 Kirpich IA, Marsano LS, McClain CJ. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. Clin Biochem. 2015;48:923-930. [PMID: 26151226 DOI: 10.1016/j.clinbiochem.2015.06.023] [Cited by in Crossref: 128] [Cited by in F6Publishing: 132] [Article Influence: 18.3] [Reference Citation Analysis]
616 Lehtonen HM, Lindstedt A, Järvinen R, Sinkkonen J, Graça G, Viitanen M, Kallio H, Gil AM. 1H NMR-based metabolic fingerprinting of urine metabolites after consumption of lingonberries (Vaccinium vitis-idaea) with a high-fat meal. Food Chem 2013;138:982-90. [PMID: 23411204 DOI: 10.1016/j.foodchem.2012.10.081] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
617 Bercik P, Collins SM, Verdu EF. Microbes and the gut-brain axis. Neurogastroenterol Motil. 2012;24:405-413. [PMID: 22404222 DOI: 10.1111/j.1365-2982.2012.01906.x] [Cited by in Crossref: 189] [Cited by in F6Publishing: 172] [Article Influence: 18.9] [Reference Citation Analysis]
618 Montgomery MK, Hallahan NL, Brown SH, Liu M, Mitchell TW, Cooney GJ, Turner N. Mouse strain-dependent variation in obesity and glucose homeostasis in response to high-fat feeding. Diabetologia 2013;56:1129-39. [DOI: 10.1007/s00125-013-2846-8] [Cited by in Crossref: 224] [Cited by in F6Publishing: 212] [Article Influence: 24.9] [Reference Citation Analysis]
619 Wang F, Xu J, Jakovlić I, Wang W, Zhao Y. Dietary betaine reduces liver lipid accumulation via improvement of bile acid and trimethylamine- N -oxide metabolism in blunt-snout bream. Food Funct 2019;10:6675-89. [DOI: 10.1039/c9fo01853k] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
620 Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology. 2009;136:65-80. [PMID: 19026645 DOI: 10.1053/j.gastro.2008.10.080] [Cited by in Crossref: 806] [Cited by in F6Publishing: 708] [Article Influence: 57.6] [Reference Citation Analysis]
621 Probert F, Rice P, Scudamore CL, Wells S, Williams R, Hough TA, Cox IJ. 1 H NMR Metabolic Profiling of Plasma Reveals Additional Phenotypes in Knockout Mouse Models. J Proteome Res 2015;14:2036-45. [DOI: 10.1021/pr501039k] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
622 Anania C, Perla FM, Olivero F, Pacifico L, Chiesa C. Mediterranean diet and nonalcoholic fatty liver disease. World J Gastroenterol 2018; 24(19): 2083-2094 [PMID: 29785077 DOI: 10.3748/wjg.v24.i19.2083] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 51] [Article Influence: 14.3] [Reference Citation Analysis]
623 Rovella V, Rodia G, Di Daniele F, Cardillo C, Campia U, Noce A, Candi E, Della-Morte D, Tesauro M. Association of Gut Hormones and Microbiota with Vascular Dysfunction in Obesity. Nutrients 2021;13:613. [PMID: 33668627 DOI: 10.3390/nu13020613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
624 Kadar H, Dubus J, Dutot J, Hedjazi L, Srinivasa S, Fitch KV, Grinspoon SK, Nicholson JK, Dumas ME, Gauguier D. A multiplexed targeted assay for high-throughput quantitative analysis of serum methylamines by ultra performance liquid chromatography coupled to high resolution mass spectrometry. Arch Biochem Biophys 2016;597:12-20. [PMID: 27036856 DOI: 10.1016/j.abb.2016.03.029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
625 Yamagata H, Ikejima K, Takeda K, Aoyama T, Kon K, Okumura K, Watanabe S. Altered expression and function of hepatic natural killer T cells in obese and diabetic KK-A(y) mice. Hepatol Res 2013;43:276-88. [PMID: 22834991 DOI: 10.1111/j.1872-034X.2012.01062.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
626 Zhang M, Sun Y, Chen K, Yu N, Zhou Z, Chen L, Du Z, Li E. Characterization of the intestinal microbiota in Pacific white shrimp, Litopenaeus vannamei, fed diets with different lipid sources. Aquaculture 2014;434:449-55. [DOI: 10.1016/j.aquaculture.2014.09.008] [Cited by in Crossref: 104] [Cited by in F6Publishing: 50] [Article Influence: 13.0] [Reference Citation Analysis]
627 Srikanth CV, McCormick BA. Interactions of the intestinal epithelium with the pathogen and the indigenous microbiota: a three-way crosstalk. Interdiscip Perspect Infect Dis. 2008;2008:626827. [PMID: 19259328 DOI: 10.1155/2008/626827] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
628 Sukumaran DK, Garcia E, Hua J, Tabaczynski W, Odunsi K, Andrews C, Szyperski T. Standard operating procedure for metabonomics studies of blood serum and plasma samples using a 1H-NMR micro-flow probe. Magn Reson Chem 2009;47 Suppl 1:S81-5. [PMID: 19688872 DOI: 10.1002/mrc.2469] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
629 Abdou RM, Zhu L, Baker RD, Baker SS. Gut Microbiota of Nonalcoholic Fatty Liver Disease. Dig Dis Sci. 2016;61:1268-1281. [PMID: 26898658 DOI: 10.1007/s10620-016-4045-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
630 Gentile CL, Weir TL. The gut microbiota at the intersection of diet and human health. Science. 2018;362:776-780. [PMID: 30442802 DOI: 10.1126/science.aau5812] [Cited by in Crossref: 294] [Cited by in F6Publishing: 257] [Article Influence: 98.0] [Reference Citation Analysis]
631 Llorente C, Schnabl B. The gut microbiota and liver disease. Cell Mol Gastroenterol Hepatol 2015;1:275-84. [PMID: 26090511 DOI: 10.1016/j.jcmgh.2015.04.003] [Cited by in Crossref: 93] [Cited by in F6Publishing: 86] [Article Influence: 13.3] [Reference Citation Analysis]
632 Fonville JM, Richards SE, Barton RH, Boulange CL, Ebbels TMD, Nicholson JK, Holmes E, Dumas M. The evolution of partial least squares models and related chemometric approaches in metabonomics and metabolic phenotyping. J Chemometrics 2010;24:636-49. [DOI: 10.1002/cem.1359] [Cited by in Crossref: 101] [Cited by in F6Publishing: 52] [Article Influence: 8.4] [Reference Citation Analysis]
633 Waller-Evans H, Hue C, Fearnside J, Rothwell AR, Lockstone HE, Caldérari S, Wilder SP, Cazier JB, Scott J, Gauguier D. Nutrigenomics of high fat diet induced obesity in mice suggests relationships between susceptibility to fatty liver disease and the proteasome. PLoS One 2013;8:e82825. [PMID: 24324835 DOI: 10.1371/journal.pone.0082825] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
634 Pers T, Martin F, Verdich C, Holst C, Johansen J, Astrup A, Polak J, Martinez J, Rezzi S, Blaak E, Saris W, Kochhar S, Macdonald I, Sørensen T, Ramadan Z. Prediction of fat oxidation capacity using 1H-NMR and LC-MS lipid metabolomic data combined with phenotypic data. Chemometrics and Intelligent Laboratory Systems 2008;93:34-42. [DOI: 10.1016/j.chemolab.2008.03.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
635 Vinke PC, El Aidy S, van Dijk G. The Role of Supplemental Complex Dietary Carbohydrates and Gut Microbiota in Promoting Cardiometabolic and Immunological Health in Obesity: Lessons from Healthy Non-Obese Individuals. Front Nutr 2017;4:34. [PMID: 28791292 DOI: 10.3389/fnut.2017.00034] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
636 Brial F, Alzaid F, Sonomura K, Kamatani Y, Meneyrol K, Le Lay A, Péan N, Hedjazi L, Sato TA, Venteclef N, Magnan C, Lathrop M, Dumas ME, Matsuda F, Zalloua P, Gauguier D. The Natural Metabolite 4-Cresol Improves Glucose Homeostasis and Enhances β-Cell Function. Cell Rep 2020;30:2306-2320.e5. [PMID: 32075738 DOI: 10.1016/j.celrep.2020.01.066] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
637 Houghton D, Stewart CJ, Day CP, Trenell M. Gut Microbiota and Lifestyle Interventions in NAFLD. Int J Mol Sci. 2016;17:447. [PMID: 27023533 DOI: 10.3390/ijms17040447] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 7.8] [Reference Citation Analysis]
638 Catron TR, Gaballah S, Tal T. Using Zebrafish to Investigate Interactions Between Xenobiotics and Microbiota. Curr Pharmacol Rep 2019;5:468-80. [DOI: 10.1007/s40495-019-00203-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
639 Brown JM, Hazen SL. Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery. J Biol Chem 2017;292:8560-8. [PMID: 28389555 DOI: 10.1074/jbc.R116.765388] [Cited by in Crossref: 52] [Cited by in F6Publishing: 33] [Article Influence: 10.4] [Reference Citation Analysis]
640 Nakagawa H. Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesis. World J Hepatol 2015; 7(17): 2110-2118 [PMID: 26301053 DOI: 10.4254/wjh.v7.i17.2110] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
641 Gratz SW, Mykkanen H, El-Nezami HS. Probiotics and gut health: A special focus on liver diseases. World J Gastroenterol 2010; 16(4): 403-410 [PMID: 20101763 DOI: 10.3748/wjg.v16.i4.403] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
642 Just S, Mondot S, Ecker J, Wegner K, Rath E, Gau L, Streidl T, Hery-Arnaud G, Schmidt S, Lesker TR, Bieth V, Dunkel A, Strowig T, Hofmann T, Haller D, Liebisch G, Gérard P, Rohn S, Lepage P, Clavel T. The gut microbiota drives the impact of bile acids and fat source in diet on mouse metabolism. Microbiome 2018;6:134. [PMID: 30071904 DOI: 10.1186/s40168-018-0510-8] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 18.8] [Reference Citation Analysis]
643 Zhou L, Li X, Li S, Wen X, Peng Y, Zhao L. Relationship between dietary choline intake and diabetes mellitus in the National Health and Nutrition Examination Survey 2007-2010. J Diabetes 2021;13:554-61. [PMID: 33301237 DOI: 10.1111/1753-0407.13143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
644 Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018;15:111-128. [PMID: 29018272 DOI: 10.1038/nrgastro.2017.119] [Cited by in Crossref: 339] [Cited by in F6Publishing: 324] [Article Influence: 67.8] [Reference Citation Analysis]
645 Abdul-Hai A, Abdallah A, Malnick SD. Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease. World J Hepatol 2015; 7(12): 1679-1684 [PMID: 26140087 DOI: 10.4254/wjh.v7.i12.1679] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
646 Fitch MN, Phillippi D, Zhang Y, Lucero J, Pandey RS, Liu J, Brower J, Allen MS, Campen MJ, McDonald JD, Lund AK. Effects of inhaled air pollution on markers of integrity, inflammation, and microbiota profiles of the intestines in Apolipoprotein E knockout mice. Environ Res 2020;181:108913. [PMID: 31753468 DOI: 10.1016/j.envres.2019.108913] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
647 Yu D, Shu XO, Xiang YB, Li H, Yang G, Gao YT, Zheng W, Zhang X. Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women. J Nutr 2014;144:2034-40. [PMID: 25320186 DOI: 10.3945/jn.114.197533] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
648 Han R, Ma J, Li H. Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota. Front Med. 2018;12:645-657. [PMID: 30178233 DOI: 10.1007/s11684-018-0645-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
649 Barrea L, Annunziata G, Muscogiuri G, Di Somma C, Laudisio D, Maisto M, de Alteriis G, Tenore GC, Colao A, Savastano S. Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome. Nutrients. 2018;10. [PMID: 30551613 DOI: 10.3390/nu10121971] [Cited by in Crossref: 74] [Cited by in F6Publishing: 72] [Article Influence: 18.5] [Reference Citation Analysis]
650 Janeiro MH, Ramírez MJ, Milagro FI, Martínez JA, Solas M. Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target. Nutrients 2018;10:E1398. [PMID: 30275434 DOI: 10.3390/nu10101398] [Cited by in Crossref: 156] [Cited by in F6Publishing: 132] [Article Influence: 39.0] [Reference Citation Analysis]
651 Simmons-boyce JL, Purcell SL, Nelson CM, Mackinnon SL. Dietary Ascophyllum nodosum Increases Urinary Excretion of Tricarboxylic Acid Cycle Intermediates in Male Sprague-Dawley Rats. The Journal of Nutrition 2009;139:1487-94. [DOI: 10.3945/jn.109.107920] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
652 Willing B, Van Kessel A. Host pathways for recognition: Establishing gastrointestinal microbiota as relevant in animal health and nutrition. Livestock Science 2010;133:82-91. [DOI: 10.1016/j.livsci.2010.06.031] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
653 Fellows R, Varga-Weisz P. Chromatin dynamics and histone modifications in intestinal microbiota-host crosstalk. Mol Metab 2020;38:100925. [PMID: 31992511 DOI: 10.1016/j.molmet.2019.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
654 He J, Chen J, Wu L, Li G, Xie P. Metabolic Response to Oral Microcystin-LR Exposure in the Rat by NMR-Based Metabonomic Study. J Proteome Res 2012;11:5934-46. [DOI: 10.1021/pr300685g] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
655 Cronin M, Ventura M, Fitzgerald GF, van Sinderen D. Progress in genomics, metabolism and biotechnology of bifidobacteria. Int J Food Microbiol 2011;149:4-18. [PMID: 21320731 DOI: 10.1016/j.ijfoodmicro.2011.01.019] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
656 Erickson ML, Malin SK, Wang Z, Brown JM, Hazen SL, Kirwan JP. Effects of Lifestyle Intervention on Plasma Trimethylamine N-Oxide in Obese Adults. Nutrients 2019;11:E179. [PMID: 30654453 DOI: 10.3390/nu11010179] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
657 Schlecht I, Gronwald W, Behrens G, Baumeister SE, Hertel J, Hochrein J, Zacharias HU, Fischer B, Oefner PJ, Leitzmann MF. Visceral adipose tissue but not subcutaneous adipose tissue is associated with urine and serum metabolites. PLoS One 2017;12:e0175133. [PMID: 28403191 DOI: 10.1371/journal.pone.0175133] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
658 El Aidy S, Stilling R, Dinan TG, Cryan JF. Microbiome to Brain: Unravelling the Multidirectional Axes of Communication. Adv Exp Med Biol 2016;874:301-36. [PMID: 26589226 DOI: 10.1007/978-3-319-20215-0_15] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
659 Lees HJ, Swann JR, Poucher S, Holmes E, Wilson ID, Nicholson JK. Obesity and Cage Environment Modulate Metabolism in the Zucker Rat: A Multiple Biological Matrix Approach to Characterizing Metabolic Phenomena. J Proteome Res 2019;18:2160-74. [PMID: 30939873 DOI: 10.1021/acs.jproteome.9b00040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
660 Campo L, Eiseler S, Apfel T, Pyrsopoulos N. Fatty Liver Disease and Gut Microbiota: A Comprehensive Update. J Clin Transl Hepatol. 2019;7:56-60. [PMID: 30944821 DOI: 10.14218/jcth.2018.00008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 4.8] [Reference Citation Analysis]
661 Wieland A, Frank DN, Harnke B, Bambha K. Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2015;42:1051-1063. [PMID: 26304302 DOI: 10.1111/apt.13376] [Cited by in Crossref: 102] [Cited by in F6Publishing: 97] [Article Influence: 14.6] [Reference Citation Analysis]
662 Shenderov BA. Gut indigenous microbiota and epigenetics. Microb Ecol Health Dis. 2012;23. [PMID: 23990811 DOI: 10.3402/mehd.v23i0.17195] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
663 Huang W, Metlakunta A, Dedousis N, Zhang P, Sipula I, Dube JJ, Scott DK, O'Doherty RM. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes. 2010;59:347-357. [PMID: 19934001 DOI: 10.2337/db09-0016] [Cited by in Crossref: 310] [Cited by in F6Publishing: 306] [Article Influence: 23.8] [Reference Citation Analysis]
664 Nagatomo Y, Tang WH. Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis. J Card Fail 2015;21:973-80. [PMID: 26435097 DOI: 10.1016/j.cardfail.2015.09.017] [Cited by in Crossref: 99] [Cited by in F6Publishing: 81] [Article Influence: 14.1] [Reference Citation Analysis]
665 Tian N, Wang J, Wang P, Song X, Yang M, Kong L. NMR-based metabonomic study of Chinese medicine Gegen Qinlian Decoction as an effective treatment for type 2 diabetes in rats. Metabolomics 2013;9:1228-42. [DOI: 10.1007/s11306-013-0535-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
666 Feng J, Liu H, Zhang L, Bhakoo K, Lu L. An insight into the metabolic responses of ultra-small superparamagnetic particles of iron oxide using metabonomic analysis of biofluids. Nanotechnology 2010;21:395101. [DOI: 10.1088/0957-4484/21/39/395101] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
667 Nicholson G, Rantalainen M, Li JV, Maher AD, Malmodin D, Ahmadi KR, Faber JH, Barrett A, Min JL, Rayner NW, Toft H, Krestyaninova M, Viksna J, Neogi SG, Dumas ME, Sarkans U, Donnelly P, Illig T, Adamski J, Suhre K, Allen M, Zondervan KT, Spector TD, Nicholson JK, Lindon JC, Baunsgaard D, Holmes E, McCarthy MI, Holmes CC; MolPAGE Consortium. A genome-wide metabolic QTL analysis in Europeans implicates two loci shaped by recent positive selection. PLoS Genet 2011;7:e1002270. [PMID: 21931564 DOI: 10.1371/journal.pgen.1002270] [Cited by in Crossref: 106] [Cited by in F6Publishing: 92] [Article Influence: 9.6] [Reference Citation Analysis]
668 Holmes E, Nicholson J. Human Metabolic Phenotyping and Metabolome Wide Association Studies. In: Kroemer G, Mumberg D, Keun H, Riefke B, Steger-hartmann T, Petersen K, editors. Oncogenes Meet Metabolism. Berlin: Springer Berlin Heidelberg; 2008. pp. 227-49. [DOI: 10.1007/2789_2008_096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
669 Gowda GA, Zhang S, Gu H, Asiago V, Shanaiah N, Raftery D. Metabolomics-based methods for early disease diagnostics. Expert Rev Mol Diagn 2008;8:617-33. [PMID: 18785810 DOI: 10.1586/14737159.8.5.617] [Cited by in Crossref: 397] [Cited by in F6Publishing: 354] [Article Influence: 30.5] [Reference Citation Analysis]
670 Holmes E, Li JV, Athanasiou T, Ashrafian H, Nicholson JK. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol. 2011;19:349-359. [PMID: 21684749 DOI: 10.1016/j.tim.2011.05.006] [Cited by in Crossref: 327] [Cited by in F6Publishing: 281] [Article Influence: 29.7] [Reference Citation Analysis]
671 Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S. Host-gut microbiota metabolic interactions. Science. 2012;336:1262-1267. [PMID: 22674330 DOI: 10.1126/science.1223813] [Cited by in Crossref: 2386] [Cited by in F6Publishing: 2100] [Article Influence: 238.6] [Reference Citation Analysis]
672 Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis. 2015;26:26191. [PMID: 25651997 DOI: 10.3402/mehd.v26.26191] [Cited by in Crossref: 377] [Cited by in F6Publishing: 441] [Article Influence: 53.9] [Reference Citation Analysis]
673 Hussey S, Bergman M. The Gut Microbiota and Effects on Metabolism. Pathobiology of Human Disease. Elsevier; 2014. pp. 508-26. [DOI: 10.1016/b978-0-12-386456-7.02009-8] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
674 Gao T, Wang Z, Dong Y, Cao J, Lin R, Wang X, Yu Z, Chen Y. Role of melatonin in sleep deprivation-induced intestinal barrier dysfunction in mice. J Pineal Res 2019;67:e12574. [PMID: 30929267 DOI: 10.1111/jpi.12574] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 9.7] [Reference Citation Analysis]
675 Collino S, Martin FP, Kochhar S, Rezzi S. Monitoring healthy metabolic trajectories with nutritional metabonomics. Nutrients 2009;1:101-10. [PMID: 22253970 DOI: 10.3390/nu1010101] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
676 Muscogiuri G, Cantone E, Cassarano S, Tuccinardi D, Barrea L, Savastano S, Colao A; on behalf of the Obesity Programs of nutrition, Education, Research and Assessment (OPERA) group. Gut microbiota: a new path to treat obesity. Int J Obes Suppl 2019;9:10-9. [PMID: 31391921 DOI: 10.1038/s41367-019-0011-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 24.0] [Reference Citation Analysis]
677 Yan S, Zhao G, Liu X, Zhao J, Zhang H, Chen W. Production of exopolysaccharide by Bifidobacterium longum isolated from elderly and infant feces and analysis of priming glycosyltransferase genes. RSC Adv 2017;7:31736-44. [DOI: 10.1039/c7ra03925e] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 2.4] [Reference Citation Analysis]
678 Xu J, Chen HB, Li SL. Understanding the Molecular Mechanisms of the Interplay Between Herbal Medicines and Gut Microbiota. Med Res Rev. 2017;37:1140-1185. [PMID: 28052344 DOI: 10.1002/med.21431] [Cited by in Crossref: 116] [Cited by in F6Publishing: 114] [Article Influence: 23.2] [Reference Citation Analysis]
679 Tang WH, Hazen SL. The contributory role of gut microbiota in cardiovascular disease. J Clin Invest 2014;124:4204-11. [PMID: 25271725 DOI: 10.1172/JCI72331] [Cited by in Crossref: 364] [Cited by in F6Publishing: 209] [Article Influence: 45.5] [Reference Citation Analysis]
680 Bervoets L, Massa G, Guedens W, Louis E, Noben JP, Adriaensens P. Metabolic profiling of type 1 diabetes mellitus in children and adolescents: a case-control study. Diabetol Metab Syndr 2017;9:48. [PMID: 28674557 DOI: 10.1186/s13098-017-0246-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
681 Plaza A, Antonazzi M, Blanco-Urgoiti J, Del Olmo N, Ruiz-Gayo M. Potential Role of Leptin in Cardiac Steatosis Induced by Highly Saturated Fat Intake during Adolescence. Mol Nutr Food Res 2019;63:e1900110. [PMID: 31298470 DOI: 10.1002/mnfr.201900110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
682 Zhou J, Yue S, Peng Q, Wang L, Wang Z, Xue B. Metabonomic Responses of Grazing Yak to Different Concentrate Supplementations in Cold Season. Animals (Basel) 2020;10:E1595. [PMID: 32911680 DOI: 10.3390/ani10091595] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
683 Chang CC, Wu CL, Su WW, Shih KL, Tarng DC, Chou CT, Chen TY, Kor CT, Wu HM. Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease. Sci Rep 2015;5:10096. [PMID: 25961500 DOI: 10.1038/srep10096] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
684 Marques TM, Wall R, Ross RP, Fitzgerald GF, Ryan CA, Stanton C. Programming infant gut microbiota: influence of dietary and environmental factors. Curr Opin Biotechnol. 2010;21:149-156. [PMID: 20434324 DOI: 10.1016/j.copbio.2010.03.020] [Cited by in Crossref: 191] [Cited by in F6Publishing: 171] [Article Influence: 15.9] [Reference Citation Analysis]
685 Jiménez B, Abellona U MR, Drymousis P, Kyriakides M, Clift AK, Liu DSK, Rees E, Holmes E, Nicholson JK, Kinross JM, Frilling A. Neuroendocrine Neoplasms: Identification of Novel Metabolic Circuits of Potential Diagnostic Utility. Cancers (Basel) 2021;13:374. [PMID: 33498434 DOI: 10.3390/cancers13030374] [Reference Citation Analysis]
686 Cazier J, Kaisaki PJ, Argoud K, Blaise BJ, Veselkov K, Ebbels TMD, Tsang T, Wang Y, Bihoreau M, Mitchell SC, Holmes EC, Lindon JC, Scott J, Nicholson JK, Dumas M, Gauguier D. Untargeted Metabolome Quantitative Trait Locus Mapping Associates Variation in Urine Glycerate to Mutant Glycerate Kinase. J Proteome Res 2012;11:631-42. [DOI: 10.1021/pr200566t] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
687 Dumas M. Metabolome 2.0: quantitative genetics and network biology of metabolic phenotypes. Mol BioSyst 2012;8:2494. [DOI: 10.1039/c2mb25167a] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
688 Wang M, Zhang X, Wang Y, Li Y, Chen Y, Zheng H, Ma F, Ma CW, Lu B, Xie Z, Liao Q. Metabonomic strategy for the detection of metabolic effects of probiotics combined with prebiotic supplementation in weaned rats. RSC Adv 2018;8:5042-57. [DOI: 10.1039/c7ra12067b] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
689 Bu Q, Yan G, Deng P, Peng F, Lin H, Xu Y, Cao Z, Zhou T, Xue A, Wang Y, Cen X, Zhao YL. NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration. Nanotechnology 2010;21:125105. [PMID: 20203358 DOI: